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Our ability to read and write DNA is fundamental for understanding Biology. While the
past decade has brought about exponential improvements in our DNA sequencing and synthesis
capabilities, major challenges remain. First, many DNA sequencers are hindered by their short
read lengths, which has hindered genome assemblies, molecular haplotyping, and more recently,
multiplexed functional assays. Synthetic Long Reads (SLRs) are a recently developed method that
address this issue. SLRs leverage molecular barcodes to guide the computational reassembly of
multiple short reads into a longer contiguous molecule. Here we present a novel SLR technology,
BAGEL-seq, that can theoretically sequence molecules up to ∼40 kb, and achieve read lengths of ∼1
kb in a proof-of-principle experiment. Second, large-scale synthesis of gene-length, synthetic DNA is
cost-prohibitive for many research applications. We present two complementary methods to address
this limitation – one to quantify errors in synthetic gene constructs using next-generation sequencing
(NGS), and another, DropSynth, to synthesize > 10, 000 ∼1 kb genes using emulsions and DNA
microarrays. Despite these limitations, researcher have recently leveraged DNA sequencing and
synthesis to test the functional effects of thousands of variants in multiplex. Known as multiplexed
functional assays (MFAs), these experiments have revolutionized the investigation of biological
processes across the Central Dogma. In this dissertation we present three different MFAs. In the first,
we used DropSynth to build homologogs of an essential E. coli protein, and tested their function in
a complimentation assay. In the second, we measured the response of 39 murine olfactory receptors
against hundreds of different odorants. Lastly, we assessed the effects of ∼7,800 single amino acid
changes to the β2-adrenergic receptor in the presence of increasing agonist concentration. Taken
together, this dissertation represents a fundamental improvement in our ability to read and write
ii
DNA, and pushes the state of the art in combining these technologies for large-scale, multiplexed
experiments.
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1.1 The cost of DNA Sequencing and Synthesis is decreasing exponentially. The
advent of Next-generation Sequencing in 2005 resulted in ∼ 106-fold decrease in price in
10 years. Prices are reported per base sequenced or synthesized. At the time of writing
(November, 2018) the price per base of microarray-base oligos is approximately $10−4 − 10−5
(data not shown). Figure c©Bioeconomy Capital http://www.bioeconomycapital.com/
bioeconomy-dashboard/ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2 Typical gene synthesis workflow. An oligo library that tiles the gene of interest are
synthesized and optionally purified. Using polymerase cycling assembly (PCA), overlapping
oligos anneal together and the gaps are filled by a polymerase. After PCA, the full length
product is amplified by PCR and optionally subjected to a round of error correction. Finally,
the synthetic gene is cloned and verified by Sanger Sequencing. c©atdbio https://www.
atdbio.com/content/63/Gene-synthesis . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.3 Typical dilution-based SLR overview. In a dilution-based SLR, or haplotyping experi-
ment, molecules of interest are diluted and amplified in 96- or 384-well plates. The dilution
ensures sufficient diversity within each well and that haploids remain separated. The molecules
are then fragmented and tagged (tagmented) with a unique barcode for each well. After
sequencing, these barcodes are used to reassemble the molecules within each well. Due to the
diversity of each well, it is unlikely, but not impossible that reads from one molecule could be
incorrectly assigned to a different molecule. . . . . . . . . . . . . . . . . . . . . . . . . . 6
ix
1.4 Overview of a hypothetical multiplexed functional assay (MFA). In this MFA, the
activity of a given variant in the library is linked to a genetic reporter through a molecular
barcode. Agonist stimulation of the expressed variant results in a signalling cascade that
activates the transcription of its unique barcode. The level of activity can then be quantified
by measuring the expression of the barcode with RNA-seq . . . . . . . . . . . . . . . . . . 7
2.1 Dilution-limited haplotyping overview. Current methods rely on various techniques to
separate long pieces of DNA into various compartments, where they are amplified, barcoded,
and prepared for NGS. A. Historically, most haplotyping libraries were generated with
fosmids. Briefly, genomic DNA is sheared and ligated with a fosmid backbone. Phages then
package the ∼40 kb molecules and infect E. coli. The resulting library is diluted and grown in
96-well plates to amplify the selected DNA (purple and blue). B. Alternatively, the sheared
genomic DNA can be diluted and amplified in vitro with multiple displacement amplification.
The resulting product is then sheared and prepared for sequencing. C. Recently, a number
of droplet-based technologies have been developed that obviate cumbersome plate-based
protocols. These techniques separate the sheared genomic DNA into droplets containing Tn5
conjugated to beads, and perform an in-droplet tagmentation reaction. . . . . . . . . . . . 19
2.2 General overview of BAGEL-seq. In the current iteration, we first clone a sequence of
interest into a backbone containing a sequencing primer (purple), a unique barcode (blue),
and a LoxP site. Next, we use dilute amounts of Tn5 transposase to randomly insert a single
copy of a complimentary LoxP site on average throughout our sequence of interest. These
LoxP sites will be inserted either in cis (left), trans (right), or not at all (middle). Next we
dilute the sample and use Cre recombinase to perform intramolecular recombination between
the two LoxP sites. This brings our sequencing primer and barcode adjacent to wherever Tn5
inserted the second LoxP site. Importantly, both excision (left) and inversion (right) result in
readable sequence (orange). Finally, we tagment the products with Nextera and use PCR to
amplify our sequences of interest. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
x
2.3 Illustration of BAGEL-seq primer walking. Here, Tn5 has inserted LoxP sites at
different locations in three copies of the same sequence. After Cre recombination, the
sequencing primer (purple) is brought adjacent to wherever the second LoxP site was inserted.
In addition, the sequencing primer reads through the barcode, maintaining the one-to-one
linkage between barcode and molecule throughout the process. Lastly, the barcode enables
reconstruction of the individual molecules by in silico. . . . . . . . . . . . . . . . . . . . . 24
2.4 In vitro validation of BAGEL-seq steps. A. Serial dilution of Tn5 insertion with either
full-length LoxP or Y-adapter LoxP. A supercoiled (−) and linearized (+) plasmid are provided
for reference. At low concentration, both full-length LoxP and Y-adapter LoxP insertions
linearize the plasmid. However, the full-length LoxP does not fragment the plasmid at higher
concentrations and even has high-molecular weight species. This suggests that Tn5 insertion
is not proceeding properly. B. Cre recombination control. The NEB control plasmid with
two LoxP sites behaves as expected upon incubation with Cre (+). Similarly, a plasmid
containing one Lox71 and two Lox67 sites recombines upon Cre addition regardless if it is
supercoiled or linearized. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.5 BAGEL-seq preliminary results. A. Coverage of the top 5 most abundant barcodes. We
see that reads are randomly distributed throughout the plasmid, albiet with some biases
for specific positions. B. Overall coverage of the target plasmid combining all of the SLRs.
Again, we find significant bias for a few positions on the plasmid. Due to the low diversity of
the input DNA, this could be a result of Tn5’s insertion bias. C. Length distribution of SLRs.
We find the majority of SLRs are shorter than the maximum 300 bp (red line) possible with
paired 150 nt reads. However, this implies that we over-fragemented our input DNA before
sequencing. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
xi
3.1 Schematic of Enzymatic Error Correction and Downstream Data Processing. We
assembled our 142 bp product from two 113 nt oligos consisting of a 21 nt primer, a 64 nt
payload, and a 28 nt overlap region. After annealing and overlap extension, we amplified
our template via PCR, yielding 100 bp of template in-between the primer sites. We then
denatured and re-annealed the PCR products to form heteroduplexes, thereby exposing any
errors (shown in green). After, we subjected the pool of heteroduplexes to two successive
rounds of ten different enzymatic error correction treatments. At each step, we took aliquots
and sequenced the products on an Illumina MiSeq with fully overlapping forward and reverse
reads. To mitigate sequencing errors, we used BBMerge to merge reads with a perfect
agreement between the forward and reverse reads. We then aligned these sequences to the
designed reference using an exhaustive Neeleman-Wunsch aligner to minimize alignment
artifacts. Finally, we further processed the alignments to quantitate the types and extent of
different errors across all conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3.2 Analysis of Model Gene Assembly Error Rates. A. The error rates per base are
plotted across each position in our model separated by the four major classes of error types.
We do not see strong positional effects for errors across the template. B. We find a majority
of errors on the template are mismatches (MM), followed by single (Del.) and multiple base
(M. Del.) deletions; Single (Ins.) and multiple base (M. Ins.) insertions occur at even lower
frequencies. C. There are no significant differences between the median rate ofmismatches at
any base (Mann-Whitney U, NS). D. Similarly, there are no significant differences between
transitions and transversions (Mann-Whitney U, NS), implying that the errors were doped
uniformly into our oligos. Note: Blue line is a LOESS fit; box plots are first and third
quartile for hinges, median for bar, and 1.5× the inter-quartile range for whiskers. . . . . . 44
xii
3.3 Effectiveness of Enzymatic Error Correction Methods. Here we compare the error
frequency (errors/kb) and number of perfect assemblies for ten different enzymatic error
correction methods. We find that MutS is the most effective enzyme at increasing the
percentage of perfect assemblies. However, ErrASE is the most effective at decreasing error
frequency. Additionally, we see that the efficacy of T7 Endonuclease I is dependent on
protocol, and that the addition of a ligase had detrimental effects on sequence quality. Note:
the x-axis is ordered by decreasing number of perfect assemblies. . . . . . . . . . . . . . . 45
3.4 Relative Decrease of Different Error Types. A. All enzymes were able to correct
both single- and multiple-base insertions and deletions. Additionally, we find that the best
performing enzymes corrected the highest amount of mismatches. Note: the x-axis is ordered
by increasing error frequency. B. We measure significant differences between the median
decrease in C/G → G/C mismatches and the bulk median of all other mismatches after two
treatments of ErrASE. Similarly, two treatments of T7 Endonuclease I results in a significant
difference between the median decrease in A/T → T/A mismatches compared to the bulk
median of all other mismatches (both Mann-Whitney U, p << 0.001). . . . . . . . . . . . 47
3.5 Effect of Polymerase on Assembly Quality. We assembled two different 220 bp con-
structs (C1 and C2) from five 60 nt oligos with 20 bp overlaps with Q5 and Taq polymerase.
A. We used our method to compare the error frequency (errors per kb) and percent perfect
assemblies. We see that the average error frequency for both constructs is significantly
higher for Taq than for Q5 (9.7 vs 2.5 errors/kb). We observe similar trends for the average
percentage of perfect assembiles (60.5% for Q5 and 10.4% for Taq). B. Similar to the two-oligo
assembly, we find that the Taq-based KAPA2G Robust polymerase also has a higher rate of
transitions than transversions (mean of 5.32 × 10−5 vs. 6.40 × 10−6 over both constructs;
Mann-Whitney U, p << 0.001). C. We find that the median rate of multiple base deletions
per base in the overlap regions decreased ∼2-fold relative to non-overlapping regions for both
polymerases (Mann-Whitney U, p << 0.001). Similarly, the median rate of multiple base
deltions per base also significantly decreases in the priming regions for both Taq (∼6-fold)
and Q5 (∼13-fold) for both constructs (both Mann-Whitney U, p << 0.001). The difference
in decrease between the polymerases was not significant. . . . . . . . . . . . . . . . . . . . 49
xiii
3.6 Effect of read aligner on error rates. Here we mapped reads from the standard IDT
oligo with BBMap (red), Bowtie2 (green), and our Needleman-Wunsch aligner (blue), and
quantified the error rates with our pipeline. We see that the choice of aligner affects the
resulting error rates, especially for detecting multiple-base deletions. . . . . . . . . . . . . 63
3.7 Distributions of error rates per position for the standard oligo assembly before
and after ErrASE treatment. We were unable to detect a significant change between the
median error rate after two treatments for mismatches. Note: black bar is median value. . 64
3.8 In-depth analysis of standard assemblies. A) The error rates per base are plotted
across each position in our model separated by the four major classes of error types. We
do not see strong positional effects for errors across the template. B) We find a majority
of errors on the template are mismatches (MM), followed by single (Del.) and multiple
base (M. Del.) deletions; Single (Ins.) and multiple base (M. Ins.) insertions occur at even
lower frequencies. (C) We measure a significantly higher mismatch rate at A’s (4.33× 10−3)
and T’s (4.25× 10−3) than at G’s (1.68× 10−3) and C’s (1.91× 10−3) (Mann-Whitney U,
p << 0.001). (D) We measure a significantly higher number of transitions (purple) than
transversions (green) at each base (Mann-Whitney U, p << 0.001). The higher error rates at
A’s and T’s is consistent with Taq polymerase errors. Note: Blue line is a LOESS fit; box
plots are first and third quartile for hinges, median for bar, and 1.5× the inter-quartile range
for whiskers. Note: here we performed the same analysis as Figure 2 in the main text with
the error-doped assembly. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
3.9 Comparison of measured error rates from error-doped and standard oligos. Here
we plot the distribution of error rates per position and see that for every error sub-type the
error rates are significantly higher for the error-doped oligos than those produced by the
standard process (Mann-Whitney U Test, all p << 0.001). Note: Black bar is the median
value. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
3.10 Mismatch correction preferences relative to the error-doped oligo for every en-
zyme across two consecutive treatments. Error rates are plotted as the log2-fold-change
in error rate relative to the error-doped template. Note: box plots are first and third quartile
for hinges, median for bar, and 1.5× the inter-quartile range for whiskers. . . . . . . . . . . 67
xiv
3.11 Single-base deletion correction preferences relative to the error-doped oligo for
every enzyme across two consecutive treatments. Error rates are plotted as the log2-
fold-change in error rate relative to the error-doped template. Note: box plots are first and
third quartile for hinges, median for bar, and 1.5× the inter-quartile range for whiskers. . . 68
3.12 Single-base insertion correction preferences relative to the error-doped oligo for
every enzyme across two consecutive treatments. Error rates are plotted as the log2-
fold-change in error rate relative to the error-doped template. Note: box plots are first and
third quartile for hinges, median for bar, and 1.5× the inter-quartile range for whiskers. . . 69
3.13 Correlations between error rates for five-oligo assembly technical replicates. We
see that technical replicates are almost perfectly correlated (all r > 0.995), with the black
line being y = x. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
3.14 Positional error rate distributions two assemblies using KAPA2G Robust and
Q5 polymerase. We see that KAPA2G Robust, a Taq-based low-fidelity polymerase,
incorporates Mismatches (MM) at nearly two-orders of magnitude higher than Q5, a high-
fidelity polymerase. We find that both polymerases incorporate single base deletions (Del.),
multiple base deletions (M. Del.), single base insertions (Ins.), and multiple base insertions (M.
Ins.) at nearly identical rates. With the exception of multiple base insertions, these trends
are robust to the different sequence contexts of the two constructs. We note that KAPA2G
Robust incorporates a higher number of multiple base insertions around three tandem GGA
repeats, likely due to polymerase slippage. . . . . . . . . . . . . . . . . . . . . . . . . . . 71
xv
4.1 DropSynth assembly and optimization. A. We amplified array-derived oligos and
exposed a single-stranded region that acts as a gene-specific microbead barcode. Barcoded
beads display complementary single-stranded regions that selectively pull down the oligos
necessary to assemble each gene. The beads are then emulsified, and the oligos are assembled
by PCA. The emulsion is then broken, and the resultant assembled genes are barcoded and
cloned. B. We used a model gene library that allowed us to monitor the level of specificity
and coverage of the assembly process. We then optimized various aspects of the protocol
including purification steps, DNA ligase, and bead couplings to improve the specificity of
the assembly reaction. Enrichment is defined as the number of specific assemblies observed
relative to what would be observed by random chance in a full combinatorial assembly. C. We
attempted 96-plex gene assemblies with 3, 4, 5, or 6 oligonucleotides and the resultant libraries
displayed the correct-sized band on an agarose gel. D. The distribution of read-counts for all
96 assemblies (4-oligo assembly) as determined by NGS. . . . . . . . . . . . . . . . . . . . 80
4.2 DropSynth assembly of 10,752 genes. A. We used DropSynth to assemble 28 libraries
of 10,752 genes representing 1,152 homologs of PPAT and 4,992 homologs of DHFR. The
number of library members with at least one perfect assembly and the median percent perfects
determined using constructs with at least 100 barcodes is shown for each library. B. We
observe that 872 PPAT homologs (75%) had at least one perfect assembly, and 1,002 homologs
(87%) had at least one assembly within a distance of 5 a.a. from design. C. We assembled
two codon variants for each designed DHFR homolog, allowing us to achieve higher coverage. 82
xvi
4.3 PPAT complementation assay. A. We used DropSynth to assemble a library of 1152
homologs of phosphopantetheine adenylyltransferase (PPAT), an essential enzyme catalyzing
the second-to-last step in coenzyme A biosynthesis, and functionally characterized them using
a pooled complementation assay. The barcoded library was transformed into E. coli ∆coaD
cells containing a curable rescue plasmid expressing E. coli coaD. The rescue plasmid was
removed allowing the homologs and their mutants to compete with each other in a batch
culture. We tracked assembly barcode frequencies over four serial 1000-fold dilutions, and
used the frequency changes to assign a fitness score. B. This phylogenetic tree shows 451
homologs each with at least 5 assembly barcodes, a subset of the full data set, where leaves
are colored by fitness. Despite having a median 50% sequence identity, we find that the
majority of PPAT homologs are able to complement the function of the native E. coli PPAT,
with 70% having positive fitness values, while low-fitness homologs are dispersed throughout
the tree without much clustering of clades. . . . . . . . . . . . . . . . . . . . . . . . . . . 84
xvii
4.4 Broad mutational scanning (BMS) analysis. A. The fitness landscape of 497 comple-
menting PPAT homologs and their 71,061 mutants (within a distance of 5 a.a.) is projected
onto the E. coli PPAT sequence, with each point in the heatmap showing the average fitness
over all sequences containing that amino acid at each aligned position. Mutations are highly
constrained at a core group of residues involved in catalytic function. Other positions show rel-
atively little loss of function, when averaged over many homologs, despite known interactions
with the substrates. The E. coli WT sequence is indicated by green squares, while the average
position fitness, fitness of a residue deletion, mean EVmutation evolutionary statistical energy
[20], site conservation, relative solvent accessibility, and secondary structure information is
shown above.B. The average fitness at each position, with blue and red representing low and
high fitness respectively, overlaid on the E. coli PPAT (PDB: 1QJC, 1GN8 [21]) structure
complexed with 4’-phosphopantetheine and ATP. We observe loss-of-function for mutations
occurring at the active site, while other residues involved with allosteric regulation by coen-
zyme A or dimer interfaces show large promiscuity, highlighting different strategies employed
among homologs. C. In addition to complementing homologs, we can also analyze mutants
of the 129 low-fitness (< -2.5) homologs, finding 385 gain-of-function (GoF) mutants across
55 homologs. We project this data onto the E. coli PPAT sequence and plot the number of
GoF mutants at each position shaded by the number of different homologs represented. We
find a total of 8 statistically significant positions (residues: 34, 35, 64, 68, 69, 103, 134, 135)
corresponding to four regions in the PPAT structure. . . . . . . . . . . . . . . . . . . . . 86
4.5 The histogram of read distributions for six of the 96-plex 4-oligo assemblies
shown in Fig 1B. A. T7 ligase and 20 ug beads. B. T4 and 20 ug beads. C. Taq ligase
and 20 ug beads. D. T7 ligase and 100 ug beads. E. T4 ligase and 100 ug beads. F. Taq
ligase and 100 ug beads. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
4.6 A. A maximum likelihood phylogenetic tree for all 1,152 PPAT homologs as well as E. coli
MG1655. Color scale represents percent amino acid sequence identity relative to E. coli PPAT
(NP_418091.1). B. The gene length distribution for the 5,775 DHFR homologs assembled
using either four or five 230-mer oligos with median gene lengths of 489 bp and 564 bp
respectively. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
xviii
4.7 A. Histogram of protein sequence lengths for all 1,152 PPAT library members. Lengths do
not include start or stop codon. The longest, shortest, and median lengths are 516, 381,
and 483 bp respectively. B. Although they share the same function, PPAT homologs have
evolutionarily divergent sequences. The 662,976 pairwise percentage identities between the
1,152 members of the PPAT library at the amino acid level have a distribution with a median
of 50% (σ = 5%). C. Without oligo isolation, amplification in bulk fails to produce the
correct product [11]. A 4% agarose gel comparing the assembly products of a 24-member
library of PPAT homologs (120 oligos) when the polymerase cycling assembly is done in bulk
(BA) and in emulsion (EA). The expected product size upon correct assembly is between 520
bp to 550 bp. D. Each of the three 384-member PPAT libraries (1,920 oligos each) produced
correct assembly products. A 4% agarose gel showing amplified assembly products, with the
expected size for most amplicons around ∼530 bp. Lane 1 and 2: High- and low-template
PCR products for Lib 1. Lane 4 and 5: High- and low-template PCR products for Lib 2.
Lane 7 and 8: High- and low-template PCR products for Lib 3. High- and low-template
concentrations refer to either 2 uL or 0.2 uL of the purified assembly products from an
emulsion used in a 50 uL PCR reaction. . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
4.8 Agilent TapeStation gel image of DropSynth assembly of 28 384-member libraries
of DHFR. A total of 3 libraries of length 610bp (14, 15, 29) are assembled using 5 oligos
while the remaining libraries of length 510bp are assembled using 4 oligos. Another 2 libraries
(13, 30) are not shown with one having low yield on the oligo processing steps and another
failing to amplify at the oligo stage. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
4.9 Agilent TapeStation gel image of 25 4-oligo DHFR libraries after assembly, di-
gestion, ligation into barcoded plasmid and library preparation for sequencing.
5-oligo libraries (14, 15, 29) were not prepared for sequencing due to limitations on Illumina
read length capabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
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4.10 Sequencing statistics from sample S0. These data are a set of paired end 600-cycle
Miseq runs which read through the entire assembled gene and its assembly barcode for all
three 384-member libraries. A. The number of reads per assembly barcode, with a median
value of 2. S0 contains 7,038,274 unique assembly barcodes across 20,263,445 reads. Of these,
209,868 assembly barcodes 2.98% (739,771 reads 3.65%) mapped to the designed protein
sequences without any amino acid mutations, of which 199,208 assembly barcodes contained
at least one synonymous mutation. A total of 2,982,539 (42%) of the mapped assembly
barcodes correspond to sequences containing a premature stop codon in the reading frame, of
which the large majority (2,404,348) were due to indel mutations causing a frameshift while
the rest were due to nonsense mutations. B. The long tail distribution of assembly barcodes
per homolog, for assembly barcodes mapped to a perfect sequence. Median value is 56 and a
total of 872 out of 1152 homologs are represented with at least one assembly barcode. C. The
percentage of perfect protein sequences for constructs with at least 100 assembly barcodes.
The solid line is the median value of 1.9%. D. Individually rank-ordered plots showing the
number of barcodes with perfect assemblies, barcodes with assemblies within distance of 2
a.a., and all barcodes with an aligned homolog. E. The distribution of sequencing reads for
the PPAT libraries. F. The coverage of the PPAT homologs as a function of the minimum
percent identity. Most of the library members have assemblies with high identity to the
respective designed homologs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
4.11 A. The library coverage shows strong correlation (ρ=0.73 (Pearson), p-value=3.4E-5) with
the amount of DNA used to load the DropSynth beads prior to assembly. The coverage is
defined as the number constructs with at least one perfect assembly. B. The number of
constructs with the same barcode which dropout among different libraries. The red line is the
level with an expectation value close to one for libraries of size 384 given a uniform dropout
distributions. Values above this line are higher than would be expected by chance. About a
dozen barcodes fall in this region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
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4.12 DropSynth assembly of 10,752 genes. We used DropSynth to assemble 28 libraries of
10,752 genes representing 1,152 homologs of PPAT and 4,992 homologs of DHFR. The number
of barcodes per million representing assemblies within 5 a.a. of each gene is shown alongside
the number of library members with at least one perfect assembly and the percent perfects
determined using constructs with at least 100 barcodes. . . . . . . . . . . . . . . . . . . . 118
4.13 A. The expected percentage of perfect assemblies for a given number of oligos and the amount
of perfect oligos. B. The maximum gene assembly length possible for a given number of
oligos and an oligo size ranging from (200 to 300bp). . . . . . . . . . . . . . . . . . . . . 119
4.14 Error analysis of DropSynth Assemblies. Using the error analysis pipeline developed by
Lubock et. al [16], we randomly sampled one million reads from Miseq paired-end 600-cycle
assembly barcode mapping data, performed an exhaustive alignment of each read against
every perfect assembly and returned the best scoring alignment. A. Mismatches are the
most common form of error, followed by multiple base deletions, single base deletions, and
single base insertions. In particular, mismatches appear to be localized to the overlap regions.
B. Raw counts of mismatches. A higher number of transitions than transversions were
measured - in agreement with previous experiments where Taq-mediated amplification errors.
This suggests that the majority of mismatches were likely introduced by KAPA2G Robust
polymerase during assembly (evolved Taq variant). . . . . . . . . . . . . . . . . . . . . . 120
4.15 Phosphopantetheine adenylyltransferase (PPAT) metabolic pathway. PPAT shown
in red, catalyzes the second to last step in the five step biosynthesis of coenzyme A. It produces
dephospho-coenzyme A from 4’-phosphopantetheine by transferring a adenylyl group from
ATP [17], as shown. Either Mn2+ or Mg2+ acts as a cofactor. E. coli PPAT is hexameric and
encoded by the 477 bp gene coaD. Several gene knockout [44, 45] and genetic footprinting
[46] studies have confirmed coaD to be essential for growth on rich media in E. coli K-12
strains MC1061, MG1655, and DH10β. Both coenzyme A and dephospho-coenzyme A act
as inhibitors of the forward reaction. PPAT’s low homology to its mammalian counterpart,
which is encoded as one of the two domains on the bifunctional CoASy (CoA Synthase)
enzyme, makes it a potential target for new antimicrobials [18]. At least a dozen different
PPAT homologs have crystal structure data available. . . . . . . . . . . . . . . . . . . . . 121
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4.16 A. Rescue plasmid pTKcoaD allows λ−red recombination of the essential coaD gene. Wild-
type E. coli coaD is expressed constitutively along with GFP, which allows for confirmation
of plasmid loss upon heat curing. B. High-copy expression plasmid pEVBC allows for IPTG-
inducible expression of an homolog PPAT gene cloned in between the NdeI and KpnI sites.
A 20-mer random assembly barcode is present downstream. C. Verification of the coaD gene
knockout using colony PCR with two sets of internal primers. Four 42◦C heat-cured colonies
(c1-c4) are shown as well as four colonies (c5-c8) grown at 30◦C which still contain the rescue
plasmid. Red arrows indicate expected amplicon size when coaD gene sequence is present. D.
Colony PCR verification of the coaD genomic knockout using external genomic primers for 9
knockout colonies and one wildtype control. Wildtype (no knockout) amplicon length is 590
bp while the knockout (KAN cassette knockin) amplicon length is 1150 bp, as marked by
the red arrows. E. Comparison of E. coli DH10β ∆ coaD pTKcoaD cells grown at 30◦C
(left) and 42◦C (right). Cells were grown in LB+Kan for 15 hours at the corresponding
temperature, to allow for sufficient outgrowth, before plating on LB+Kan and incubating at
the corresponding temperature. By comparing the number of GFP-positive colonies seen in
each case we estimated an escape frequency of 1 in 16,500 (σ = 1,600). We also tracked the
escape frequency of cells after transformation with PPAT homologs and growth at 42◦C, by
determining the ratio of GFP negative to GFP positive cells, finding an escape frequency
of 1 in 20,200 (σ = 9500) as determined by 8 independent transformations. These escape
frequencies are similar to those previously reported for coaD (a.k.a. kdtB) upon heat curing
of coaD expressing pMAK705 plasmid in a conditional knockout [44]. . . . . . . . . . . . . 122
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4.17 PPAT complementation assay. A. The fitness values for 651 homologs across two
independent biological replicates shows strong correlation (ρ=0.94; Pearson). Six negative
controls lacking the H/TxGH motif required for nucleophilic attack on the α phosphate of
the ATP have very low fitness values (<3) in the assay. We colored each point based on
the number of assembly barcodes that corresponded to errorless constructs, and find that
reproducibility among replicates improves with increasing number of assembly barcodes (Fig.
4.18B). C. Despite having a median 50% sequence identity, distant homologs are typically
still able to complement the function of the native E. coli PPAT (bottom row). This multiple
sequence alignment table shows the fitness scores, percent sequence identity to E. coli PPAT,
and source organism. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
4.18 A. Fitness values of 329,897 individual assembly barcodes in each biological replicate, with a
correlation of 0.948. A large number of low-fitness assembly barcodes correspond to assemblies
with frameshifts due to indels. B. We see the reproducibility of the fitness values increase
with the number of assembly barcodes. The absolute difference in homolog fitness values
between the two biological replicates as a function of their number of assembly barcodes
(ρ=-0.34; Spearman, p-value <2.2E-16). C. Fitness values are noisy with a median standard
deviation of around 2.4. Box plots of individual assembly barcode fitness values for homologs
in replicate A which have at least 50 assembly barcodes. Homologs are rank-ordered by their
final fitness value. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
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4.19 A. Assembly barcode fitness for six of the homologs missing the H/TxGH motif required
for catalytic activity. No simple mutation would be able to restore catalytic activity to
these homologs, so they serve as a useful measure of the false positive rate for individual
assembly barcodes. Of the 994 assembly barcodes only 9 assembly barcodes (0.9%) have a
positive fitness value, indicating a low rate of false positives at the individual barcode level. B.
Mean sequence fitness is reduced with increasing number of mutations (ρ=-0.38; Spearman,
p-value <2.2E-16). Analysis of 144,573 sequences’ fitness as a function of their a.a. distance
from the designed homolog sequence. C. Very few sequences with less than ∼94% sequence
identity show high fitness. For sequences represented by at least 2 assembly barcodes, we plot
their fitness as a function of their sequence identity (relative to their corresponding designed
sequences), within bins of 1%. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
4.20 The population of perfect and low mutational distance sequences expand as a function of time,
while sequences with low sequence identity (primarily due to indels) are depleted. We see
that non-functional assemblies are lost from the population primarily between the first two
dilutions. Distribution of mapped assembly barcodes (top. and mapped reads (bottom.,
for each replicate (left & right., based on distance from the designed sequence. . . . . . . 126
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4.21 Synthesis verification. Sequence-verified clones were obtained for 37 of 49 homologs. A.
The amount of colonies observed after transformation of amplified constructs into E. coli
DH10β ∆ coaD pTKcoaD cells grown at 30◦C (positive control) and 42◦C (complementation).
Symbol indicates 42◦C colony size relative to 30◦C colonies. Dashed line shows slope of one
and is not a fit. The presence of a cluster with low colony counts in both conditions made
up primarily of low-fitness homologs suggests possible toxicity effects. Two false positives
are observed which had positive fitness in the pooled assay but produced no colonies in this
transformation. Both of these had a low number of assembly barcodes (1 and 25). The
majority of high fitness homologs produced large numbers of colonies in both conditions
with high correspondence between the two. B. Comparison of growth rate of individual
homologs (log-scale) and gain-of-function mutants as determined on a plate reader with
experimentally-determined fitness from pooled complementation assay, with a Spearman’s
correlation of rS=0.86. Growth rate (hr−1) is defined as the maximum slope of OD600 vs.
time on a log/linear plot. Fit is carried out using log growth rate and does not include the
eight homologs with a growth rate of zero. Wildtype PPAT E. coli had a growth rate of
0.132 indicative of gene dosage toxicity effects due to overexpression. C. Correlation between
the residual error of the fit of growth rate to fitness and number of assembly barcodes in
homologs (rs=-0.50, Spearman, p-value 1.7E-3). Constructs with fewer assembly barcodes
tend to have higher error between individual growth rate and fitness in the pooled assay,
highlighting the need for many assembly barcodes to determine fitness. . . . . . . . . . . . 127
4.22 PPAT phylogenetic tree. The majority of homologs listed complement wildtype E. coli,
with low-fitness homologs randomly dispersed throughout the tree with minimal clustering.
A phylogenetic tree of 451 homologs labeled, similar to Fig. 4.3D, with each leaf labeled with
the organism name and shaded by fitness. . . . . . . . . . . . . . . . . . . . . . . . . . . 128
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4.23 A. Phylogenetic tree of 411 homologs based on NCBI taxonomy rather than PPAT sequence,
generated using phyloT (http://phylot.biobyte.de). The median fitness was used when
multiple sequences were annotated with the same taxonomic ID. B. Fitness of PPAT homologs
from organisms annotated as extremophiles. Of the different classes, alkaliphiles show a weak
shift to lower fitness values (p=0.059 Wilcoxon rank sum test). Previous characterization
of E. coli PPAT showed a maximum activity at pH 6.9 which was reduced to 68% of the
maximum by pH 8 [47]. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
4.24 A. The average BMS position fitness compared to the conservation (Jensen-Shannon di-
vergence). As expected mutations tend to be more constrained at highly conserved sites
(ρ=-0.64; Pearson, p-value <2.2E-16). B. The average BMS position fitness compared to
the relative solvent accessibility based on a DSSP analysis of the 1H1T crystal structure
(dimer not hexamer). Buried residues tend to be more constrained (ρ=0.42; Pearson, p-value
3.9E-8). C. Mutational scanning coverage decreases at site of low fitness (ρ=0.76; Pearson,
p-value <2.2E-16). This effect is due to assembly barcodes with low read numbers which,
due to their low fitness, never pass the minimum 10 read threshold. D. Residues appearing
in wildtype E. coli PPAT are associated with higher fitness values. The distribution of fitness
values for residues present in the E. coli PPAT sequence (median = 2.16, σ = 0.24) compared
to all others (median = 1.86, σ = 2.16). . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
4.25 Variant classifier. We implemented a classifier to predict how different BMS variants would
perform in our assay. Each BMS variant was categorized into two bins based on whether or
not their measured fitness score was greater than 0. We then performed a logistic regression
using 6 features for our model - the amino acid mutation, secondary structure class as assigned
by DSSP (loop, beta-sheet, or alpha-helix), relative solvent accessibility as assigned by DSSP,
sequence conservation, evolutionary coupling as predicted by EVMutation, and the frequency
of residue substitution from the sequence alignment used for EVMutation’s prediction. To
assess the performance of our classifier, we performed 10 repeats of 5-fold cross-validation on
our dataset and measured the precision and recall of each model on its respective hold-out
set. We found that on average, our simple classifier has A. an average accuracy of 0.825 +/-
0.013, B. a precision of 0.853 +/- 0.009, and an average recall of 0.931 +/- 0.014. . . . . . . 131
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4.26 A. The relative solvent accessibility and conservation of each of the eight gain of function
positions. B.Weblogo showing the probability of each residue at the gain-of-function positions
for low-fitness homologs. C. Weblogo of GoF residues for homologs which complemented.
D. The mean fitness of each GoF mutation at the significant positions, with the number
of mutants observed at each a.a. E. The same plot with the data derived from the broad
mutational scan using complementing homologs and their mutants. F. E. coli PPAT structure
with the eight GoF residues shaded in red. Glu-134 is involved in hydrophobic interactions
with coenzyme A [42], suggesting a role for GoF mutations in modulating the inhibitory
feedback, while Ala-103 participates in hydrophobic interactions between the PPAT dimers. 132
4.27 A. The oligo design process. Briefly, a.a sequences are assigned random weighted codons
and appended with restriction and primer sites used in DropSynth assembly. Sequences
are then split into five oligos with ∼20-nt overlap regions. Individual oligo sequences are
appended with restriction sites, padding sequences, gene-specific microbead barcodes flanked
by nicking sites, and amplification primer sites leading to a library of 200-nt sequences. B.
The DropSynth microbead barcoding process. Microbead barcode oligos are individually
mixed with 3’ biotinylated ligation oligos and dual 5’ biotinylated anchor oligos, ligated
using T4 ligase and phosphorylated with T4 PNK, exposing the microbead barcode sequence
(NNNNNNNNNNNN). Biotinylated duplexes are then individually bound to M270 streptavidin
Dynabeads and pooled together. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
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4.28 Nick processing to generate single-stranded microbead barcode overhang. A. A
10% TBE-Urea denaturing gel highlighting the steps in nick processing. Lanes 1, 5, 7: a
10 bp ladder. Lane 2: Before processing, all oligos should be 200 nt. Lane 3: After nick
processing we expect fragments of 165 nt, 177 nt, 35 nt, and 23 nt. Lane 4: After streptavidin
Dynabead cleanup of nick processed oligos we expect fragments of 165 nt and 177 nt. Lane 6:
The captured Dynabead fraction after boiling at 90◦C for 10 min in 10 mM EDTA pH 8.2. B.
A non-denaturing 4% agarose gel showing the nick processing which takes a 200 bp duplex
and leaves a 12-nt single-stranded microbead barcode overhang on a 165 bp dsDNA fragment.
Lanes p1-p4 showing several samples after nick processing and also one before processing
(NP). Lanes b1-b4 show the corresponding Dynabead fractions after denaturing at 80◦C for
3 min. Full length oligos containing errors in the nt.BspQI sites will not have both strands
nicked and are likely to be pulled down by the Dynabeads together with the short fragment. 134
4.29 Characterization of the distribution of droplet sizes for the vortex emulsions.
Briefly, 100 uL of Kapa Robust buffer was added to an eppendorf tube with 600 uL of
Bio-Rad Droplet Generation Oil and vortexed upright for 4 minutes on the highest setting
of a Vortex-Genie 2. Samples were then taken from the bottom, middle, and top of the
resulting emulsion and imaged under 40X magnification. The mode of the droplet diameter
distribution peaks below 5 um. Scale bars are 100 um. Bottom right: Histogram of droplet
diameters as determined by image analysis. Median droplet diameter is below 5 um. . . . . 135
5.1 A Genomically Integrated Synthetic Circuit Allows Screening for Mammalian
Olfactory Receptor Activation. A. Schematic of the synthetic circuit for stable OR
expression and function in an engineered HEK293T cell line (ScL21). Heterologous accessory
factors expressed include (pink): RTP1S, RTP2, Gαolf, and Ric8b. B. MOR42-3 reporter
activation expressing the receptor transiently (left) or genomically integrated (right) at varying
copy number, under constitutive or inducible expression in HEK293T cells. C. MOR258-5
reporter activation with/without accessory factors (A.F.s), RTP1S and RTP2, transiently
coexpressed in HEK293T cells compared to stable receptor expression in ScL21. D. Reporter
activation response curves for MOR258-5 and MOR41-1 genomically integrated in ScL21
with/without doxycycline induction of receptor expression. . . . . . . . . . . . . . . . . . 148
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5.2 Large-Scale, Multiplexed Screening of Olfactory Receptor-Odorant Interactions.
A. Experimental workflow for OR library generation and high-throughput screening. To
perform assay, we cloned OR genes and barcodes into plasmids, engineered cell lines via
individual transposition of plasmids, pooled cell lines and performed screen in 96 well plates.
We assayed the equivalent of 81,012 wells of a screen where interactions are tested individually.
B. Heatmap of interactions from the screen clustered by odorant and receptor responses, and
shaded by the minimum activating odorant concentration that triggered reporter activity.
Only ORs and chemicals that registered at least one interaction are shown. C. Chemical
names and structures for odorants that activate MOR23-1 and MOR5-1. D. Chemical
names and structures for odorants that activate MOR258-5 and MOR13-1. E. Chemical
hits identified for MOR170-1 and MOR139-1 (black) mapped onto a PCA projection of the
chemical space of our odorant panel (grey). Shaded areas highlight hits that cluster together
in chemical space. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
5.3 Schematic of the Synthetic Olfactory Activation Circuit in the Engineered Cell
Line. Full graphical representation of the expressed components for expression/signaling of
the ORs and the barcoded reporter system as shown in Fig. 5.1 of the main text. Receptor
expression is controlled by the Tet-On system (Orange). After doxycycline induction, the OR
is expressed on the cell surface with assistance from two exogenously expressed chaperones,
RTP1S and RTP2 (pink). Upon odorant activation, G protein signaling triggers cAMP
production. Signaling is augmented by transgenic expression of the native OR G alpha
subunit, Gαolf, and its corresponding GEF, Ric8b (pink). cAMP leads to activation of the
kinase PKA that phosphorylates the transcription factor CREB leading to expression of the
barcoded reporter. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
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5.4 Engineering HEK293T Cells for Stable, Functional OR Expression. A. Comparison
of MOR42-3 activation under inducible receptor expression either transiently transfected (left)
or integrated at single copy into the H11 genomic locus (right). B. Comparison of MOR42-3
reporter activation integrated at multiple copies in the genome with the PiggyBac Transposon
System under constitutive or inducible receptor expression. C. Relative receptor/reporter
copy number determined with qPCR for three transposed ORs relative to a single copy
integrant. D. Comparison of MOR258-5 and MOR30-1 reporter activation (stimulated with
2-coumaranone and Decanoic Acid respectively) co-transfected with or without Accessory
Factors (AF) Gαolf, Ric8b, RTP1S, and RTP2. E. Cell line generation for stable accessory
factor expression. After transfection, clones were isolated and screened for activation of ORs,
MOR258-5 and OR7D4, that require accessory factors for functional expression. The dark
purple bar represents the clone (ScL21) selected for further experiments. . . . . . . . . . . 162
5.5 Design of a Multiplexed Genetic Reporter for OR Activation. A. Annotated Vector
map for the plasmid containing the OR expression cassette and genetic reporter for integration.
B. MOR42-3 reporter activation in cells transiently co-expressing the receptor and genetic
reporter on separate plasmids or together. C. Fold activation of MOR42-3 driven by an
engineered CRE enhancer (7 CREB binding sites) compared to Promega’s pGL4.19 CRE
enhancer. D. Genetic reporter basal activation upon inducible expression of MOR42-3 with
or without a DNA insulator upstream of the CRE enhancer. . . . . . . . . . . . . . . . . . 163
5.6 Evolutionary Tree of Mouse ORs. Phylogenetic tree inferred from amino acid sequence
of functional murine ORs. The length of lines indicate degree of divergence between ORs.
Red dots indicate ORs that were selected for inclusion in this study. . . . . . . . . . . . . 164
5.7 Pilot-Scale Recapitulation of Odorant Response in Multiplex. A. Heatmap display-
ing 39 pooled receptors’ activity against 9 odorants and 2 mixtures. Interactions are colored
by the log2-fold activation of the genetic reporter (see methods). Odorant interactions previ-
ously identified are boxed in yellow [12]. B. Dose-response curves for odorants or forskolin
(adenylate cyclase stimulator) at 5 concentrations screened against the OR library. Curves
for ORs known to interact with the odorant are colored. Stimulation with forskolin does not
show substantial differential activity between ORs in our assay. . . . . . . . . . . . . . . . 165
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5.8 Library Representation. Representation of individual ORs in the library for the 39/42
ORs that had sufficient cellular coverage (see Methods). A. Frequency of each OR as a
fraction of the library determined by the relative activation of each reporter stimulated with
DMSO. B. The relationship between frequency of each OR in the library and the average
coefficient of variation between biological replicate measurements of reporter activation for
all conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
5.9 Replicability of the Large-Scale Multiplexed Screen. A. Histogram displaying the
distribution of the coefficient of variation for the OR library when stimulated with DMSO.
B. Histogram displaying the distribution of the coefficient of variation for the OR library
against all conditions assayed. C. Dose-response curves for the control odorants included on
each 96-well plate assayed. Each color represents a different plate. . . . . . . . . . . . . . . 167
5.10 Significance and Fold Change of High-Throughput Assay Data. A. The False
Discovery Rate (FDR; Benjamini-Hochberg corrected, see Methods) plotted against the fold
change for each OR-odorant interaction. The dashed line represents the 1% FDR, the cutoff
used to identify positive interactions. B. The subset of interactions tested by a follow-up
orthogonal luciferase assay (color indicates whether it was recapitulated in the orthogonal
system). Of the interactions passing a 1% FDR, 20 of 27 also showed interaction in the
orthogonal follow-up assay. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
5.11 Recapitulation of the Screen in a Transient, Orthogonal System. Secondary screen
of chemicals in a transient OR reporter activation system with a luciferase reporter gene
readout [26]. Each plot shows the behavior of a control cell line expressing the reporter gene
but no OR (black line), as well as a cell line expressing a specific OR and reporter gene. In
addition, data from the high throughput screen (labeled as Seq) is plotted for reference. . . 170
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5.12 Assay Correspondence with Previously Screened Odorant-Receptor Pairs. A.
FDR plotted against fold induction for the 540 odorant-OR interactions that were previously
tested by Saito et al.12. Points are colored by the EC50 of the interaction in the previous
work. Grey points represent interactions not identified in the previous screen. Comparing the
results from transient versus integrated luciferase assays revealed that, in some cases, the
integrated system required a higher concentration of odorant to achieve significant activation,
likely because of the lower DNA copy number of the CRE-driven luciferase and receptor.
Since the highest concentration of odorant assayed was 1 mM, low affinity interactions may
not have been detectable in this screen. B. The FDR in the assay related to the EC50 of the
hit from the previous screen, colored by the fold activation from the multiplexed screen. . . 171
5.13 Location of Odors Tested with Respect to a Learned Chemical Space. Locations
of the chemicals tested in this assay in chemical space. The molecular autoencoder was used
to generate a 292-dimensional representations of 250,000 randomly sampled molecules from
the ChEMBL 23 database (blue) as well as the chemicals tested in our assay (red) projected
onto two dimensions with Principal Component Analysis (PCA)[27]. . . . . . . . . . . . . 172
5.14 Clustering of Odorant Response for Receptors. The locations of any hits (black) with
respect to other chemicals tested (grey) for each OR on the PCA on the 292-dimensional
latent representation. PC1 explains 34.4% of variance and PC2 explains 14.0% of the variance.173
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6.1 Platform for Deep Mutational Scanning of GPCRs and Variant-Activity Land-
scape. A. Graphical Display of Multiplexed GPCR Activity Assay. ADRB2 variants with
their barcoded genetic reporter are integrated into a defined genomic locus such that one
variant is integrated per cell. Upon isoproterenol agonization, G protein signaling induces
transcription of the cAMP-responsive genetic reporter and the barcode. The barcode sequence
in the 3’ UTR of the reporter encodes the identity of the receptor within the same cell. B.
Overview of workflow for Multiplexed GPCR Activity Assay. The variant library is generated,
barcoded, and cloned into a vector with a genetic reporter. The library is then integrated into
HEK293T cells and agonized with various concentrations of isoproterenol. After stimulation,
mutant activity is determined by measuring the relative abundance of each variant’s barcoded
cAMP-responsive genetic reporter transcripts with RNA-seq. C. Top: Secondary structure
diagram represents the N and C termini in black, the transmembrane domains as blocks, and
the intra- and extracellular domains in blue and green respectively. The EVmutation track
displays average effect of every mutation as predicted by EVmutation. The Conservation track
displays the sequence conservation of each residue. The shaded guides represent positions
of the protein in the transmembrane domain. Bottom: The heatmap representation of the
activity of every missense mutation and frameshift at each agonist condition. Cells are colored
by the relative activity to the mean frameshift mutation. . . . . . . . . . . . . . . . . . . 185
6.2 Unsupervised Learning Elucidates Broad Structural Features and Critical Residues
of the β2AR. A. We averaged amino acid substitutions into classes based on their physico-
chemical properties. We then used Uniform Manifold Approximation and Projection (UMAP)
to learn a 2D representation of every residue’s response to these classes of substitutions across
all agonist conditions. Each residue is assigned into one of six clusters using HDBSCAN (see
Supplementary Fig. 6.10). B. The class averages of each of these cluster reveals their distinct
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Chapter 1
Introduction
“It is the writer who might catch the imagination of young people, and plant a seed
that will flower and come to fruition.” — Issac Asimov
1.1 Background
Literacy is the fundamental underpinning of all human progress. The invention of writing enabled
humans to store information over generations, and our ability to read enabled us to learn from it.
The concept of literacy is even found in Biology itself. Life evolved its own language as outlined
by the Central Dogma – genes are written in DNA, transcribed to RNA, and then translated into
proteins. While we have made considerable progress understanding and engineering Biology, our
ability to read and write DNA is still in its infancy.
By the early 1960’s, researchers understood the basics of the Central Dogma, but did not know
its actual molecular mechanism. In particular, the question of how cells translated RNA into amino
acids remained. To solve this problem, Har Gobind Khorana and colleagues developed methods to
synthesize defined DNA oligonucleotides (oligos) [1]. They systematically synthesized all possible
codons and used RNA polymerase to transcribe them to RNA. Extending the experiments of Marshal
Nirenberg, they combined radio-labeled amino acids, the transcribed mRNAs, and translation
machinery extracted from E. coli together. By measuring the amount of radioactive amino acid
incorporation, they were able to associate each codon to its amino acid, and cracked the genetic
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code in 1965.
Reading DNA proved to be much harder than writing it. In the 1950’s Fredrick Sanger invented
a method for sequencing proteins by degrading the peptide strand one amino acid at a time and
characterizing the results [2]. Researchers extended this idea to RNA in the 1960’s through sequential
exonuclease digestion [3]. However, DNA sequencing by degradation was feckless, as it was too slow
to scale to molecules longer than ∼50 nucleotides. In 1977, almost 20 years after receiving the Nobel
Prize for protein sequencing, Fredrick Sanger published an eponymous DNA sequencing method
that enabled researchers to effectively read DNA [4, 5, 6]. Briefly, Sanger Sequencing leverages trace
amounts of chain-terminating, fluorescently-labeled nucleotides to halt a primer extension reaction
at every position in the sequence. The terminated fragments are separated with electrophoresis
and the identity of the terminal base is determined from its fluorescent signal. Finally, the original
sequence is recovered by concatenating the terminal bases together.
Since then, progress in both DNA synthesis and sequencing has proceeded exponentially (Figure
1.1). The development of solid-phase phosphoramidite chemistry by Beaucage and Caruthers in
the 1980’s enabled the robust, scalable, and automatable synthesis of oligos [7]. In the early 1990’s,
researchers modified the phosphoramidite synthesis process to enable oligo synthesis on the surface
of microchips, vastly increasing the number of oligos synthesized in a single run [8, 9]. Today,
researchers can purchase oligo libraries of up to a million members for < $0.00001 − 0.0001 per
nucleotide [10].
Progress in DNA sequencing has improved even more rapidly. Spurred by the Human Genome
Project, a number of major breakthroughs in DNA sequencing led to the development of Next-
generation Sequencing (NGS) in the mid-2000’s [11, 12, 13, 14]. These instruments primarily differ
from Sanger Sequencers in that they track the incorporation of each nucleotide, rather than measuring
fragment lengths. In addition, they are highly multiplexed, and are now capable of reading billions
of sequences simultaneously. These advances lead to an astounding rate of progress, with the cost of
sequencing falling 10x every year between 2005-2010.
While these advances are nothing short of a revolution, our reading and writing capabilities are
still limited in many respects. For reading DNA, it is still challenging to sequence long, contiguous
pieces of DNA with the current NGS platforms. This has limited our understanding of many regions
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Figure 1.1: The cost of DNA Sequencing and Synthesis is decreasing exponentially. The advent
of Next-generation Sequencing in 2005 resulted in ∼ 106-fold decrease in price in 10 years. Prices are
reported per base sequenced or synthesized. At the time of writing (November, 2018) the price per base
of microarray-base oligos is approximately $10−4 − 10−5 (data not shown). Figure c©Bioeconomy Capital
http://www.bioeconomycapital.com/bioeconomy-dashboard/
in the genome, and has hampered the sequencing of novel genomes [15, 16]. For writing DNA, this is
most apparent in gene synthesis, or the construction of gene-length fragments from synthetic oligos
[17]. Currently, synthesizing even multi-kilobase genes remains challenging. Large-scale applications
such as engineering synthetic gene pathways or even entire organisms require would require similar
million-fold improvements to those brought about by NGS [18]. Lastly, these limitations in reading
and writing DNA have hampered progress in an emerging technique know as multiplexed functional
assays [19].
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Figure 1.2: Typical gene synthesis workflow. An oligo library that tiles the gene of interest are
synthesized and optionally purified. Using polymerase cycling assembly (PCA), overlapping oligos anneal
together and the gaps are filled by a polymerase. After PCA, the full length product is amplified by PCR
and optionally subjected to a round of error correction. Finally, the synthetic gene is cloned and verified by
Sanger Sequencing. c©atdbio https://www.atdbio.com/content/63/Gene-synthesis
1.2 Gene Synthesis
Current methods in gene synthesis use ∼ 40− 150 nucleotide (nt) oligos to assemble longer genes
(Figure 1.2)[17, 20]. Most often, these oligos are designed to have complementary overlapping
sequences. In a PCR-like reaction known as Polymerase Cycling Assembly (PCA), a polymerase fills
in the gaps between oligos and generates the full-length gene of interest. The full-length product is
then amplified out of the reaction in a separate PCR reaction.
However, the error rate of oligo synthesis makes generating error-free genes almost impossible.
For example, imagine we assembled a gene from 10 oligos that are 99% pure. The percent perfect
assemblies would be 90.44% = 0.9910. In reality, most column oligos today are ∼ 50% pure, meaning
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we can expect 0.098% perfect assemblies [10]. This problem is exacerbated with cheaper, but lower
quality array-based oligos. Thus, researchers have developed a number of error correction schemes
to enable practical gene synthesis [21].
Broadly, error correction methods can occur either at the level of the oligos, or on the synthesized
genes themselves. The most common oligo-based error correction methods use either HPLC or
PAGE to remove truncated oligos from the input stock [22, 23]. Other more exotic methods use
hybridization [24, 25] or even sequencing to select oligos with perfect sequences [26, 27, 28]. However,
the most cost-effective and widely used error correction method employs a variety of different enzymes
a the gene-level.
Enzymatic error correction leverages classes of proteins that recognize distortions in the DNA
helix brought about by mishybridized bases [29, 30, 31, 32]. In a typical experiment, researchers will
denature and re-anneal their gene synthesis product, a mixture of perfect and imperfect assemblies,
to expose errors through mishybridization. Next, mismatch binding proteins such as MutS are
used to filter out imperfect assemblies [33]. Alternatively, mismatch cleaving proteins such as T7
Endonuclease I recognize and cut at any errors [34]. Perfect sequences can be recovered either
through size selection or by a second round of PCA.
Lastly, a number of researchers are attempting to move away from the phosphoramidite chemistry
given its inherent limitations. One of the most promising of these techniques leverages the enzyme
terminal deoxynucleotidyl transferase (TdT) to synthesize oligos [35]. Discovered in 1959 by F. J.
Bollum, TdT randomly incorporates nucleotides in a template-independent manner, and can even
produce oligos up to 8000 nt long [36, 37]. Given these properties, F. J. Bollum proposed that it
could be used for the synthesis of oligos with defined sequences in 1962 [38]. However, controlling the
incorporation of defined nucleotides has proven to be challenging, and the first practical demonstration
occurred late 2018 [39]. In it, researchers synthesized a 10 nt oligo with step-wise incorporation
efficiencies ranging from 93.5 to 99.5%. While this is still worse than traditional oligo synthesis,
further optimizations could make enzymatically synthesized oligos a reality.
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Figure 1.3: Typical dilution-based SLR overview. In a dilution-based SLR, or haplotyping experiment,
molecules of interest are diluted and amplified in 96- or 384-well plates. The dilution ensures sufficient
diversity within each well and that haploids remain separated. The molecules are then fragmented and tagged
(tagmented) with a unique barcode for each well. After sequencing, these barcodes are used to reassemble the
molecules within each well. Due to the diversity of each well, it is unlikely, but not impossible that reads
from one molecule could be incorrectly assigned to a different molecule.
1.3 Synthetic Long Reads
While NGS has undoubtedly revolutionized Biology, today’s sequencers still have a number of
drawbacks. For Illumina, the de facto NGS platform, this is read length. At the time of writing,
their sequencers can only read up to 600 bp at a time, and are unlikely to be able to read much more
than that with their current technology. Since Illumina has a near monopoly on NGS, progress in
areas that require long reads, such as genome assembly or haplotyping, has arguably been limited.
Recently, real-time single-molecule sequencers from Pacific Biosciences (PacBio) and Oxford
Nanopore Technologies (ONT) have emerged as potential competitors to Illumina. As the name
suggests, real-time single-molecule sequencers directly read single molecules of DNA in real time.
PacBio sequencers directly record the color of fluorescent dyes cleaved from derivatized nucleotides
as they are incorporated into a single molecule of DNA in real time [40]. Alternatively, ONT detects
changes in current as DNA molecules are pulled through a biological nanopore [41, 42]. Both methods
have demonstrated read lengths of up to 100,000 bp, but have significantly higher error rates, lower
throughput, and are more expensive than Illumina sequencing [43, 44].
Due to these limitations, researchers have developed a number of methods known as synthetic long
reads (SLRs) as a compromise between the accuracy of Illumina sequencing and the read length of
single-molecule sequencers. In general, SLRs use molecular barcoding techniques to computationally
stitch together short reads into long, contiguous molecules [45]. The most common SLRs extend
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methods used for molecular haplotyping, where molecules are segregated into compartments, diluted,
fragmented, and tagged with a unique barcode for every compartment (Figure 1.3) [46, 47]. The
dilution ensures that haplotypes remain separated, and aids in the barcode-guided reassembly of the
molecules in the compartment.
However, the physical dilution step is cumbersome, inefficient, and does not scale well. In addition,
PCR amplification of highly dilute molecules is often biased. Alternative SLR technologies that do
not require dilution address some of these issues [48, 49, 50]. Nonetheless, every SLR technology to
date relies on PCR to amplify long molecules, capping the maximum SLR length to approximately 10
kb. They also require an extreme amount of read depth to ensure each molecule is completely covered
by reads, adding to the cost. Finally, no method currently exists that maintains a one-to-one linkage
between a unique barcode and a single molecule. Thus, applications that require long, accurate reads
will be hampered until single-molecule sequencers improve or better SLR methods are developed.
Agonist
Variant Library Reporter BC
Variant Activity Linked to Barcoded Genetic Reporter
Agonist Stimulation Activates Signaling
Signalling Activates 
Genetic ReporterSingle Variant 
Expressed 
Figure 1.4: Overview of a hypothetical multiplexed functional assay (MFA). In this MFA, the
activity of a given variant in the library is linked to a genetic reporter through a molecular barcode. Agonist
stimulation of the expressed variant results in a signalling cascade that activates the transcription of its
unique barcode. The level of activity can then be quantified by measuring the expression of the barcode with
RNA-seq
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1.4 Multiplexed Functional Assays
Understanding sequence-function relationships is a central goal of Biology. Typically, the functional
consequences sequence changes are tracked in a one-by-one manner. For example, large-scale
mutagenesis experiments such as alanine-scans require the time consuming cloning and testing of
each individual mutant. Even the massive drug screening efforts by large pharmaceutical corporations
measure drug binding through individual luciferase assays. However, by leveraging NGS and DNA
microarray synthesis researchers are now capable of probing sequence-function relationships on
unprecedented scales [19].
These experiments are broadly termed multiplexed functional assays (MFAs; Figure 1.4). First,
researchers design and build libraries of genetic variants using DNA synthesis. Each variant is
associated with a unique barcode that encodes its identity. Next, researchers deliver these variants
either episomally or stably. Importantly, it is now possible to assay these variants in a native genomic
context using recently developed genome engineering tools [51]. Finally, the functional consequences
of these variants is quantified by measuring the abundance of the variant barcodes. Using this
framework, researchers have used MFAs to investigate sequence-function relationships across the
Central Dogma, such as promoters, regulatory elements, untranslated regions, splicing, and protein
function [19]. One particular area where MFAs could be beneficial but have yet to been applied is
drug development.
Progress in drug discovery has halted. Adjusted for inflation, the number of new FDA approved
drugs per billion dollars of R&D spending has halved every 9 years since 1950 [52]. One way to
address this issue is to screen drugs against un- or under-tested targets, as the vast majority of
the “drugable genome” has yet to be investigated [53, 54]. This problem is exemplified in G protein
coupled receptors (GPCRs), which are the targets of ∼34% of all FDA approved drugs [55]. Only
∼100 of the ∼400 non-olfactory GPCRs are currently drugged, with > 65% of the drugs targeting
only 36 receptors [56]. Additionally, new insights into the role of ∼400 olfactory GPCRs outside
olfaction suggest that they could also be valuable drug targets [57].
However, screening GPCRs in a comprehensive manner remains technically challenging. Their
diverse role in modulating cellular physiology requires they operate through a number of downstream
effectors. Thus, bespoke reporters are required to measure the activity of different classes of GPCRs.
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Alternatively, the vast majority of GPCRs recruit β-arrestin upon receptor activation [58]. Recent
techniques have leveraged this property to enable high-throughput, genome-wide screening of GPCR
activity [59, 60, 61]. Regardless, both β-arrestin recruitment and traditional GPCR reporter assays
typically use fluorescent read-outs, thereby prohibiting multiplexing and hampering scale.
Multiplexing GPCR screening technologies could enable large-scale screening of all GPCRs. This
could be achieved by adding molecular barcodes to existing genetic reporters of GPRC activity. The
abundance of each of these barcodes would correlate with GPCR activity and could be quantified
in multiplex by RNA-seq. However, a number of technical challenges must be addressed before
multiplexed GPCR screening is realized. First, one would have to extend existing GPCR genetic
reporters to have barcoded outputs. Second, individual reporters and their target GPCR would have
to be integrated concurrently into individual cell lines to avoid cross-activation by other GPCRs
in the library. Lastly, these cell lines will likely need to be further engineered to enable robust
expression of diverse GPCRs.
1.5 This Work
Here we describe methods for improving out base capacity to read (Chapter 1) and write (Chapters
2 & 3) DNA. We then leverage these capabilities to investigate protein function over evolutionary
space (Chapter 3) and to test the function of GPCRs in multiplex (Chapters 5 & 6).
Chapter 1 describes a method called BAGEL-seq that generates synthetic long reads. In a
proof of principle experiment, we achieved read lengths that exceed the capability of any Illumina
sequencer. We also provide commentary on further optimizations and experiments, as this method
remains in development.
In Chapter 2, we develop novel methodology to accurately measure error rates in DNA sequences
using NGS. We use this method to characterize the most commonly employed enzymatic error
correction methods in gene synthesis, and estimate the error rates of different polymerases.
Chapter 3 details a multiplexed gene synthesis method called DropSynth and used it to
synthesize >10,000 genes of up to 669 bp in length. We then tested these genes in a multiplexed
functional assay and explored the evolutionary and functional landscape of an essential enzyme in E.
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coli.
In Chapter 4, we present a method that enables the stable expression and screening of olfactory
receptors in multiplex. We test hundreds of chemicals against 39 murine olfactory receptors and use
recently developed chemical learning tools to begin to understand the chemical features that these
receptors are recognizing.
Finally, in Chapter 5 we test 99.6% of all possible missense variants of the β2-adrenergic receptor
across several drug conditions in multiplex. We use unsupervised learning methods to identify known
and novel mutants, including a “structural latch” that is conserved across Class A GPCRs.
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Chapter 2
BAGEL-seq – A Novel Method for
Generating Synthetic Long Reads
2.1 Abstract
Next-generation sequencing (NGS) has revolutionized our understanding of biology. However, NGS
is still a nascent technique and consequently, the base technologies are limiting for many applications.
In particular, the read length of most NGS platforms (<500 nucleotides) is too short, and the error
rate of long read NGS technologies is too high, making it difficult to assemble and haplotype genomes.
Synthetic long reads (SLRs) are a recently developed method that represent a compromise between
the the accuracy and throughput of current short read technologies, and the read length of long read
technologies. SLRs are generated by using molecular barcodes to computationally assemble short
reads back to the individual longer fragments of DNA from which they came. However, all current
SLRs are limited to ∼10 kb by PCR. Here we bypass this limit with a novel library preparation that
can theoretically produce SLRs that are ∼40 kb or greater.
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2.2 Introduction
Long Read Technologies
The impact of Next-generation Sequencing (NGS) technologies on our understanding of genetics and
biology is staggering [1, 2, 3]. Consequently, NGS technologies are now a fundamental tool in the
analysis of genetic information across a broad spectrum of fields [4, 5]. However, these technologies
are still in their infancy and suffer from a number of drawbacks. Of particular concern is the inability
to read long (>10,000 bp), contiguous pieces of DNA accurately. This is most apparent in de
novo genome assembly and haplotyping experiments, where long reads are required to span highly
repetitive or variable regions of the genome, or are needed to phase sparsely populated heterozygous
variants [6, 7].
Traditionally, long reads have been limited to single molecule sequencing platforms such as
those developed by Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (ONT). As
the name suggests, single molecule sequencers aim to directly read the sequence of long DNA
molecules, in contrast to the shotgun style approach of Illumina. In particular, the PacBio sequencer
directly images fluorescent dyes cleaved from labeled nucleotides as they are incorporated into
a single molecule of DNA. This process is parallelized by separating the reactions in zeptoliter
(10−21L) reaction chambers [8]. In contrast, ONT uses an array of biological pores conjugated to an
integrated circuit to detect current changes brought about by individual nucleotides in parallel [9].
The theoretical maximum read length of PacBio sequencers is limited by the polymerase, while the
read length of ONT sequencers is limited only by the length input DNA [10]. Although PacBio and
ONT have demonstrated read lengths longer than 10,000 bp, the error rates are typically too high
for practical use [11, 12]. Consequently, researchers leveraged the accuracy of existing short-read
sequencers (Illumina, Ion Torrent, etc.) with molecular barcoding techniques to computationally
stitch together short reads into long, contiguous molecules known as synthetic long reads (SLRs).
The first SLR technology, termed subassembly, was developed by Hiatt et al. in 2010, and extended
the concept of hierarchical shotgun genome assembly [13]. Subassembly works by first ligating
barcoded adapters to gDNA fragments, which are diluted then amplified by PCR. This effectively
creates sub-libraries of a limited number of fragments. Next, the amplicons are concatenated and
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fragmented, producing random break-points. A second primer is ligated to these break-points, and a
sequencing library is prepared by amplifying on the barcode and break-point adapters. One read from
a paired-end read is a barcode that identifies groups of reads originating from the same fragment,
while the other is a small portion of a random portion of this fragment. Reads with the same barcode
are then collapsed together into a long read in silico. The authors were able to generate ∼700 bp
reads from 36 bp paired end reads, on par with the state of the art pyrosequencing platforms of the
time. However, subassembly could only produce SLRs on the order of ∼1 kb due to limitations of
the length of sequence that can fit on an Illumina flow-cell [14].
Since then, two different library preparations for generating SLRs have emerged. The first,
leverages intramolecular circularization to bring a random sequence next to a barcoded primer.
Specific implementations vary slightly in the way they barcode fragments and generate random
ligation points. For example, Tile-seq and BAsE-Seq (Barcode-directed Assembly for Extra-long
Sequences) use PCR to barcode and amplify targeted regions of various genomes. They then use
exonuclease digestion to generate random sequences to bring in conjunction with the barcoded
sequencing primer [14, 15]. These methods are limited to known sequences, and the resulting coverage
is lessened in the 3′-end due to ligation bias. A more recent implementation developed by Stapleton
et al. addresses these two fundamental weaknesses. First, they ligate two independent barcoded
primers to either end of randomly sheared fragments, eliminating the need to know the sequences
a priori. After amplification, a single break (on average) is introduced enzymatically, separating
the two barcodes. Next, two fragments undergo an intramolecular circularization separately, and
are subsequently fragmented and sequenced. Finally, a secondary sequencing step maps the two
barcodes together, allowing the researchers to combine data from each of the barcodes, eliminating
much of the ligation bias [16]. This method is able to generate reads of up to ∼10 kb, but is unlikely
to generate much higher due to the length limits of PCR and the inefficiency of longer intramolecular
ligations.
In 2013, Stephen Quake’s group developed an alternative library preparation for generating SLRs
and quickly spun out a company named Moleculo. Moleculo’s technology bypassed the need for
circularization or concatenation, but does not barcode every molecule uniquely [17, 18]. Instead,
their method amplifies, barcodes, and converts dilute pools of hundreds to thousands of molecules
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into NGS libraries in plate format. The libraries are then pooled, sequenced in bulk, and the
content of each well is reconstructed in silico. Unlike similar dilution-limited haplotyping methods
(discussed below), this method effectively over-sequences each well to ensure that every molecule
can be reconstructed [17]. This method has been the most widely adopted SLR technology to date,
likely due to its ability to generate SLRs from arbitrary sequences. As with previous SLRs, the
length Moleculo’s SLRs are still limited by PCR. Additionally, this method is particularly susceptible
to PCR biases and errors imparted by the highly dilute nature of the amplification step. Finally,
Moleculo’s 384-well protocol is much more difficult and cumbersome than microtube based methods.
Direct Haplotyping with NGS
Haplotypes are the unique collection of mutations that co-occur along single chromosomes, and are
crucial for understanding both human disease and genetics. For example, haplotype information is
critical for determining the phenotype of many diseases, is used to increase the power of genome-wide
association studies (GWAS), and is important for studying human history and migration [19, 20].
However, it has been difficult for researchers to directly obtain accurate haplotype information
with short read sequencers. Consequently, inferential methods that use populations or pedigree
information to impute haplotypes have been utilized more extensively [21]. Nevertheless, inferential
methods are often unable to detect low-frequency, de novo, and private variants; and are limited by
linkage disequilibrium [20]. As a result, there has been a resurgence in the development of direct
haplotyping methods over the last few years that leverage increased sequencing power.
Many direct haplotyping methods rely on variations of the same technique (Figure 2.1), which
I will refer to as dilution-limited haplotyping for convenience [22, 23]. In essence, high molecular
weight (HMW) gDNA is diluted into compartmentalized pools such that each pool is sub-haploid in
content, or genomic fragments are either represented once or not at all same pool. Although each
pool is sub-haploid, there are enough pools to cover a given genome sufficiently. Next, the pools
are barcoded, amplified, combined together, and sequenced in bulk. Reads corresponding to each
barcode are then assembled back together into longer blocks of coverage corresponding to a single
haplotype. Since haplotype variants are often spaced multiple kbs apart, it is crucial that input
DNA is as long as possible so that the size of these reconstructed blocks spans as many variants as
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Figure 2.1: Dilution-limited haplotyping overview. Current methods rely on various techniques to
separate long pieces of DNA into various compartments, where they are amplified, barcoded, and prepared
for NGS. A. Historically, most haplotyping libraries were generated with fosmids. Briefly, genomic DNA is
sheared and ligated with a fosmid backbone. Phages then package the ∼40 kb molecules and infect E. coli.
The resulting library is diluted and grown in 96-well plates to amplify the selected DNA (purple and blue).
B. Alternatively, the sheared genomic DNA can be diluted and amplified in vitro with multiple displacement
amplification. The resulting product is then sheared and prepared for sequencing. C. Recently, a number
of droplet-based technologies have been developed that obviate cumbersome plate-based protocols. These
techniques separate the sheared genomic DNA into droplets containing Tn5 conjugated to beads, and perform
an in-droplet tagmentation reaction.
possible [7]. These blocks are then fed into phasing algorithms that attempt to order the blocks
into two different haplotype assemblies. Finally, the completeness of the resulting assemblies are
often assessed by their N50, or the (in the context of haplotyping) “the smallest haplotype block in
which the sum of that block and all larger blocks total to 50% (by length) of the complete haplotype
assembly" [20].
Dilution-limited haplotyping methods differ primarily in the manner by which they compart-
mentalize and amplify the sub-haploid gDNA. Clonal techniques, like those pioneered by Burgtorf
and Kitzman encapsulate 40 kb fragments in fosmids or 50-250 kb fragments in bacterial artificial
chromosomes (BACs) before outgrowth in E. coli and pooling in plates (Figure 2.1A) [23, 24].
Alternatively, in vitro techniques partition raw gDNA into plates before amplification by multiple
displacement amplification (MDA) [25, 26] or long range PCR (Figure 2.1B) [18]. These methods
have a number of trade-offs. While clonal methods require complex and time consuming library
preparations that do not scale for multiple samples, they generate the highest N50’s [7]. In contrast,
in vitro methods (Figure 2.1B) have a lower experimental burden and are less expensive to perform,
but are limited by their amplification methods. In the case of MDA, very deep sequencing (200-500
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Gb) is required to rectify biases inherent to the amplification process [25, 26]. Long range PCR
is less susceptible to these biases, but limits the input fragment length to <10 kb, making longer
haplotype assemblies more difficult [20].
Importantly, the amount of dilution required to keep maternal and paternal DNA separated is
proportional to the number of total compartments. The physical compartments of a plate are thus a
major limitation to scaling these methods. To address this, researchers have devised a number of
alternative methods that avoid cumbersome plate-based protocols. The simplest of these uses Tn5
conjugated to beads to distribute copies of a barcode along a long DNA molecule [27, 28, 29, 30].
The reaction is carried out such that one or few molecules associate with a single bead, creating a
“virtual” compartment. By using 105 − 107 beads, these methods obviate the need for dilution and
amplification. Alternatively, microfluidic methods physically separate DNA and enzymatic mixtures
into droplets, but they require expensive and complicated machinery [31, 32].
Eventually, SLRs could be useful for haplotyping, but as of now, their read length is too short. For
example, before supplementation with population based phasing, Moleculo achieved haplotype blocks
of ∼60 kb [18]. In contrast, similar dilution based haplotying methods have achieved N50s of up to
∼700 kb [26]. In an analysis of the parameters that underlie a successful haplotyping experiment,
Lo et al. found the fragment length of DNA to be the key limiting factor for haplotype contiguity
[7]. This likely explains why SLR methods with fragment lengths of ∼10 kb are unable to compete
with MDA or clonal based haplotype methods that have fragments of ∼50-100 kb. Regardless, SLR
methods have the distinct advantage of being able to directly phase multiple variants on a single
read without the need for cumbersome dilution or cloning steps. Thus, an SLR method that could
increase its read length to be on the same order of the fragment length of existing haplotyping
methods would likely be competitive in this space.
De Novo Assembly
De novo assembly is the process of assembling an organism’s genome from sequencing data without
any a priori information about its content. Like haplotyping, de novo assembly involves the assembly
of short reads into longer contiguous pieces (contigs). Using connectivity information from mate-pair
libraries or other techniques, these contigs can then be ordered into a genome. Longer contigs ease
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the assembly process by better spanning highly repetitive genomic regions that are hard to map,
and by lessening the long-range information needed to accurately order the contigs [33]. De novo
assembly is in some ways easier than haplotyping, as genomes can be assembled into a single contig
when the read length exceeds the longest repeat or structural variant in the genome. In contrast,
haplotyping requires long stretches of heterozygous variants that are typically spaced ∼1.5 kb apart
in order to stitch together haplotype blocks [7]. Nevertheless, many genomes are still incomplete as
mapping these repetitive regions remains a challenge. Consequently, a deep understanding of these
regions is limited, and tremendous amounts of effort must be expended to rectify them [6, 34, 35].
Typically, genomes are assembled de novo by using a combination of NGS library preparation
techniques – often traditional whole genome sequencing (100-600 bp fragments), mate-pair libraries
(2-20 kb inserts), and fosmid libraries (∼40 kb fragments) [36]. Since standard whole genome
sequencing reads are often shorter than the structural variants and repeats they are attempting to
span, longer-range connectivity information is needed to properly map the shorter reads. Mate-pair
libraries provide this information by linking together ends of fragmented gDNA to a specially designed
tag, forming a circle [37]. This circularized construct can then be enriched and converted into a
sequencing library, with each of the resulting paired-end reads representing the beginning or end of
the original fragment. Since the distance between these two fragments is known to an approximate
degree, assembly algorithms can constrain contigs to certain regions. Fosmid libraries can also
provide mate-pair like linkage information [38], but are often reconstructed into longer reads to span
gaps in the whole genome assembly instead, or act as scaffolds on which to map short reads [39].
As long-read sequencers have matured, researchers have begun using them in-place of fosmid and
mate-pair libraries for many assembly applications [40, 41]. This circumvents the labor-intensive
mate-pair and fosmid library preparation processes and is particularly useful in finishing difficult
regions. The error rate of these technologies is still too high to be used for the de novo assembly
of larger genomes, but they have demonstrated success with smaller bacterial genomes [42, 43].
Alternatively, researchers have employed previously mentioned SLR technologies such as Moleculo to
assemble genomes de novo [17, 44]. However, in a direct comparison, PacBio was able to generate a
hundreds-fold more continuous assembly of the Drosophila genome [45]. This was attributed in part
by PacBio’s increased read depth (90x vs 34x), but was mainly due to their longer reads (mean, max:
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∼9, ∼45 vs ∼4.5, ∼15) [45]. As PacBio is currently limited by throughput and error rate, newer
SLR methods with longer read lengths would be immediately beneficial for the de novo assembly.
Tn5
Transposition
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Primer
Barcode
LoxP
Readable
Tagmentation
PCR
Figure 2.2: General overview of BAGEL-seq. In the current iteration, we first clone a sequence of
interest into a backbone containing a sequencing primer (purple), a unique barcode (blue), and a LoxP site.
Next, we use dilute amounts of Tn5 transposase to randomly insert a single copy of a complimentary LoxP
site on average throughout our sequence of interest. These LoxP sites will be inserted either in cis (left), trans
(right), or not at all (middle). Next we dilute the sample and use Cre recombinase to perform intramolecular
recombination between the two LoxP sites. This brings our sequencing primer and barcode adjacent to
wherever Tn5 inserted the second LoxP site. Importantly, both excision (left) and inversion (right) result in
readable sequence (orange). Finally, we tagment the products with Nextera and use PCR to amplify our
sequences of interest.
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BAGEL-seq
With their low error rates, SLRs should perform better than existing technologies for applications
requiring long reads. However, direct comparisons against current haplotyping methods [20] and
PacBio reads [45], reveal that the read length of current SLRs is too short. Since every SLR method
to date relies on PCR to amplify its initial library, their maximum read length is limited to <20
kb. Moleculo has the additional limitation of not barcoding each molecule uniquely, making read
assembly more difficult. This results in a bimodal read length distribution with a peak at 8-10
kb and a mass of shorter sequences. Many of these come from the library preparation itself, but
some come from repetitive regions of the genome that cannot be mapped with short reads [46]. To
increase read length, any future SLR method will need to bypass the length restriction of PCR.
Additionally, uniquely barcoding each molecule will ease downstream read assembly, and unlock a
variety of applications. We will address these issues with a novel library preparation.
Termed BAGEL-seq, or Barcode-directed Assembly of Genomes Enabled by LoxP, our method
generally works as follows (Figure 2.2). First we, clone random fragments into a backbone with a
unique barcode, a sequencing primer, and a LoxP site. For large ∼40kb fragments, this could be
accomplished with a fosmid. After clonal amplification, we then use Tn5 transposase incorporate
a second LoxP site at random positions along each copy’s sequence. Subsequent incubation with
Cre recombinase results in a recombination even between the two LoxP sites, juxtaposing our
sequencing primer and barcode next to the random sequence adjacent to the second LoxP site.
This is functionally equivalent to primer walking every original molecule in multiplex, given that
Tn5 integrates the second LoxP sites uniformly throughout their sequences (Figure 2.3). We then
fragment and add an additional sequencing primer with Nextera. We can select for our sequences of
interest through PCR amplification with the existing primer and the Nextera adapter. Finally, we
group reads together from each barcode and assemble the original molecules computationally.
We believe BAGEL-seq has a number of practical advantages over existing SLR technologies.
First, BAGEL-seq’s read length is not limited by PCR. This theoretically allows researchers to
create synthetic long reads that are only limited by Cre-recombinase’s ability to circularize DNA. In
the current embodiment, this comes at the cost of having to clone the initial library or use fosmids
for extremely long constructs. Second, BAGEL-seq is not as susceptible to circularization biases
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as other library preparations. These methods use a ligase under dilute conditions to circularize
constructs. However, it is much more efficient to circularize shorter constructs (to a point), resulting
in a bias towards shorter SLRs [15]. In contrast, Cre exhibits minimal bias towards circularizing
small fragments and has practically unlimited range; researchers have used Cre to circularize ∼
20kb constructs in vitro [47, 48, 49], and ∼ 100kb bacterial artificial chromosomes in vivo. Lastly,
BAGEL-seq will not require cumbersome plate-based protocols [18, 27] or precisely timed digestion
time courses [14, 15, 16].
Cre
Recombination
Assemble
in silico
Figure 2.3: Illustration of BAGEL-seq primer walking. Here, Tn5 has inserted LoxP sites at different
locations in three copies of the same sequence. After Cre recombination, the sequencing primer (purple) is
brought adjacent to wherever the second LoxP site was inserted. In addition, the sequencing primer reads
through the barcode, maintaining the one-to-one linkage between barcode and molecule throughout the
process. Lastly, the barcode enables reconstruction of the individual molecules by in silico.
2.3 Results
Tn5 Insertion
Although the final realization of BAGEL-seq will generally consist of the steps above, we have yet to
determine its optimal reaction conditions. With respect to Tn5, we must tune its concentration so
that performs a single insertion on average per molecule. Multiple insertion events will fragment
our input DNA a la Nextera. In our initial tests, we performed a serial dilution of Tn5 loaded with
LoxP and found that the resulting DNA was not fragmented at high concentrations (Figure 2.4 A).
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Tn5 is known to insert into any double stranded DNA longer than ∼ 34 bp, as this is approximately
the length of DNA that is protected by Tn5’s molecular footprint [50]. At 34 bp, the LoxP sites are
right on the edge of this length restriction. However, Tn5 requires a 19 bp recognition sequence (the
ME sequence), bringing the total length of the inserted construct to 53 bp. We hypothesized the
∼ 20 bp of extra DNA could serve as a substrate for Tn5 insertion, interfering with insertion into
our target DNA.
Researchers have addressed this issue by loading Tn5 with Y-adapters. As the name might
suggest, Y-adapters are formed by annealing two unevenly sized oligos together. In this case of
Nextera, the shorter oligo only contains the ME sequence, while the longer oligo contains the ME
Sequence and a 15 nt priming sequence. Unfortunately for BAGEL-seq, the LoxP site is an inverted
repeat and is likely to be double stranded. We addressed this by extending the shorter oligo through
the complimentary region of the LoxP site. This brings the double stranded portion to 32 bp. A
serial dilution of Tn5 loaded with the LoxP Y-adapters resulted in the expected fragmentation
pattern (Figure 2.4 A). While 32 bp is less than the proposed cutoff, it is possible that at least some
of the double-stranded portion is serving as a template for Tn5.
Figure 2.4: In vitro validation of BAGEL-seq steps. A. Serial dilution of Tn5 insertion with either
full-length LoxP or Y-adapter LoxP. A supercoiled (−) and linearized (+) plasmid are provided for reference.
At low concentration, both full-length LoxP and Y-adapter LoxP insertions linearize the plasmid. However,
the full-length LoxP does not fragment the plasmid at higher concentrations and even has high-molecular
weight species. This suggests that Tn5 insertion is not proceeding properly. B. Cre recombination control.
The NEB control plasmid with two LoxP sites behaves as expected upon incubation with Cre (+). Similarly, a
plasmid containing one Lox71 and two Lox67 sites recombines upon Cre addition regardless if it is supercoiled
or linearized.
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Cre Recombination
The Cre recombination step also requires detailed consideration. First, we must bias intra-molecular
recombination over inter-molecular recombination. Any inter-molecular recombination will scramble
the one-to-one linkage between a barcode and it’s molecule. This is compounded by the fact that
as the distance between LoxP sites increases (i.e. longer molecules), inter-molecular recombination
becomes more favorable [51]. Fortunately, researchers have developed a rigorous set of mathematical
models that predict the amount of dilution required to favor intra-molecular Cre recombination for
arbitrarily spaced LoxP sites [49, 52, 53].
Second, Cre recombination is an equilibrium reaction, with excision efficiencies reaching a
maximum of 65-70% [54]. In addition, increasing the reaction time or Cre concentration often results
in the formation of high molecular weight aggregates [55]. We hypothesize that asymmetric LoxP
sites could bias the reaction in a specific direction [56, 57, 58]. Briefly, these asymmetric sites contain
mutations in one half of the inverted repeat region that do not affect Cre recognition or recombination.
However, recombination results in a double mutant site that Cre cannot recognize. For BAGEL-seq,
we used the asymmetric Lox71 on our cloning plasmid and had Tn5 insert its complementary Lox67.
A successful intra-molecular recombination between Lox67 and Lox71 results in the double mutant
Lox72. This drives the reaction forward and also stops inter-molecular recombination between
successfully recombined products.
Next, we had to address issues arising from the Tn5 insertion. For one, the Y-adapters are not
valid substrates for Cre. We had to develop a protocol to fill in the single stranded portion of the
Y-adapter and the 9-bp gaps left over from the Tn5 insertion. Additionally, we had to confirm that
Cre could recombine the asymmetric LoxP sites in vitro. This is complicated by the fact that a
single Tn5 insertion event adds two LoxP sites – one on the 5′ and 3′ end of the linearized sequence.
To test this, we cloned two separate Lox67 and a single Lox71 site into a pUC19 backbone. Cre was
able to recombine both the supercoiled and linearized version of this plasmid in vitro (Figure 2.4 B).
After Cre recombination, we fragmented the products with Nextera to prepare them for Illumina
sequencing. This adds a second primer to the 5′ and 3′ ends of every species in the reaction mixture
(Figure 2.2). Unfortunately, our sequencing primer will be downstream of the Nextera primer (Figure
2.2 box). To ensure our sequencing primer is at the 5′ end of the resulting PCR product, we
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performed 10 rounds of a primer extension with biotinylated primers. We purified the product with
streptavidin beads and used that as an input for a standard PCR with our sequencing primer and
Nextera primer.
Proof of Principle
For a proof of principle, we cloned a random fragment from the S. cerevisiae genome into a
pUC19 containing our BAGEL-seq cassette. We successfully generated SLRs that were distributed
throughout the plasmid (Figure 2.5 A). Interestingly, there were distinct biases in the coverage for
all of the SLRs (Figure 2.5 B). This could be due to a combination of the low diversity of our library
and the known insertion bias of Tn5 [59, 60]. While we were able to generate SLRs that had read
lengths longer than what was possible on this Miseq (Figure 2.5 C), the vast majority were < 300
bp long. This implies that we over-fragemented our library during the NGS preparation step since
we sequenced with paired-end 150 reads. Nonetheless, it is promising that we were able to produce
up to ∼ 1000 bp reads in this preliminary experiment.
2.4 Future Directions
At this point BAGEL-seq is very much a prototype that would require numerous optimizations
before it can be applied robustly. First, we need to improve the fragmentation and size selection step
to increase the size of the read length distribution. With longer input molecules at the sequencing
step, we can more accurately measure any potential bias for shorter recombination products. Next,
we need to improve the overall efficiency of the current protocol. The limiting step appears to be
Cre recombination step as Tn5 inserts with almost perfect efficiency (Figure 2.4A). Currently our
efficiency, as measured by % recombined Lox72 site in the sequencing data, is only 3− 10%, which is
far from the reported ∼ 70% maximal efficiency. The lack of efficiency could come from the mutant
Lox66 and Lox71. Alternatively, we may need to include extra sequence context on the end of
our Y-adapter for proper Cre recognition. Lastly, we could try to peform the recombination in an
emulsion, thereby increasing the local concentration of Cre and isolating individual DNA molecules
from eachother.
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Figure 2.5: BAGEL-seq preliminary results. A. Coverage of the top 5 most abundant barcodes. We
see that reads are randomly distributed throughout the plasmid, albiet with some biases for specific positions.
B. Overall coverage of the target plasmid combining all of the SLRs. Again, we find significant bias for a few
positions on the plasmid. Due to the low diversity of the input DNA, this could be a result of Tn5’s insertion
bias. C. Length distribution of SLRs. We find the majority of SLRs are shorter than the maximum 300 bp
(red line) possible with paired 150 nt reads. However, this implies that we over-fragemented our input DNA
before sequencing.
Another important metric to quantify is the amount of intra- vs inter-molecular recombination.
We could quantify this by using BAGEL-seq to sequence a library of plasmids with known sequences.
If there is no inter-molecular recombination, all barcodes will only have reads that map to their
unique sequences. We can use this metric to quantify inter-molecular recombination rates as a
function of input DNA length, library complexity, and concentration. If we cannot minimize the
amount of inter-molecular recombination, we will lose the ability to uniquely sequence individual
molecules, and our data will resemble those of existing haplotyping methods.
It is also important to note that BAGEL-seq does not require Tn5 transposase and Cre recombinase
– any combination of recombinase and transposase will suffice. For example we could use Mu
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transposase to insert FLP recombinase sites. Nonetheless, a robust BAGEL-seq protocol that can
uniquely sequence individual molecules will have profound ramifications. This is especially poingant
in multiplexed assays of long regulatory regions or proteins, which currently require convoluted and
time consuming methods to map variants to barcodes.
2.5 Materials and Methods
Tn5 Purification and Loading
All following methods are adapted from Picelli et al. [61]. After purification, we stored unassembled
Tn5 at -20◦C in a 55% glycerol stock by adding 1.1 volume of 100% glycerol, 0.33 volume of
2x Tn5 dialysis buffer (100 HEPES-KOH at pH 7.2, 0.2 M NaCl, 0.2 mM EDTA, 2 mM DTT,
0.2% Triton X-100, 20% glycerol). To load Tn5, we incubated this glycerol stock at 1:7 ratio
with 100µM annealed oligos at room temperature for an hour. A drop-in Nextera replacement,
these oligos are: Tn5MERev 5′-[phos]CTGTCTCTTATACACATCT-3′; Tn5ME-A (Illumina FC-
121-1030) 5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-3′; and Tn5ME-B (Illumina
FC-121-1031) 5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG-3′. We carried out all
annealing reactions by adding equal volumes of 200µM single stranded oligos (e.g. Tn5ME-A and
Tn5MERev), heating to 98◦C for two minutes, then decreasing at 1◦C a minute until 25◦C.
Tn5 Insertion
We carried out Tn5 insertion reactions as in Picelli et al. [61]. Specifically the reaction conditions
were:
Buffer (TAPS/DMF/MgCl2) - 4 uL
Tn5 (pre-loaded) - 1 uL
DNA (<= 50 ng) - x uL
H20 (to 20 uL) - 15 - x
We incubated this mixture at 55◦C for 7 minutes, and halted the reaction by adding 5µL of 0.2%
SDS. The reaction can be purified by either Zymo CC5 or Agencourt beads. The 5x TAPS-DMF
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buffer consists of 50 mM TAPS-NaOH at pH 8.5 [RT], 25 mM MgCl2, and 50% DMF. A serial
dilution of the pre-loaded Tn5 should be performed with a test plasmid of similar size to determine
the optimal concentration to introduce a single insertion. This will result in a linearized species that
can be determined on a gel.
Gap Fill
After Tn5 insertion, it is important to fill the gap’s left behind before recombination. We attempted
a number of different protocols with varying effect. Since a more thorough characterization would
be necessary to determine the optimal one, I’ve included them all. All enzymes, unless noted were
purchased from NEB.
Wang et al. Gap Fill
This protocol is taken directly from Wang et al. [62].
Ampligase Buffer - 2 uL
dNTP (2.5 mM each) - 2 uL
T4 Pol (3 U/uL) - 1 uL
Ampligase (5 U/uL) - 2.5 uL
DNA (<50 ng) - x
H2O (to 20 uL) - 12.5 - x
Incubate at 37C for 30 mins
Heat inactivate at 75C for 20 mins
T4 Polymerase and Taq Ligase
This protocol is modified from Wang et al. by switching out Ampligase for Taq Ligase. Based on the
EpiCentre literature, the amount of Ampligase used in the protocol is equivalent to 187.5 cohesive
end units.
Taq Ligase Buffer - 2 uL
dNTP (2.5 mM each) - 2 uL
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T4 Pol (3 U/uL) - 1 uL
Taq Ligase (40 U/uL) - 2.5 uL
DNA (<50 ng) - x
H2O (to 20 uL) - 12.5 - x
Incubate at 37C for 30 mins
Heat inactivate at 75C for 20 mins
It should be noted that we could substitute Cut Smart for NEB Buffer 2.1. It could also be useful
to add NAD to the reaction. It should be noted that T4 Polymerase has strong 3′ → 5′ exonuclease
activity at elevated temperatures. To reduce this, NEB recommends 15 mins at 12◦C. Taq ligase
will still be active at this temperature, but to a lesser extent.
Klenow Fragment and Taq Ligase
To eliminate any 3′ → 5′ exonuclease activity we can use Klenow fragment. Klenow shows optimal
activity in Buffer 2, but can be used in all NEB buffers.
Taq Ligase Buffer - 5 uL
dNTPs (2.5 mM each) - 5 uL
Klenow (50 U/uL) - 1 uL
Taq Ligase (40 U/uL) - 2.5 uL
DNA (<50 ng) - x
H2O (to 50 uL) - 35.5 - x
Incubate at 37C for 30 mins
Heat inactivate at 75C for 20 mins
Cre Recombination
We purchased purified Cre recombinase from NEB. In order to avoid inter-molecular recombination,
we must diluted the DNA in our sample. For most sequences < 10kb, nanomolar concentrations of
DNA will typically suffice.
Buffer (10x) - 8.6 uL
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Cre (NEB 15U/uL) - 1 uL
DNA (< 1 nM) - x
H2O (to 86 uL) - 76.4 - x
Incubate at 37C for 30 mins, followed by 70C for 10 mins.
It’s important to note that Cre recombination is an equilibrium reaction that proceeds with ∼ 20−30%
efficiency. Additionally, adding more Cre or incubating for longer periods of time tends to bias the
reaction to high molecular weight aggregates [54, 55, 63].
Next-generation Sequencing
After recombination, we use a Nextera reaction to fragment and add sequencing adapters to our
library. We then perform a primer extension with a biotinylated primer that anneals to our sequencing
primer to enrich for our barcoded species. As the standard Nextera amplification protocol suggests,
we perform a 3 minute gap fill at 72◦C. After a 30 second denature at 98◦C, we then carry out the
linear amplification with 10 cycles of 98◦C for 10 seconds, 55◦C for 30 seconds, 72◦C for 60 seconds,
and a 3 minute final extension at 72◦C. We then used the M-270 Streptavidin beads and protocol
from ThermoFisher to purify the biotinylated products. Next, we performed a 10 rounds of PCR on
the purified biotinylated using our sequencing primer and one of the Nextera Primers. We quantified
the concentration using an Agilent TapeStation and sequenced the resulting product on an Illumina
Miseq.
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Chapter 3
A Systematic Comparison of Error
Correction Enzymes by Next-generation
Sequencing
3.1 Abstract
Gene synthesis, the process of assembling gene-length fragments from shorter groups of oligonu-
cleotides (oligos), is becoming an increasingly important tool in molecular and synthetic biology.
The length, quality, and cost of gene synthesis are limited by errors produced during oligo synthesis
and subsequent assembly. Enzymatic error correction methods are cost-effective means to ameliorate
errors in gene synthesis. Previous analyses of these methods relied on cloning and Sanger sequencing
to evaluate their efficiencies, limiting quantitative assessment and throughput. Here we develop a
method to quantify errors in synthetic DNA by next-generation sequencing. We analyzed errors in
a model gene assembly and systematically compared six different error correction enzymes across
11 conditions. We find that ErrASE and T7 Endonuclease I are the most effective at decreasing
average error rates (up to 5.8-fold relative to the input), whereas MutS is the best for increasing
the number of perfect assemblies (up to 25.2-fold). We are able to quantify differential specificities
†This chapter has been published as: N. B. Lubock, D. Zhang, G. M. Church, and S. Kosuri. “A systematic
comparison of enzymatic error-correction methods using deep sequencing," Nucleic Acids Research, vol. 45, no. 15,
pp. 9206-9217, 2017
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such as ErrASE preferentially corrects C/G transversions whereas T7 Endonuclease I preferentially
corrects A/T transversions. More generally, this experimental and computational pipeline is a fast,
scalable, and extensible way to analyze errors in gene assemblies, to profile error correction methods,
and to benchmark DNA synthesis methods.
3.2 Introduction
Synthetic DNA is a central tool for biological research [1]. Notably, the initial development of nucleic
acid synthesis led directly to the cracking of the genetic code [2]. Today, progress in biology is often
limited by the difficulty in producing long, high-quality synthetic DNA [3, 4]. This bottleneck is
particularly apparent in the assembly of gene-sized fragments of DNA known as gene synthesis [5].
Currently, gene synthesis relies on the assembly of many oligonucleotides (oligos) of ∼40-150
nucleotide (nt) into a single larger piece of DNA of >1,000 base-pairs (bp) [5]. A variety of methods
to assemble oligos into gene-sized fragments exist, but ligation- and polymerase-based assembly
methods are the most common [6, 7, 8, 9]. Regardless of the method, the quality of the final product
is largely dependent on the quality of the oligos used in the assembly.
Oligos are primarily synthesized using phosphoramidite chemistry first developed by Beaucage
and Caruthers in the 1980s [10]. Although these oligos are of high enough quality for common
applications such as PCR, their error rates make practical gene synthesis challenging. Several
groups have managed to synthesize genes from such oligos, but only find about 5-60% perfect
products depending on the size and complexity of the template [11, 12, 13, 14]. This problem is
further exacerbated when using lower-cost, but often lower quality oligos from array-based synthesis
approaches [15, 16, 17, 18, 19, 20].
Consequently, researchers have developed a number of methods to ameliorate oligo error rate
post-synthesis. Size selection methods such as HPLC or PAGE can filter truncated sequences,
but are labor-intensive and ineffective against small errors such as single-base deletions, insertions,
or substitutions [21, 22]. Hybridization-selection techniques can filter large pools of oligos, but
are cost-prohibitive as the number of oligos needed effectively doubles [16, 23]. Sequencing-based
retrieval methods can physically pick perfect sequences or separate them by barcoded PCR, but are
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time-intensive and can require specialized equipment [24, 25, 26]. Enzymatic error correction is a
more commonly-used technique that is relatively inexpensive and effective against most errors. This
method employs a variety of different enzymes traditionally used for mutation detection to filter out
by binding to or cutting at errors [27, 28, 29, 30].
Two particular classes of proteins are most prevalent in error correction: mismatch binding
proteins and mismatch cleaving proteins. Generally, these enzymes recognize distortions in the DNA
helix that are caused by mishybridized bases on either strand. In gene synthesis, a pool of perfect
and imperfect sequences will be melted and re-annealed pairing perfect and imperfect strands to one
another. This produces mishybridized bases that can be recognized by these enzymes. Mismatch
binding proteins are used to enrich perfect sequences, while mismatch cleaving proteins are used
(often in conjunction with exonuclease trimming) to remove imperfect sequences. The most commonly
used mismatch binding protein, MutS, recognizes and binds to all single-base mismatches and a
variety of small single stranded loops caused by insertions or deletions (indels) with varying affinity
[31, 32, 33, 34, 35]. There are a number of different ways to bind and separate error-containing
DNA with MutS including: gel-shift assays, MutS-functionalized columns, and MutS-functionalized
magnetic beads [11, 20, 36]. Mismatch cleaving enzymes operate by cutting at or near an error
and a variety of different mismatch cleaving enzymes are in use [37]. Broadly, these enzymes can
correct errors in two different ways. Similar to mismatch binding methods, perfect sequences can
be recovered by filtering them from those cut by mismatch cleaving enzymes. Alternatively, the
exonuclease activity is used to trim the error-containing region left over by the mismatch cleaving
enzymes. The full length sequences are then recovered by performing a PCR assembly with the
trimmed sequences.
Previous assessments of different enzymatic error correction methods have relied on Sanger
sequencing of finished gene synthesis products to determine their efficiencies [11, 12, 14, 19, 20].
These studies find that, broadly, the dominant mode of errors in gene synthesis products are single-
base deletions and mismatches. However, the prohibitive cost of Sanger sequencing hundreds of
thousands of bases has limited the effective characterization and comparison of existing methods.
Alternatively, one can turn to the mutation detection literature to find biochemical characterizations
of enzymes commonly used in error correction [30, 34, 38, 39, 40]. Although these reports provide
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more detailed affinity data, they typically rely on electrophoretic methods and are thus similarly
limited in sample size.
In order to overcome these limitations, we developed a custom experimental and computational
pipeline that leverages Next-generation Sequencing (NGS) to characterize error rates. Here we
report the first in-depth characterization via NGS of both the errors arising from the assembly
process, as well as the ability of six of the most commonly used error correction enzymes to eliminate
these errors across 11 total conditions. With sample sizes three to four orders of magnitude larger
than previous reports, we are able to gain detailed insights into the modality of errors as well as
each enzyme’s relative ability to correct them. We also used our method to assess the effect of
polymerase on assembly quality by comparing a high-fidelity polymerase (Q5) to a low-fidelity one
(KAPA2G Robust). We believe that our method can act as a generalizable platform to rapidly and
cost-effectively test, characterize, and optimize oligo synthesis parameters or new enzymatic error
correction methods.
3.3 Results
Next-generation Sequencing Based Analysis of a Model Gene Assembly
To assess different enzymatic error correction methods, we first constructed a constant reference
sequence that served as the base for downstream analyses. We designed this sequence to have a
length of 100 bp (not including two 21 bp priming regions for amplification and sequencing), a
balanced nucleotide content (26:23:23:28 A:C:G:T content), good coverage of all nucleotide pairs and
most triplets (80%) while limiting homo-polymer repeats greater than two, and a 28 bp region in the
center that has good melting temperature and low secondary structure to facilitate overlap-extension
assembly of the two primers. We assembled this sequence from two 85 nt oligos by a preliminary
round of polymerase chain assembly (PCA). We then diluted the products of that reaction and
used PCR to amplify the full-length 142 bp construct (Figure 3.1) . We then subject the resulting
assembly to multiple rounds of enzymatic error correction and sequence the products at each step.
We expect that errors arising during sequencing will convolute our true signal. In order to limit
these errors as much as possible, we developed a stringent data processing pipeline briefly outlined
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Figure 3.1: Schematic of Enzymatic Error Correction and Downstream Data Processing. We
assembled our 142 bp product from two 113 nt oligos consisting of a 21 nt primer, a 64 nt payload, and a
28 nt overlap region. After annealing and overlap extension, we amplified our template via PCR, yielding
100 bp of template in-between the primer sites. We then denatured and re-annealed the PCR products
to form heteroduplexes, thereby exposing any errors (shown in green). After, we subjected the pool of
heteroduplexes to two successive rounds of ten different enzymatic error correction treatments. At each step,
we took aliquots and sequenced the products on an Illumina MiSeq with fully overlapping forward and reverse
reads. To mitigate sequencing errors, we used BBMerge to merge reads with a perfect agreement between the
forward and reverse reads. We then aligned these sequences to the designed reference using an exhaustive
Neeleman-Wunsch aligner to minimize alignment artifacts. Finally, we further processed the alignments to
quantitate the types and extent of different errors across all conditions.
as follows: First, we cleaned our raw sequencing reads (509,717 per sample on average) by trimming
sequencing adapters, removing any reads containg “N” base calls (212 reads on average), and filtering
out any reads that aligned to either the PhiX or E. coli genomes with BBDuk (822 reads on average).
This ensures that any spurious reads will not contaminate our alignments and lead to false-positive
error calls. Next, we merged our paired end reads together with BBMerge, only keeping alignments
with perfect correspondence between the forward and reverse reads. Since we sequenced our assembly
with fully overlapping reads, each base is effectively sequenced twice. We found that an average of
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95.2% of all bases in the merged reads had a Phred33 score (Q) of 41 (∼1/12,600 chance of being
miscalled), and 99.8% of all bases on average were above Q30 (1/1000 chance of being miscalled).
It should also be noted that most bases were probably above Q41 as this is the default maximum
Phred score for most read mergers to maintain backwards compatibility with legacy software. The
merging step removed an average of 15.8% of input reads, resulting in an average of 426,514 reads
per sample at the end of processing.
After pre-processing the reads, we used a Python implementation of the Needleman-Wunsch
aligner, uta-align, to align our reads to the perfect reference sequence. We elected to use a
Needleman-Wunsch aligner as it is guaranteed to converge on the optimal alignment for a given
scoring system [41, 42]. In contrast, typical short read aligners such as BWA and Bowtie2 do not
offer such guarantees as they use heuristics to trade accuracy for speed [43, 44]. We find that these
heuristics often result in sub-optimal alignments and miscategorization of error sub-types (Figure
3.6, Table 3.2).
Error-doped Oligos Enable Comparisons
In order to assess the sensitivity of our assay, we treated our two-oligo assembly with the error
correction cocktail ErrASE and measured the resulting error rates (Figure 3.7). Although we were
able to measure significant (Mann-Whitney U, p << 0.001, Holm-corrected) reductions in the rate of
single-base deletions, multiple-base deletions, and single-base insertions, we were not able to find a
significant (Mann-Whitney U, NS, Holm-corrected) reduction between the median rate of mismatches.
To ensure that we had a measurable change in error rates for mismatches after enzymatic treatment,
we assembled our template from oligos that had errors doped into the sequence. Specifically, we
ordered each base with 97% of the intended base, and 1% of the other three nucleotides (not including
the 21 bp priming region and the last base of the oligo).
We found that the errors were doped uniformly into our assembly (Figure 3.2A), with the
majority of errors being mismatches (90.9%), followed by single base deletions (3.1%), multiple base
deletions (2.7%), single base insertions (1.9%), and multiple base insertions (1.5%; Figure 3.2B).
Unlike the standard oligo assembly (Figure 3.8), we found no significant difference between the
median mismatch rate (3.99× 10−2) at any of the four bases (Mann-Whitney U, NS; Figure 3.2C).
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Figure 3.2: Analysis of Model Gene Assembly Error Rates. A. The error rates per base are plotted
across each position in our model separated by the four major classes of error types. We do not see strong
positional effects for errors across the template. B. We find a majority of errors on the template are
mismatches (MM), followed by single (Del.) and multiple base (M. Del.) deletions; Single (Ins.) and multiple
base (M. Ins.) insertions occur at even lower frequencies. C. There are no significant differences between
the median rate ofmismatches at any base (Mann-Whitney U, NS). D. Similarly, there are no significant
differences between transitions and transversions (Mann-Whitney U, NS), implying that the errors were
doped uniformly into our oligos. Note: Blue line is a LOESS fit; box plots are first and third quartile for
hinges, median for bar, and 1.5× the inter-quartile range for whiskers.
Similarly, the median rate of individual transitions and transversions were not significantly different
from each other (Mann-Whitney U, NS; Figure 3.2D). These data suggest that incorrect bases were
doped in to our oligos at an approximately equal rate that exceeded the baseline error rate of KAPA
SYBR Fast – the other potential source of mismatches. We note that the median rates of all error
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Figure 3.3: Effectiveness of Enzymatic Error Correction Methods. Here we compare the error
frequency (errors/kb) and number of perfect assemblies for ten different enzymatic error correction methods.
We find that MutS is the most effective enzyme at increasing the percentage of perfect assemblies. However,
ErrASE is the most effective at decreasing error frequency. Additionally, we see that the efficacy of T7
Endonuclease I is dependent on protocol, and that the addition of a ligase had detrimental effects on sequence
quality. Note: the x-axis is ordered by decreasing number of perfect assemblies.
types were significantly higher in the error-doped assembly (Table 3.3, Figure 3.9; Mann-Whitney U,
p << 0.001). Although this is expected for mismatches, we suspect that the higher median error
rates for the other error sub-types are a result of the non-standard synthesis required to dope the
errors into our oligos.
Enzymatic Error Correction Improves Assembly Quality
Having established the error profile of the error-doped assembly, we evaluated 10 different enzymatic
error correction methods using six different enzymes on their ability improve the quality of this
assembly (Figure 3.3). As expected, consecutive rounds of enzymatic error correction improved
both the relative error frequencies and the number of perfect assemblies. ErrASE was the most
effective at decreasing the error frequency, with two rounds of treatment dropping the error frequency
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from the doped oligo rate of 45.1 to 7.9 errors/kb. The next most effective enzyme at decreasing
error frequency was T7 Endonuclease I (9.1 errors/kb). Based on previous reports in the mutation
detection literature, we hypothesized that the addition of a ligase with T7 Endonucluase I would
improve correction [39]. We find that the addition of T7 ligase actually decreased assembly quality
relative to the no ligase control. In agreement with previous studies, we also find that T7 Endonuclase
I is highly sensitive to protocol and concentration as exhibited by the wide range of error frequencies
[12, 14]. After T7 Endonuclease I, we found MutS to be the third most effective enzyme at 10.9
errors/kb, with T4 Endonuclease VII, Surveyor, and Endonuclease V following.
However, when looking at number of perfect assemblies sequences, MutS was the most effective
enzyme treatment. MutS increased the percentage of perfect sequences in the doped oligo from 1.9%
to 47.8% (47.6% for 950nM), while ErrASE increased it to 45.6%, and T7 Endonuclease I increased
it to 41.7%. In other words, the oligos that are imperfect after the MutS treatment have more errors
on average than those after the T7 Endonuclease I and ErrASE treatments.
Differences in Enzymatic Error Correction
With an average of 426,514 reads per round of error correction, our method provides sample sizes
three to four orders of magnitude higher than any previous study. This enabled us to compare the
effectiveness of these enzymes on rarer errors such as insertions that would be inadequately sampled
with Sanger sequencing. Using the error-doped template as a reference, we measured the relative
change in error rates for each position across all different enzymatic error correction methods (Figure
3.4A).
We see that in general, all enzymes tested were able to correct insertions and deletions. We
find that enzyme performance (as measured by error frequency or number of perfect assembliess)
is directly related to the ability to correct mismatches. For example the best performing enzymes,
ErrASE, T7 Endonuclease I, and MutS, were able to decrease the median mismatch error rate
relative to the error-doped input by 6.2-, 5.1-, and 4.2-fold, respectively. In contrast, the worst
performing enzyme, Endonuclease V, was unable to decrease the median mismatch error rate relative
to the error-doped input.
We next sought to measure differences in affinity for specific errors between enzymes (Figures
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Figure 3.4: Relative Decrease of Different Error Types. A. All enzymes were able to correct both
single- and multiple-base insertions and deletions. Additionally, we find that the best performing enzymes
corrected the highest amount of mismatches. Note: the x-axis is ordered by increasing error frequency. B.
We measure significant differences between the median decrease in C/G → G/C mismatches and the bulk
median of all other mismatches after two treatments of ErrASE. Similarly, two treatments of T7 Endonuclease
I results in a significant difference between the median decrease in A/T → T/A mismatches compared to the
bulk median of all other mismatches (both Mann-Whitney U, p << 0.001).
3.10-3.12). We were unable to measure any significant differences between bases for the median fold
reduction of insertions and deletions (Kruskal-Wallis, NS) across all enzymes after two treatments.
However, we were able to detect significant differences between the median fold reduction of different
mismatches (Kruskal-Wallis, p << 0.001) across all enzymes after two treatments. Based on these
data, we searched for specific mismatch correction biases in our best performing enzymes. For
example, we found that two rounds of ErrASE or MutS treatment resulted in a significantly different
change in the median fold reduction of C/G → G/C mismatches as compared to the bulk median
of all other mismatches (15.2- vs 5.4-fold for ErrASE; 5.1- vs 4.1-fold for MutS; Mann-Whitney U,
p << 0.001). In contrast, two rounds T7 Endonuclease I did not result in significant changes in the
median fold reduction of C/G → G/C mismatches (5.6- vs 5.1-fold; Mann-Whitney U, NS). They
did however, significantly change the median fold reduction of A/T → T/A mismatches as compared
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to the bulk median of all other mismatches (12.7- vs 4.2-fold; Mann-Whitney U, p << 0.001).
Taken together, these data suggest that different enzymatic error correction methods could be
used for different applications. For example, GC- or AT-rich constructs would be best corrected
by ErrASE and T7 Endonuclease I, respectively. Alternatively, MutS can be used for applications
such as protein libraries, where the proportion of perfect sequences are paramount. We also note
that the relative rate of correction for transitions and mismatches in general is likely lower than
what is measured here due to errors incorporated by the Taq-based KAPA SYBR Fast polymerase
during the NGS preparation [45, 46, 47, 48, 49, 50]. For example, the median fold correction of A/T
→ G/C transitions (the most common Taq-based error) was significantly different than that of the
bulk median for all other mismatches for ErrASE, MutS, and T7 Endonuclase I (2.6- vs 7.1-fold
for ErrASE; 2.8- vs 4.4-fold for MutS; 2.5- vs 6.8-fold for T7 Endonuclease I; Mann-Whitney U,
p << 0.001).
Analysis of Two Five-oligo Assemblies
In order to investigate the effect of polymerase fidelity on assembly quality, as well as the performance
of our method on longer constructs, we assembled two 220-bp constructs from five 60 nt oligos with
20 bp overlaps. To facilitate annealing, we designed the overlap regions to have approximately 50%
GC content and minimal secondary structure. We used random nucleotide sequences between the
overlap regions with the single restriction being no single nucleotide repeats longer than 4. The
resulting nucleotide content of the two constructs are relatively balanced (47:50:62:61 – A:C:G:T
for construct one, and 52:53:58:57 – A:C:G:T for construct two). We assembled both constructs
with either Q5 or KAPA2G Robust polymerases, and sequenced the assemblies in duplicate with
an Illumina MiSeq (∼242,000 reads per sample on average after the pipeline filtering). Technical
replicates show high correspondence (Figure 3.13) and the error profiles were consistent for each
polymerase across the two constructs (Figure 3.14).
As expected, constructs assembled with Q5, a high-fidelity polymerase, had lower error frequencies
(2.5 vs 9.7 errors/kb) and a larger percentage of perfect constructs (60.5 vs 10.4%) than KAPA2G
Robust, a Taq-based polymerase (Figure 3.5A). The majority of this difference is caused by the
higher mismatch frequency in the KAPA2G Robust samples (Table 3.1). The frequencies of errors
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Figure 3.5: Effect of Polymerase on Assembly Quality. We assembled two different 220 bp constructs
(C1 and C2) from five 60 nt oligos with 20 bp overlaps with Q5 and Taq polymerase. A. We used our method
to compare the error frequency (errors per kb) and percent perfect assemblies. We see that the average error
frequency for both constructs is significantly higher for Taq than for Q5 (9.7 vs 2.5 errors/kb). We observe
similar trends for the average percentage of perfect assembiles (60.5% for Q5 and 10.4% for Taq). B. Similar
to the two-oligo assembly, we find that the Taq-based KAPA2G Robust polymerase also has a higher rate of
transitions than transversions (mean of 5.32× 10−5 vs. 6.40× 10−6 over both constructs; Mann-Whitney
U, p << 0.001). C. We find that the median rate of multiple base deletions per base in the overlap regions
decreased ∼2-fold relative to non-overlapping regions for both polymerases (Mann-Whitney U, p << 0.001).
Similarly, the median rate of multiple base deltions per base also significantly decreases in the priming regions
for both Taq (∼6-fold) and Q5 (∼13-fold) for both constructs (both Mann-Whitney U, p << 0.001). The
difference in decrease between the polymerases was not significant.
other than mismatches are very similar between the two polymerases (Table 3.1). These errors
are likely due to oligonucleotide synthesis, as polymerase and sequencing errors are most often
mismatches. Using the previously measured error rates of ∼ 2× 10−4 errors/kb/cycle for Q5, we
estimate the expected error frequencies of our assemblies to be ∼0.01 error/kb after 50 rounds
of amplification with Q5 polymerase [48]. Since this value is an order of magnitude lower than
our measured mismatch rate (0.21 mismatch/kb), we estimate the upper bound of mismatches in
oligonucleotide synthesis to be 0.2 mismatches/kb.
In agreement with our two-oligo assemblies (Figure 3.8), the KAPA2G Robust amplified assemblies
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Table 3.1: Estimated error frequencies for five-oligo gene assemblies. Here, we averaged the
errors/kb for both five-oligo assemblies using Q5 and KAPA2G Robust polymerases and their technical
replicates across each error type (errors are standard error of the mean). We see that all error subtypes are
similar except for mismatches.
Error Type Q5 KAPA2G Robust
Mismatches 0.2131 ± 0.0019 7.1388 ± 0.0121
Single Base Deletions 2.0121 ± 0.0062 2.1891 ± 0.008
Single Base Insertions 0.0747 ± 0.0011 0.0816 ± 0.0014
Multiple Base Deletions 0.2326 ± 0.002 0.2342 ± 0.0029
Multiple Base Insertions 0.0014 ± 2e-04 0.0083 ± 4e-04
also had a higher median error rate per base for transitions (5.32 × 10−5) than for transversions
(6.39×10−6) across both constructs (Mann-Whitney U, p << 0.001; Figure 3.5B). These errors agree
with previous single-molecule studies of this polymerase, and suggest that KAPA SYBR Fast was
indeed incorporating mismatches during our NGS preparation for the two-oligo assembly [46, 48]. We
note that the KAPA2G Robust assemblies had a very high mismatch rate at the bases immediately
before and after the third and fifth overlaps. We did not observe this issue in assemblies of the same
oligonucleotide mixtures assembled by Q5.
Next, we measured the effect of the overlapping regions on the number of multiple base deletions
(Figure 3.5C). In congruence with our data from the two-oligo assembly, we found that the median
rate of multiple base deletions (for a given position in the assembly) was significantly different in the
overlap regions than in the rest of the assembly with an average reduction of ∼2-fold for both Q5
and KAPA2G Robust across the constructs (Mann-Whitney U, Holm corrected; p << 0.001). We
found no significant decrease in the rates of single base deletions in the overlapping regions. Since
we added our sequencing primers by annealing to the first and last 15 bp of the constructs, we could
also measure the effect of multiple base deletions in the priming region. Again, we found that the
rate of multiple base deletions in the priming region was significantly different than both the overlap
region and the rest of the assembly, with an average reduction of ∼13-fold for Q5 and ∼6-fold for
KAPA2G Robust (Mann-Whitney U, Holm corrected; p << 0.001). The differences in reduction
between Q5 and KAPA2G Robust were not significant, likely due to a small sample size (n≈25).
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3.4 Discussion
One of the most promising methods to improve the quality of gene synthesis products is enzymatic
error correction. Previous characterizations of error correction enzymes were limited by Sanger
sequencing, which prohibited deep enough sequencing to adequately sample rare variants. Here we
surpass this bottleneck by leveraging next-generation sequencing (NGS) and a custom computational
pipeline to analyze errors in a model gene assembly. With sample sizes of three to four orders of
magnitude greater than any previous study, we were able to accurately quantify error frequencies
sample rare errors such as insertions. In addition, NGS precludes the need for time consuming cloning
steps. This enabled us to rapidly compare six of the most commonly used error correction enzymes
in a total of eleven different conditions in a single experiment, and marks the first comprehensive
comparison of enzymatic error correction methods via NGS.
We took multiple steps to minimize the number of false error calls resulting from our method.
First, we sequenced our assembly with fully overlapping paired-end reads. Since each base is
called independently twice and we only merge reads with a perfect match between the forward and
reverse reads, it is unlikely that many sequencing errors made it through this filter. We compared
the error profile of the Needleman-Wunsch alignment to two commonly used short-read aligners,
BBMap and Bowtie2. As BBMap and Bowtie2 use heuristics that trade accuracy for speed, we found
that their resulting alignments were sub-optimal and led to higher false error calls relative to the
Needleman-Wunsch alignment.
We assessed the sensitivity of our method by comparing the error rates of a two-oligo assembly
before and after ErrASE treatment. We could measure significant changes in all errors except for
mismatches. We hypothesized that our polymerase had re-incorporated mismatches during the NGS
preparation. To ensure that we could measure changes in the amount of mismatches, we re-assembled
our model sequence with oligos synthesized with 3% of the incorrect base at every position. We
expected that the net change in mismatches in the error-doped template after error correction
would be larger than the basal error rate of the polymerase, enabling quantification. Additionally,
increasing the error rate gives a more realistic number of errors (3-4) per assembly that might occur
in a longer gene synthesis.
We then used our method to test the ability of six of the most common error correction enzymes
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in eleven total conditions to improve the quality of the error-doped assembly. As expected, we found
that all error correction enzymes were able to decrease the error frequency and increase the number
of perfect assemblies. We also found that two consecutive treatments of error correction were more
effective than one. We then leveraged the large sample sizes generated by NGS to probe specific
differences between different enzyme treatments. These data suggest that ErrASE would be the most
effective at correcting GC-rich templates, and T7 Endonuclease I is the most effective at correcting
AT-rich templates. Alternatively, MutS would be appropriate for the most common applications
requiring a single sequenced-verified perfect assembly. The discrepancy of average error frequency
and percentage of perfect sequences highlights the importance of using the metrics that are most
appropriate for downstream application. In addition, we find that performance of these enzymatic
treatments is sensitive to the protocol used as shown in the MutS and T7 Endonuclease I assays.
To test the effect of the polymerase on assembly quality, we assembled two 220 bp constructs
from five oligos with both KAPA2G Robust and Q5 polymerases, and compared their error profiles.
As expected, we measured a significantly higher number of mismatches in the KAPA2G Robust
assemblies than in the Q5. Since the expected mismatch rate of Q5 is lower than our measured value,
we estimated an approximate upper bound on the underlying error frequencies of column-synthesized
oligos. This is corroborated by the fact that the frequencies of all error types except for mismatches
agreed between the two polymerases. Thus, the most common errors in our assemblies were single
base deletions, when controlling for polymerase effects. This agrees with previous studies of enzymatic
error correction [11, 14, 19]. Two other studies found mismatches to be the most common error.
In the first study, this is likely explained by the fact that they amplified their constructs with
Taq-polymerase [12]. The second study assembled their genes from chip-synthesized oligos, which
might have different error profiles [20]. Lastly, we found that the overlapping regions of our assembly
were effective at decreasing the rate of multiple base deletions, but were ineffective for single base
deletions.
Our method in its current iteration has limitations. For one, any polymerase misincorporations
will convolute the true mismatch correction rate of a given enzyme. While we show that using a
high-fidelity polymerase throughout the assembly and NGS library preparation steps ameliorates
this issue, we migh still be observing library preparation artifacts. Alternatively, we can incorporate
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random barcoding strategies or utilize single molecule sequencing to further eliminate polymerase
errors [46, 48, 50]. Second, Illumina sequencing limits our assessments to assemblies < 600 bp. We
could extend our methodology to long-read technologies such as PacBio or Oxford Nanopore to
assess kilobase-scale gene synthesis products [51]. At these lengths, we would likely have to switch
from a Needleman-Wunsch alignment to more optimized versions in order to avoid a significant time
penalty [52]. Lastly, our model two-oligo assembly used to analyze enzymatic error correction is not
indicative of a typical gene synthesis product as it does not code for a gene, is shorter than standard
assemblies (142 bp), is assembled from only two oligos, and has a contrived mismatch error rate.
Overall, our method is a fast and accurate method for looking at errors in arbitrary sequences.
We believe that this method will be useful for not only rapidly profiling new enzymatic error
correction methods, but for other applications such as assessing the quality of chip-synthesized oligos
or developing new gene synthesis methods.
3.5 Materials and Methods
Pre-processing
To ensure that we only analyzed high quality reads, we first ran our sequencing data through a
pre-processing pipeline. First, we used BBDuk (part of the BBMap suite; version 36.14) to trim any
Illumina adapters from our reads [53]. Next, we used BBDuk to remove any reads with at least 26
bases that match to the PhiX (NC_001422) or E. coli (U00096.3) genomes. We also removed any
read pairs that had an “N” base call in either one of the reads during this step. We then took the
filtered reads and merged read pairs with perfectly overlapping regions with BBMerge (also part of
the BBMap suite; version 36.14) using the pfilter=1 option.
Alignment and Parsing
After read pre-processing and merging, we use a custom Python script to align our reads to the
reference oligo sequence, and parse the resulting alignments to get the positions of all errors. Our
Python script uses the uta-align (version 0.1.6) package from the Python Package Index (PyPI)
to perform a Needleman-Wunsch exhaustive global alignment of the input reads to the reference
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sequence [54]. Our script can also provide functionality for performing any alignment supported by
the uta-align library (e.g. Smith-Waterman local alignments), and allows for tunable gap penalties
or match scores.
Once the alignment and parsing is complete, our script will output the results in a tidy csv file
with the name of the read, the position of the error, the type of error, and the actual error itself [55].
The types of errors are as follows: M - Mismatch, D - single-base Deletion, I - single-base Insertion,
P - multiPle-base deletion, and S - multiple-base inSertion. The errors are classified as: (Original
Base)(Mutated Base) for mismatches; the reference base(s) that were deleted for deletions; and the
base(s) that were inserted for insertions. Both single and multiple-base insertions are mapped to the
“right” of the base in the reference sequence. For example, if the reference sequence was “GATTACA”
and we inserted a C at position 3, the resulting alignment can be visualized as:
Position: 123-4567
Reference: GAT-TACA
Read: GATCTACA
CSV: Read_1, 3, I, C
Lastly, if there is a single-base deletion or insertion in a region where there is an identical base
adjacent to the mapped position of the error, we distribute the fractional count of the total number
of identical bases over each position. For example, if our alignment produced a deletion of A at
position 2 in the sequence “TAAAG,” our software will note this as a deletion of A at positions 2, 3,
and 4, with fractional counts of 1/3 at each of those positions. This compensates for the fact that
there are three equally valid alignments in that region.
Error Frequency Calculations and Definitions
To be consistent with previous studies, we calculated the relative error frequency per kb (f) as
f =
n∑
i=1
xi
1000
li
n
(3.1)
where xi is the number of errors in read i, li is the length of that read, and n is the total number of
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reads [12]. This is distinct from error rates, which are defined as the number of errors detected at
a given base, divided by the total number of sequencing reads in the sample. Error rates can be
further separated by the specific error sub-type.
Reagents
All the oligos were synthesized by Integrated DNA Technologies (IDT). The ErrASE Error Correction
Kit was purchased from Novici Biotech and is now available as CorrectASE from ThermoFisher. The
Surveyor Mutation Detection Kit was from Transgenomic. T4 Endonuclease VII was from Affymetrix.
Thermus aquaticus MutS DNA mismatch repair protein was from Excellgen. Endonuclease V, T7
Endonuclease I, and T7 DNA Ligase were all from New England Biolabs.
Error-enriched oligonucleotide synthesis and template assembly
The 85-nucleotide (nt) forward and reverse oligos contains 21nt primer sites and 64nt template regions,
63 of which, except for the last base, were doped with 3% errors at each position (Supplementary
File 1). This doping is achieved by hand-mixing 1% of every other base into the 97% of the reference
base. For example, according to the reference sequence, if a position is supposed to be an A, then
1% of C, T, and G was mixed into 97% A during the initial oligo synthesis by IDT. With 28nt
complementary regions, the two oligos were able to anneal and then assembled into a 142-base pair
(bp) doubled-stranded template. This template consists of two 21bp primer regions and a 100bp
region for error correction and for subsequent next-generation sequencing.
Specifically, to pre-assemble the forward and reverse oligos, 10.4µL nuclease-free water (Ambion),
4µL 5X HF Buffer (New England Biolabs), 0.4µL 25mM dNTP (New England Biolabs), and
0.2µL Phusion High Fidelity Polymerase (New England Biolabs) were added into 5µL 1µM mixed
aforementioned forward and reverse oligos. Initially heated at 98C for 30 seconds, the reaction was
then cycled 15 times: at 98C for 5 seconds, at 70C for 1 second, ramping down with a speed of
0.5C/second to 50C, at 50C for 30 seconds, and at 72C for 20 seconds. The final extension step was
at 72C for 5 minutes. The product after the pre-assembly step was diluted 1:10 in nuclease-free water,
2µL of which, served as template, was added into 35.25µL nuclease-free water, 10µL 5X HF Buffer,
1µL 25mM dNTP, 0.5µL Phusion High Fidelity Polymerase, 1.25µL 10mM mixture of forward (5′
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TACACGACGCTCTTCCGATCT 3′) and reverse (5′ AGACGTGTGCTCTTCCGATCT 3′) PCR
amplification primers to make the total volume of this PCR 50µL (Supplementary File 1). Initially
heated at 98C for 30 seconds, the reaction was then cycled 25 times: at 98C for 5 seconds, at 62C
for 10 seconds, at 72C for 10 seconds. The final elongation step was at 72C for 5 minutes. Pooled
PCR products were then cleaned using QIAquick PCR Purification Kit (Qiagen), and the purified
products served as the template for subsequent error correction treatments and sequencing.
Error correction of the synthetic DNA template
ErrASE
Per the manufacturer’s instructions, 60µL of ∼50ng/µL template in 1X HF Buffer was re-annealed
to form heteroduplex by heating at 98C for 1 minute, cooling at 0C for 5 minutes, and incubating
at 37C for 5 minutes. Next, 10µL of this re-annealed heteroduplex was added into each well of
the 6-well ErrASE tube and was incubated at room temperature for 1 hour. We then combined
2µL from each well as template into the recovery PCR, whose setup and thermocycling conditions
were the same as the assembly PCR in the section above. The PCR product using the treated
heteroduplex from the first well of the ErrASE tube (presumably has the highest concentration of
ErrASE) presented a band, indicating successful recovery after error correction. This product was
thus cleaned-up using QIAquick PCR Purification Kit and served as the template for the second
iteration of ErrASE treatment.
Surveyor
Per the manufacturer’s instructions, ∼50ng/µL template in 1X HF Buffer was re-annealed to form
heteroduplex by the following thermocycling conditions. First, the sample was heated at 95C for
10 minutes. Then, the temperature was ramped down at 2C/second, and was held at 85C for 1
minute. Finally, the temperature was further cooled down to 25C at 0.3C/second, and was held for 1
minute at every 10C interval. Per Saaem et al., 2µL Surveyor Nuclease S and 1µL Enhancer S were
added into 8µL re-annealed heteroduplex [19]. The reaction mixture was then incubated at 42C
for 60 minutes. After the treatment was concluded, 2µL of the mixture served as the template in
the recovery PCR, whose setup and thermocycling conditions were the same as the assembly PCR.
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The product of this recovery PCR, once cleaned-up, entered the next round of Surveyor Nuclease
treatment.
Endonuclease V
Similar to Fuhrmann et al., 10µL of ∼50ng/µL template in 1X HF Buffer was re-annealed using the
cycling condition described in the ErrASE section [12]. We then added 5U of Endonuclease V, 2µL
of NEBuffer 4, and nuclease-free water to the re-annealed heteroduplex to make the total volume
20µL. The reaction was incubated at 37C for 24h, and 2µL of this mixture served as the template
for the recovery PCR. The cleaned-up product then entered the next iteration of Endonuclease V
treatment.
T7 Endonuclease I (Fuhrmann)
As in Fuhrmann et al., 10µL of ∼50ng/µL template in 1X HF Buffer was re-annealed using the
cycling condition described in the ErrASE section [12]. We combined 2µL of NEBuffer 2, 25U of T7
Endonuclease I, and nuclease-free water to make the final volume 20µL. The reaction was incubated
at 37C for 24 hours, and 2µL of the mixture served as the template for the recovery PCR. The
cleaned-up product entered the next iteration of T7 Endonuclease I treatment.
T7 Endonuclease I with T7 DNA Ligase
We first re-annealed 100ng of template in 1X HF Buffer according to the ErrASE protocol. Then we
combined 2.5µL of T4 DNA Ligase reaction buffer, 10U of T7 Endonuclease I, T7 DNA Ligase (at 0,
1000U, or 10000U), and the appropriate amount of nuclease-free water to make the final volume
25µL. The reaction was then incubated at 25C for 4 hours, and 2µL of the treated sample served as
the template for recovery PCR. We used 100ng of the cleaned-up product for the next iteration of
T7 Endonuclease I/T7 DNA Ligase treatment.
T4 Endonuclease VII
First, 10µL of ∼50ng/µL template in 1X HF Buffer was re-annealed using the cycling condition
described in the ErrASE section. Then, 1µL 1M Tris-HCl (pH 8.0), 4µL 50mM MgCl2, 2µL 100mM
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β-mercaptoethanol, 1µL 10mg/ml BSA, and 2µL T4 Endo VII (1000U) was added to the 10µL
heteroduplex. The reaction mixture was incubated at 37C for 24 hours, and 2µL of which served as
the template for the recovery PCR. Then the cleaned-up PCR product entered the next cycle of T4
Endonuclease VII.
MutS
Per the manufacturer’s instructions, 250ng/µL in 10mM Tris-HCl (pH=7.8) and 50mM MgCl2
was heated to 95C for 5 minutes followed by cooling at 0.1C/second to 25C. To the re-annealed
template, 207.39µL 1X binding buffer (20mM Tris-HCl (pH=7.8), 10mM NaCl, 5mM MgCl2,
1mM Dithiothreitol and 5% glycerol) was added, making the concentration of DNA template to
∼11.5ng/µL. This mixture was then aliquoted into two tubes with 109µL in each. Appropriate
amount of MutS was added into each of the tubes so that the final MutS concentration was 950nM
and 1900nM, respectively. The mixtures were then incubated at room temperature for 20 minutes.
Equal volumes of Amylose Resin (New England Biolabs), washed and pre-equilibrated with 1X
binding buffer, were added into the tubes. The mixtures were incubated at room temperature for 30
minutes, before being spun down. We purified the supernatants with a Qiagen MinElute kit, and
eluted the product in 10µL EB. We used 2µL of the 1:100 diluted elution as the templates for the
recovery PCR. Lastly, we pooled the PCR products, cleaned them up, and used them for the next
iteration of MutS treatments.
Next-Generation Sequencing using Illumina MiSeq
Each of the control and enzymatically treated samples was prepared as an individual sequencing
library. In summary, the sequencing libraries were prepared using two rounds of qPCR, with the first
round appending the Illumina P5 sequence and the second appending the P7 sequence as well as
the indices. We also note that the KAPA SYBR FAST kit is a Taq-based polymerase. Specifically,
the first round of PCR was set up by mixing 25µL KAPA SYBR FAST Universal 2X qPCR Master
Mix (KAPA Biosystems), 1µL 10µM Multiplexing PCR Primer 1.0, 1µL 10µM Multiplexing PCR
Primer 2.0, 1µL ∼100pg/µL error correction DNA template, and 22µL nuclease-free water. Per the
manufacturer’s instructions, the 2-step thermocycling protocol was used for the qPCR reactions.
58
Once the signals reached the plateaus, the reactions were stopped and cleaned-up using Agencourt
AMPure beads, according to the manufacturer’s instructions. The final elution volume was 30µL.
To set up the second round of PCR, 25µL KAPA SYBR FAST Universal 2X qPCR Master Mix,
1µL 10µM Multiplexing PCR Primer 1.0, 1µL 10µM PCR Primer each with a distinct index, 1µL
∼100pg/µL template from the first round PCR, and 22µL nuclease-free water. The thermocycling and
cleaned-up procedures remained the same as those in the first round of PCR. Then, the individually
prepared sequencing libraries were quantified using the Library Quantification Kit-Illumina (KAPA
Biosystems), according to the provided protocol. Barcoded libraries were subsequently mixed to
∼10nM concentration, and the mixed libraries were quantified again before being loaded onto an
Illumina MiSeq with a V2 300 cycle kit.
Five-oligo Assembly with High- and Low-fidelity Polymerases
We designed two 220-bp constructs that can be assembled from five 60-nucleotide (nt) oligos each
(Supplementary File 1). Each overlap region between adjacent oligos is 20-bp in length, and the
first and last oligo contain 15-bp forward and reverse priming regions used for assembly. All overlap
and priming sequences were taken from the set designed in Eroshenko et. al to minimize cross-
hybridization and maximize Tm similarity [56]. Each set of five oligos was synthesized by Integrated
DNA Technologies (IDT) with no modifications and pooled into two 1µM five-oligo mixes.
To pre-assemble the five-oligo construct, 5µL of each 1µM five-oligo mix was added to 10µL of
NEBNext Q5 HotStart HiFi PCR Master Mix or KAPA2G Robust HotStart ReadyMix and 5µL
nuclease-free water. Initially heated at 98C for 30 seconds, the reaction was then cycled 15 times: at
98C for 5 seconds, at 70C for 1 second, ramping down with a speed of 0.5C/second to 50C, at 50C
for 30 seconds, and at 72C for 20 seconds. The final extension step was at 72C for 5 minutes. The
product after the pre-assembly step was diluted 1:10 in nuclease-free water, 2µL of which, served as
template, was added into 20.5µL nuclease-free water, 25µL of Q5 or KAPA2G Robust master mixes,
and 1.25µL 10mM mixture of forward and reverse amplification primers flanking the outer oligos of
each construct. Initially heated at 98C for 30 seconds, the reaction was then cycled 20 times: at 98C
for 5 seconds, at 62C for 10 seconds, at 72C for 10 seconds. The final elongation step was at 72C for
5 minutes. Pooled PCR products were then purified using a DNA Clean and Concentrator-5 (Zymo).
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We prepared each assembly as an individual sequencing library with two techincal replicates.
The sequencing libraries were prepared using a single round of PCR, which appended both the
Illumina P5 and P7 sequences as well as the indices. Specifically, 0.01ng of template was added
to 20.5µL nuclease-free water, 25µL Q5 or KAPA2G Robust (depending upon initial condition),
and 1.25µL 1µM forward and reverse sequencing primer with corresponding distinct indices. Each
library was amplified for a small number of cycles (∼12-14) empirically determined using KAPA
SYBR FAST Universal 2X qPCR Master Mix (KAPA Biosystems). We estimate the total number
of amplification cycles to be < 50 (< 15 for pre-amplification, 20 for amplification, and 12-14 for
NGS prep). Individually prepared sequencing libraries were quantified using an Agilent TapeStation
2200. Barcoded libraries were subsequently pooled and mixed to 20nM concentration, and prepared
for sequencing on a 500-cycle V2 MiSeq (Illumina).
3.6 Supplementary Information
Analysis of a Two Oligo Assembly
We applied our pipeline to quantify the different types of errors found in our two-oligo assembly of
standard (not error doped) oligos (Figure 3.8). We find that on average about one-third of assemblies
contain errors, with an overall error frequency of approximately 4.3 errors per kb. We find that
mismatches account for the majority of errors (∼75%), followed by single (∼14%) and multiple-base
deletions (∼8%) (Figure 3.8A). The mismatches segregate into two significantly different populations,
with the median error rate per base being higher at A’s (4.33×10−3) and T’s (4.25×10−3) than
at G’s (1.68×10−3) and C’s (1.91×10−3) (Figures SB, C; Mann-Whitney U, p << 0.001, Holm-
corrected). Furthermore, we find that the median rate of transitions was significantly higher than
that of transversions for each base (Figure 3.2C; Mann-Whitney U, p << 0.001, Holm-corrected).
All of these observations indicate that much of the mismatch error rate is due to polymerase
misincorporation during the amplification steps for assembly and sample-preparation for sequencing.
Specifically, we used the Taq-based KAPA SYBR Fast polymerase during next-generation sequencing
library preparation steps. Consistent with our observations, misincorporations caused by Taq occur
most often at A’s and T’s, and are preferentially A/T → G/C transitions (49–52). However, we
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cannot completely rule out the effect of errors in the oligo synthesis as our error frequency of 4.3
errors per kb is higher than the ∼3 error/kb expected from 50 rounds of amplification at previously
reported Taq error rates (52–54).
Next, we quantified the rates of single- and multiple-base deletions. We find that the median
single-base deletion rate per position (5.64×10−4), and that this rate did not vary significantly over
the positions (Mann-Whitney U, NS). We also find that multiple-base deletions occur at a similar
rate as single-base deletions (3.35×10−4), and measure positional effects for where they occur. Some
of this dependence can be explained by the fact that the positions of multiple-base deletions are
mapped to the left-most deleted base. Thus, we expect the total number of multiple-base deletions
to be highest at position one and decreasing after, since there are the most possible combinations of
multiple-base deletions at that position. In addition, we measure a significant decrease in the median
multiple-base deletion rate in the annealing region (positions 36-64) of our assembly (Mann-Whitney
U, p << 0.001). Large deletions in this region would disrupt the hybridization of the initial assembly,
leading to sequence drop-outs and a decrease in the measured number of deletions. We also expect
the multiple deletion rate to drop towards the end of the sequence due to a “TATATAT” motif at
positions 92-98. Any “TA” deletion (or other substring contained multiple times in the motif) will
map to the left-most position, 92.
Finally, we quantified single-base insertions. These errors occur at median rate per position of
9.65×10−5) and exhibit no positional dependence besides an outlier at position 1. An incomplete
primer trimming by BBDuk can explain this outlier. Here, 57 of the 152 single-base insertions
are a “T,” corresponding to the last base of the primer sequence directly upstream of our first
base. Without these 57 bases, the rate of single-base insertions falls closer to the expected median
value. Our method is also able to detect multiple-base insertions, which occur at a median rate of
6.16×10−6).
Availability
The computational pipeline described above is open source, free to use under the MIT license,
and available at https://github.com/kosurilab/errorCorrect. For the final analysis and figure
production, we used R (version 3.3.*) and ggplot2 [57, 58].
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Accession Numbers
Sequencing data are available from the sequencing read archive (SRA) with the accession number
SRP110084.
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Figure 3.6: Effect of read aligner on error rates. Here we mapped reads from the standard IDT oligo
with BBMap (red), Bowtie2 (green), and our Needleman-Wunsch aligner (blue), and quantified the error rates
with our pipeline. We see that the choice of aligner affects the resulting error rates, especially for detecting
multiple-base deletions.
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Figure 3.7: Distributions of error rates per position for the standard oligo assembly before and
after ErrASE treatment. We were unable to detect a significant change between the median error rate
after two treatments for mismatches. Note: black bar is median value.
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Figure 3.8: In-depth analysis of standard assemblies. A) The error rates per base are plotted across
each position in our model separated by the four major classes of error types. We do not see strong positional
effects for errors across the template. B) We find a majority of errors on the template are mismatches
(MM), followed by single (Del.) and multiple base (M. Del.) deletions; Single (Ins.) and multiple base (M.
Ins.) insertions occur at even lower frequencies. (C) We measure a significantly higher mismatch rate at
A’s (4.33× 10−3) and T’s (4.25× 10−3) than at G’s (1.68× 10−3) and C’s (1.91× 10−3) (Mann-Whitney U,
p << 0.001). (D) We measure a significantly higher number of transitions (purple) than transversions (green)
at each base (Mann-Whitney U, p << 0.001). The higher error rates at A’s and T’s is consistent with Taq
polymerase errors. Note: Blue line is a LOESS fit; box plots are first and third quartile for hinges, median
for bar, and 1.5× the inter-quartile range for whiskers. Note: here we performed the same analysis as Figure
2 in the main text with the error-doped assembly.
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Figure 3.9: Comparison of measured error rates from error-doped and standard oligos. Here
we plot the distribution of error rates per position and see that for every error sub-type the error rates are
significantly higher for the error-doped oligos than those produced by the standard process (Mann-Whitney
U Test, all p << 0.001). Note: Black bar is the median value.
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Figure 3.10: Mismatch correction preferences relative to the error-doped oligo for every enzyme
across two consecutive treatments. Error rates are plotted as the log2-fold-change in error rate relative
to the error-doped template. Note: box plots are first and third quartile for hinges, median for bar, and
1.5× the inter-quartile range for whiskers.
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Figure 3.11: Single-base deletion correction preferences relative to the error-doped oligo for
every enzyme across two consecutive treatments. Error rates are plotted as the log2-fold-change in
error rate relative to the error-doped template. Note: box plots are first and third quartile for hinges, median
for bar, and 1.5× the inter-quartile range for whiskers.
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Insertion Reduction Relative to Doped Assembly
Figure 3.12: Single-base insertion correction preferences relative to the error-doped oligo for
every enzyme across two consecutive treatments. Error rates are plotted as the log2-fold-change in
error rate relative to the error-doped template. Note: box plots are first and third quartile for hinges, median
for bar, and 1.5× the inter-quartile range for whiskers.
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Figure 3.13: Correlations between error rates for five-oligo assembly technical replicates. We
see that technical replicates are almost perfectly correlated (all r > 0.995), with the black line being y = x.
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Figure 3.14: Positional error rate distributions two assemblies using KAPA2G Robust and Q5
polymerase. We see that KAPA2G Robust, a Taq-based low-fidelity polymerase, incorporates Mismatches
(MM) at nearly two-orders of magnitude higher than Q5, a high-fidelity polymerase. We find that both
polymerases incorporate single base deletions (Del.), multiple base deletions (M. Del.), single base insertions
(Ins.), and multiple base insertions (M. Ins.) at nearly identical rates. With the exception of multiple base
insertions, these trends are robust to the different sequence contexts of the two constructs. We note that
KAPA2G Robust incorporates a higher number of multiple base insertions around three tandem GGA repeats,
likely due to polymerase slippage.
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Table 3.2: Examples of where various aligners fail. Here _ are padding for visualization, * are
soft-trimming, and lower-case bases are inserts.
Aligner: Ideal Needleman-Wunsch Bowtie2 BBMap
Reference: _GCTGCCGATTT... _GCTGCCGATTT... G_CTGCCGATTT... *GCTGCCGATTT...
Read: aGCTGCCGATTT... aGCTGCCGATTT... aGCTGCCGATTT... *GCTGCCGATTT...
Reference: __GCTGCCGATTT... __GCTGCCGATTT... G__CTGCCGATTT... **GCTGCCGATTT...
Read: aaGCTGCCGATTT... aaGCTGCCGATTT... aaGCTGCCGATTT... **GCTGCCGATTT...
Reference: GCTGCCGATTT... GCTGCCGATTT... GCTGCCGATTT... GCTGCCGATTT...
Read: GCT___GATTT... GCT___GATTT... ___GCTGATTT... ___GCTGATTT...
Reference: GCTGCCGATTT... GCTGCCGATTT... GCTGCCGAT_TT... GCTGCCGATTT...
Read: GCTG_____TT... GCTG_____TT... ______..T... GCTG_____TT...
Reference: ...TGTATATATCG_ ...TGTATATATCG_ ...TGTATATATC_G ...TGTATATATCG*
Read: ...TGTATATATCGa ...TGTATATATCGa ...TGTATATATCaG ...TGTATATATCG*
Reference: ...TGTATATATC__G ...TGTATATATC__G ...TGTATATATC__G ...TGTATATATCG**
Read: ...TGTATATATCatG ...TGTATATATCatG ...TGTATATATCatG ...TGTATATATCa**
Reference: ...TGTATATAT__CG ...TGTATATA__TCG ...TGTATATA__TCG ...TGTATATATCG**
Read: ...TGTATATATgtCG ...TGTATATATgtCG ...TGTATATATgtCG ...TGTATATATgt**
Reference: ...TGTATATATCG ...TGTATATATCG ...TGTATATATCG ...TGTATATATCG
Read: ...TGTATATA__G ...TGTATATA__G ...TGTATATAG__ ...TGTATATAG__
Reference: ...TGTATATAT__CG ...TGTATATA__TCG ...TGTATATA__TCG ...TGTATATATCG**
Read: ...TGTATATATgtCG ...TGTATATATgtCG ...TGTATATATgtCG ...TGTATATATgt**
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Table 3.3: Median error rate per position for assemblies using the error-doped oligos or
the standard oligos. We measure significant (Mann-Whitney U, p << 0.001) differences between
the median error rates of the error-doped and standard oligos for all error sub-types.
Type Error-Doped Oligo Standard Oligo
All Errors 4.38× 10−2 4.18× 10−3
Mismatches 3.99× 10−2 3.08× 10−3
Single Base Deletions 1.28× 10−3 5.64× 10−4
Multiple Base Deletions 1.17× 10−3 3.35× 10−4
Single Base Insertions 7.64× 10−4 9.65× 10−5
Multiple Base Insertions 6.16× 10−4 6.16× 10−6
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Chapter 4
Multiplexed Gene Synthesis in
Emulsions for Exploring Protein
Functional Landscapes
4.1 Abstract
Improving our ability to construct and functionally characterize DNA sequences would broadly
accelerate progress in biology. Here, we introduce DropSynth, a scalable, low-cost method to build
thousands of defined gene-length constructs in a pooled (multiplexed) manner. DropSynth uses a
library of barcoded beads that pull down the oligonucleotides necessary for a gene’s assembly, which
are then processed and assembled in water-in-oil emulsions. We use DropSynth to successfully build
>7000 synthetic genes that encode phylogenetically-diverse homologs of two essential genes in E.
coli. We tested the ability of phosphopantetheine adenylyltransferase homologs to complement a
knockout E. coli strain in multiplex, revealing core functional motifs and reasons underlying homolog
incompatibility. DropSynth coupled with multiplexed functional assays allow us to rationally explore
sequence-function relationships at unprecedented scale.
†This chapter has been published as: C. Plesa, A. M. Sidore, N. B. Lubock, D. Zhang, and S. Kosuri “Multiplexed
gene synthesis in emulsions for exploring protein functional landscapes,” Science, vol. 359, no. 6373, pp. 343-347, 2018
78
4.2 Main Text
The scale at which we can build and functionally characterize DNA sequences sets the pace at which
we explore and engineer biology. The recent development of multiplexed functional assays allows for
the facile testing of thousands to millions of sequences across a wide array of biological functions
[1, 2]. Currently, such assays are limited by their ability to build or access DNA sequences to test.
Natural or mutagenized DNA sequences [3, 4] allow for large libraries, but are not easily programmed
and thus limit hypotheses, applications, and engineered designs. Alternatively, researchers can use
low-cost microarray-based oligo pools that allow for large libraries of designed ∼200 nucleotide (nt)
sequences [5], but their short lengths limit many other applications. Gene synthesis is capable of
creating long-length sequences, but high costs currently prohibit building large libraries of designed
sequences [6, 7, 8, 9].
Here we develop a gene synthesis method we term DropSynth, a multiplexed approach capable of
building large pooled libraries of designed gene-length sequences. DropSynth uses microarray derived
oligo libraries to assemble gene libraries at vastly reduced costs. We and others have developed
robust parallel processes to build genes from oligo arrays, but because each gene must be assembled
individually, costs are prohibitive for large gene libraries [6, 10]. In these efforts, the ability to isolate
and concentrate DNA from the background pool complexity was paramount for robust assemblies
[11]. Previous efforts to multiplex such assemblies have not isolated reactions from one another,
and thus suffered from short assembly lengths, highly-biased libraries, the inability to scale, and
constraints on sequence homology [12, 13, 14, 15].
DropSynth works by pulling down only those oligos required for a particular gene’s assembly
onto barcoded microbeads from a complex oligo pool. By emulsifying this mixture into picoliter
droplets, we isolate and concentrate the oligos prior to gene assembly, thereby overcoming the critical
roadblocks for proper assembly and scalability (Fig. 4.1A, Supplemental Movie S1). The microbead
barcodes are unique 12 nt sequences that all oligos for a particular assembly share, and pair with
complementary strands displayed on the microbead. Within each droplet, sequences are released
from the bead using Type IIs restriction enzyme sites and assembled through polymerase cycling
assembly (PCA) into full length genes. Finally, the emulsion is broken and the gene library is
recovered. To test and optimize the protocol, we built model assemblies that were unique, but
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Figure 4.1: DropSynth assembly and optimization. A.We amplified array-derived oligos and exposed a
single-stranded region that acts as a gene-specific microbead barcode. Barcoded beads display complementary
single-stranded regions that selectively pull down the oligos necessary to assemble each gene. The beads
are then emulsified, and the oligos are assembled by PCA. The emulsion is then broken, and the resultant
assembled genes are barcoded and cloned. B. We used a model gene library that allowed us to monitor the
level of specificity and coverage of the assembly process. We then optimized various aspects of the protocol
including purification steps, DNA ligase, and bead couplings to improve the specificity of the assembly
reaction. Enrichment is defined as the number of specific assemblies observed relative to what would be
observed by random chance in a full combinatorial assembly. C. We attempted 96-plex gene assemblies with
3, 4, 5, or 6 oligonucleotides and the resultant libraries displayed the correct-sized band on an agarose gel. D.
The distribution of read-counts for all 96 assemblies (4-oligo assembly) as determined by NGS.
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shared common overlap sequences. As a result, any contaminating oligo would still participate in the
assembly reaction, allowing us to monitor assembly specificity and library coverage. We optimized
each aspect of the protocol by trying to assemble 24-, 96-, and 288-member libraries composed of
3, 4, 5, and 6 oligos at once, based on how often we saw intended targets versus their expected
frequency given random (i.e. bulk) assembly (Fig. 4.1B). Over many iterations we achieved high
enrichment rates (∼108) by modifying the amount of beads, presence of size selection after assembly,
ligase used for capture, and type of bead chemistry, testing both EDC crosslinking of carboxyl beads
and streptavidin-coupled beads. We ultimately found that using streptavidin bead chemistry, Taq
ligase for bead capture, and size-selection after assembly yielded the highest enrichment rates. Using
these protocols, we were able to build libraries of up to 6 oligos that produced correct sized bands
(Fig. 4.1C), and the resulting assembly distributions were not overly skewed (Fig. 4.1D, Fig. 4.5).
To test the scalability of DropSynth, we attempted assembly of 12,672 genes ranging in size
from 381 to 669 bp which encode homologs of two bacterial proteins from across the tree of life (Fig.
4.2A, Fig. 4.6). A total of 33 libraries of 384 genes each encoded 5,775 homologs of dihydrofolate
reductase (DHFR) with two different codon usages (11,520 DHFR genes), as well as 1,152 homologs
of the enzyme phosphopantetheine adenylyltransferase (PPAT) (Fig. 4.7, A and B). DHFR genes
were assembled from either four or five 230-mer oligos while PPAT genes were assembled from five
200-mer oligos. We obtained correctly-sized bands for 31/33 assemblies, with one failing due to
oligo amplification issues and the other due to low yield on the oligo processing steps, in contrast
to attempts using bulk assembly which produced shorter failed by-products (Fig. 4.7C). Three of
the libraries (5x 230-mers) were too long to verify using our barcoding approach, but the resulting
synthesis showed correct band formation (Fig. 4.8).
We cloned the libraries into an expression plasmid containing a random 20 bp barcode (assembly
barcode) and sequenced the remaining 28 libraries consisting of 10,752 designs (Fig. 4.7D and Fig.
4.8, Fig. 4.9). For the PPAT 5x 200-mer assemblies, sequencing revealed that a total of 872 genes
(75%) had assemblies corresponding to a perfect amino acid sequence represented by at least one
assembly barcode, with a median of 2 reads per assembly barcode and 56 assembly barcodes per
homolog (Fig. 4.2B, Fig. 4.10, A and B). This coverage increased when including sequences with
deviations from the designed sequences, with 1,002 genes (87%) represented within 5 aa from the
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Figure 4.2: DropSynth assembly of 10,752 genes. A. We used DropSynth to assemble 28 libraries of
10,752 genes representing 1,152 homologs of PPAT and 4,992 homologs of DHFR. The number of library
members with at least one perfect assembly and the median percent perfects determined using constructs
with at least 100 barcodes is shown for each library. B. We observe that 872 PPAT homologs (75%) had at
least one perfect assembly, and 1,002 homologs (87%) had at least one assembly within a distance of 5 a.a.
from design. C. We assembled two codon variants for each designed DHFR homolog, allowing us to achieve
higher coverage.
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designed sequences (all homologs have some alignments regardless of distance) (Fig. 4.10D). For
the DHFR 4x 230-mer assemblies we observed perfect sequences for 65% (6,271) of the designed
homologs, and 75% have at least one assembly within 2 aa difference from design. Since there are two
codon usages per homolog, when combined over homologs we observe 3,950 (79%) have at least one
perfect, and 88% have at least one assembly in distance 2 aa (Fig. 4.2C). We see a strong correlation
(ρ=0.73 (Pearson), p-value=3.4E-5) between the amount of DNA used to load the DropSynth beads
and the resulting library coverage (Fig. 4.11A). We also found 15 microbead barcodes that have more
dropouts than would be expected by chance (Fig. 4.11B). For constructs with at least 100 assembly
barcodes, we observed a median of 1.9% (σ = 2.9%) and 3.9% (σ = 3.8%) perfect protein assemblies
(Fig. 4.2A, Fig. 4.10C, Fig. 4.12) for PPAT and DHFR libraries respectively. The nearly double the
rate of perfects for DHFR libraries compared to PPAT can be attributed to using longer oligos (230
vs. 200 nt) that only require 4 oligos instead of 5 to assemble the gene (Fig. 4.13A). Increasing the
oligo length provides a way to assemble longer genes without significant decreases in the resulting
yields (Fig. 4.13B). Furthermore, the distribution of perfect assemblies in the PPAT libraries is
not overly skewed (Fig. 4.10D) and most library members have assemblies with high identity to
their respective designed homologs (Fig. 4.10F). The resultant error profiles were consistent with
Taq-derived mismatch and assembly errors that we have observed previously [16] (Fig. 4.14).
We sought to show how DropSynth-assembled libraries could be easily coupled as inputs into
multiplex functional assays by probing how well the PPAT homologs of various evolutionary distance
to E. coli could rescue a knockout phenotype. PPAT is an essential enzyme, encoded by the gene
coaD, which catalyzes the 2nd to last step in the biosynthesis of coenzyme A (CoA) [17] (Fig. 4.15)
and is an attractive target for the development of novel antibiotics [18]. Assembled PPAT variants
on the barcoded expression plasmid were transformed into E. coli ∆coaD cells and screened for
complementation by growing the library in batch culture through three serial 1000-fold dilutions
(Fig. 4.3A, Table 4.1), while a rescue plasmid was simultaneously heat cured (Fig. 4.16). Assembly
barcode sequencing of the resulting populations provided a reproducible estimate for the fitness of
all homologs successfully assembled without error (biological replicates ρ=0.94; Pearson, p-value
<2.2E-16) (Fig. 4.17A, Fig. 4.18A). Individual barcodes can display considerable noise, so having
many assembly barcodes per construct improved confidence (Fig. 4.18, B and C). Negative controls
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Figure 4.3: PPAT complementation assay. A. We used DropSynth to assemble a library of 1152
homologs of phosphopantetheine adenylyltransferase (PPAT), an essential enzyme catalyzing the second-to-
last step in coenzyme A biosynthesis, and functionally characterized them using a pooled complementation
assay. The barcoded library was transformed into E. coli ∆coaD cells containing a curable rescue plasmid
expressing E. coli coaD. The rescue plasmid was removed allowing the homologs and their mutants to compete
with each other in a batch culture. We tracked assembly barcode frequencies over four serial 1000-fold
dilutions, and used the frequency changes to assign a fitness score. B. This phylogenetic tree shows 451
homologs each with at least 5 assembly barcodes, a subset of the full data set, where leaves are colored by
fitness. Despite having a median 50% sequence identity, we find that the majority of PPAT homologs are
able to complement the function of the native E. coli PPAT, with 70% having positive fitness values, while
low-fitness homologs are dispersed throughout the tree without much clustering of clades.
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and sequences containing indels show strong depletion (Fig. 4.17A, Fig. 4.19A, 4.20), and fitness is
reduced with increasing numbers of mutations (ρ=-0.38; Spearman, p-value <2.2E-16) (Fig. 4.19,
B and C). Pooled fitness scores also correlated well with measured growth rates of individually
tested controls (rs=0.86, Spearman, p-value 5.9E-12) (Fig. 4.21). Approximately 14% percent of the
homologs show strong depletion (fitness below -2.5) while 70% have a positive fitness value in the
pooled assay. Low-fitness homologs are evenly distributed throughout the phylogenetic tree with only
minor clustering of clades (Fig. 4.3B, Fig. 4.17B, Fig. 4.22, 4.23A) showing the high modularity of
PPAT. There are several reasons homologs could have low fitness including environmental mismatches,
improper folding, mismatched metabolic flux, interactions with other cytosolic components, or gene
dosage toxicity effects resulting from improperly high expression [19] (Supplementary Text).
Errors during the oligo synthesis or DropSynth assembly give us mutational data across all the
homologs, which we can further analyze to better understand function. We selected all 497 homologs
that showed some degree of complementation (fitness greater than -1) as well as their 71,061 mapped
mutants within distance 5 a.a. and carried out a multiple sequence alignment to find equivalent
residue positions. For each amino acid and position, we found the median fitness among all of these
homologs and mutants. The resulting data was projected onto the E. coli PPAT sequence (Fig.
4.4A and B), providing data similar to deep mutational scanning approaches [22, 23]. We term this
approach broad mutational scanning (BMS). The average BMS fitness for each position shows strong
constraints in the catalytic site, at highly conserved sites (ρ=-0.64; Pearson, p-value <2.2E-16), and
at buried residues compared to solvent-accessible ones (ρ=0.42; Pearson, p-value 3.9E-8) (Fig. 4.24,
A and B, Supplementary Text). Surprisingly, some residues that are known to interact with either
ATP or 4’-phosphopantetheine turn out to be relatively promiscuous when averaged over a large
number of homologs. Furthermore, when mapped onto the E. coli structure (Fig. 4.4B), positions
known to be involved with allosteric regulation by coenzyme A or dimer formation, show relatively
little constraint, highlighting the diversity of distinct approaches employed among different homologs,
while maintaining the same core function. We implemented a simple binary classifier to predict the
sign of the BMS fitness value based on a number of features, achieving an accuracy of 0.825 (Fig.
4.25).
Additionally, we can search for gain-of-function (GoF) mutations amongst those homologs that
85
Figure 4.4: Broad mutational scanning (BMS) analysis. A. The fitness landscape of 497 complement-
ing PPAT homologs and their 71,061 mutants (within a distance of 5 a.a.) is projected onto the E. coli PPAT
sequence, with each point in the heatmap showing the average fitness over all sequences containing that
amino acid at each aligned position. Mutations are highly constrained at a core group of residues involved in
catalytic function. Other positions show relatively little loss of function, when averaged over many homologs,
despite known interactions with the substrates. The E. coli WT sequence is indicated by green squares,
while the average position fitness, fitness of a residue deletion, mean EVmutation evolutionary statistical
energy [20], site conservation, relative solvent accessibility, and secondary structure information is shown
above.B. The average fitness at each position, with blue and red representing low and high fitness respectively,
overlaid on the E. coli PPAT (PDB: 1QJC, 1GN8 [21]) structure complexed with 4’-phosphopantetheine and
ATP. We observe loss-of-function for mutations occurring at the active site, while other residues involved
with allosteric regulation by coenzyme A or dimer interfaces show large promiscuity, highlighting different
strategies employed among homologs. C. In addition to complementing homologs, we can also analyze
mutants of the 129 low-fitness (< -2.5) homologs, finding 385 gain-of-function (GoF) mutants across 55
homologs. We project this data onto the E. coli PPAT sequence and plot the number of GoF mutants at each
position shaded by the number of different homologs represented. We find a total of 8 statistically significant
positions (residues: 34, 35, 64, 68, 69, 103, 134, 135) corresponding to four regions in the PPAT structure.
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did not complement. A total of 385 gain-of-function (GoF) mutants out of 4,658 were found for 55
homologs out of 129 low-fitness homologs (fitness < -2.5). By aligning these mutations to the E. coli
sequence, the eight statistically significant residues (34, 35, 64, 68, 69, 103, 134, 135) shown in Fig.
4.4C localize to four small regions in the protein structure (Fig. 4.26, Supplementary Text). We
retrieved six GoF mutants of six different homologs from the library, each with fitness determined
from only a single assembly barcode, and individually tested their growth rates. Five of the six
mutants showed strong growth and one failed to complement (Fig. 4.21B). We also tested two of the
corresponding low-fitness homologs, finding increases in the growth rate of 10% and 42% for their
GoF mutants (Table 4.2).
Broad mutational scanning using DropSynth is a useful tool to explore protein functional
landscapes. By analyzing many highly divergent homologs, individual steric clashes, which might be
important to a particular sequence, become averaged across the homologs. More broadly, DropSynth
allows for building large designed libraries of gene-length sequences, with no specialized equipment,
and estimated total costs below $2 per gene (Table 4.3 & 4.4). We also show that DropSynth can be
combined with dial-out PCR [15], which could be expanded for gene synthesis applications where
perfect sequences are paramount. The scale, quality, and cost of DropSynth libraries can likely be
improved further with investment in algorithm design, better polymerases, and larger barcoded bead
libraries.
4.3 Materials and Methods
Design of PPAT library
PPAT homologs were found by running a PSI-BLAST search with 1 iteration querying the NCBI
RefSeq non-redundant protein database using E. coli PPAT (NP_418091.1). The resulting set of
11,062 homologs was further pruned to 10,277 by keeping only those with lengths ranging from 100
to 200 amino acids. T-Coffee (v11) [24] was used to align the sequences and RAxML (v8.2.10) [25]
to infer a maximum-likelihood phylogenetic tree (Fig. 4.6). A custom Python script trimmed the
tree by determining the distance from the root at which the number of nodes equaled the desired
amount of homologs, and subsequently choosing a random descendant leaf for each node at that
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distance. This reduced the tree around 1,300 homolog proteins. Each leaf on the pruned tree was
then compared to its nearest neighbours to ensure neighbouring sequences differed by at least five
amino acids. We then added in homologs from several model organisms and 34 pathogenic organisms.
The final library was dispersed among three libraries of 384 homologs, with every other leaf on the
tree distributed into a different library, for a total of 1,152 homologs. The final library contained
members sourced from 3 Archeal, 9 Eukaryotic, and 1140 Bacterial organisms (of which the top four
most represented Bacterial phyla were 414 Firmicutes, 337 Proteobacteria, 64 Actinobacteria and 38
Spirochaetes).
Design of DHFR library
DHFR homologs were found using the DHFR family (IPR012259) in InterPro database [26]. A total
of 5,760 homologs were selected, with 4,992 having lengths less than 530 bp (which can be assembled
using 4X 230-mer oligos) and the rest greater (requiring 5X 230-mer oligos). Each homolog was
encoded with two codon optimizations, creating a total of 30 libraries with 384 variants in each. We
modified the oligo design scripts to forbid the presence of any homopolymer repeats greater than
8 nt. We also added random buffer sequence in between the KpnI restriction site and the reverse
assembly primer to bring all of the assembled sequences to within 100 bp of each other to facilitate
size selection. This extra buffer sequence is removed upon cloning of the assembled sequence into the
barcoded vector. A single pool of 47,616 230-mer oligos was synthesized on a microarray by Agilent
Technologies.
Microbead barcode design
We took 2,000 20-mer primers whose design was previously described [27] and removed those
containing NdeI, XhoI, EcoRI, KpnI, NotI, SpeI, BtsI, or BspQI restriction sites. All possible 12-mer
subset primers were generated and screened for self-dimers, GC content between 45% and 55%, and
melting temperature between 40◦C and 42◦C. Barcodes were further filtered to ensure a minimum
modified Levenshtein distance of 3 between any selected barcodes [28]. The first 384 12-mer barcodes,
were used in subsequent oligo designs, with the complementary barcode sequences used to generate
the beads.
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Oligo design
Our oligo design protocol is adapted from Eroshenko et al [27] and summarized in Fig. 4.27A. Briefly,
protein sequences were assigned a random codon weighted by the frequency in the E. coli genome, in
order to generate a nucleotide sequence compatible with the restriction sites required (NdeI, KpnI,
BtsI, or BspQI). A KpnI restriction site (GGTACC ) was added on the C-terminal end of the coding
sequence, which encodes for a glycine and threonine, before the stop codon. The NdeI restriction
site (CATATG) on the N-terminal defined the start ATG codon of the ORF. Immediately flanking
these restriction sites, 20-mer assembly primer sequences were added, which are used in the emulsion
PCA. These sequences were then split into five shorter overlapping fragments [27], with overlaps
optimized to be around 20 bp with a melting temperature between 58◦C and 62◦C. Sequences which
failed to split with these parameters had a new weighted random codon assignment generated, until
a codon sequence was found which could be split successfully. BtsI sites were subsequently added on
either side of the split sequences, which would release the sequences required for assembly from the
bead inside the emulsion droplets, allowing the PCA to proceed. A padding sequence consisting of
ATGC repeats was added on the 5’ end ahead of the first BtsI site, with the repeat length such that
the final sequence length was 142 nt. Subsequently, an 8-nt Nt.BspQI site, the corresponding 12-mer
microbead barcode (described above), and another Nt.BspQI site was prepended to the 5’ end of the
sequence, with the restriction sites oriented to nick the top strand on the 5’ side of the barcode and
the bottom strand on the 3’ side of the barcode. These Nt.BspQI sites facilitate the processing of
the barcode region into a single-stranded top-strand overhang. The barcode was common to all five
fragments for each gene, such that all fragments required for each gene assembly would be pulled
down and localized onto the same beads. Finally a pair of 15-mer amplification primer sequences
were added, with each pool of 384 genes (1,920 oligos) having a unique primer pair orthogonal to the
other pools. BLAT [29] was used to screen these primers against the oligo sequences, removing those
with homologies over 10 bp. After each of these design steps, we screened for the addition of illegal
restriction sites, and modified the sequence if any were found. For PPAT three libraries of 384 genes
as well as a small test library of 24 genes were ordered as a single pool of 5,880 oligos (200-mer),
while for DHFR thirty libraries of 384 genes were ordered as a single pool of 47,616 oligos (230-mer)
and synthesized on a microarray by Agilent Technologies. For the PPAT libraries the final assembly
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length was 52 bp longer than the gene length due to the addition of restriction and primer sites.
The scripts required to generate DropSynth oligos are available at https://github.com/kosurilab.
DropSynth barcoded beads protocol
The general strategy for creating the DropSynth barcoded beads is shown in Fig. 4.27B. Three oligos
are used for each DropSynth barcoded microbead, with two of the oligos common to all beads. The
anchor oligo attaches to the streptavidin bead surface through a double biotin modification on the 5’
end and has sequences necessary to hybridize with the ligation oligo and part of the barcode oligo.
The ligation oligo has a biotin modification on the 3’ end and phosphate group on the 5’ which
allows it to ligate to the microbead barcode oligo (Table 4.6). A different microbead barcode oligo
is synthesized for each barcode with a common sequence on the 3’ end which can hybridize to the
anchor oligo and the reverse-complement of the microbead barcode on the 5’ end which can pull
down the gene fragments. This approach means only two synthesized oligos (anchor and ligation
oligos) contain expensive modifications. Briefly the anchor oligo, ligation oligo, and each barcoded
oligo are hybridized, ligated, and phosphorylated with T4 PNK. These are bound to streptavidin
coated M270 Dynabeads, washed, and pooled together to form a uniform mixture of all 384 barcoded
beads. This protocol can be scaled as necessary given the amount of multiplexing required. The
current assembly protocol utilizes 18 uL of the final pooled bead mixture (∼3.25E5 beads/uL) for
the capture of processed oligos, with the bead barcoding protocol provided producing enough pooled
beads to carry out around 210 assemblies in 384-plex.
DropSynth protocol
DropSynth assembles gene-length fragments through the hybridization of oligos to barcoded mi-
crobeads and their resulting amplification. Briefly, individual oligo libraries are PCR-amplified using
KAPA HiFi and 15-mer amplification primers. Oligo subpools are then bulk-amplified using the
reverse amplification primer and a biotinylated forward amplification primer. After amplification,
oligos are nicked using the nicking endonuclease Nt.BspQI, exposing a 12-nt ssDNA “barcode”
overhang (Fig. 4.28, Table 4.5). The short biotinylated fragment that is cleaved following nicking is
then removed by binding it to streptavidin M270 Dynabeads in a hot water bath. After a column
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cleanup, each oligo subpool is mixed with the designed DropSynth barcoded beads and Taq ligase,
and annealed overnight from 50◦C to 10◦C. In this process, all oligos required for each gene assembly
are captured when each microbead barcode overhang anneals to a corresponding complementary
microbead barcode on the bead. Captured beads are then mixed with KAPA2G Robust Mastermix,
20-mer forward and reverse assembly primers, BSA, BtsI, and BioRad Droplet Generation Oil. The
mixture is immediately vortexed for 3 minutes, allowing for compartmentalization of captured beads
in <5 um droplets (Fig. 4.29), which are subsequently heated allowing temperature-sensitive BtsI to
release the sequences required for assembly from the bead. Droplets from each subpool are then
loaded into PCR tubes and thermocycled, allowing PCA to proceed. The PCA products are then
recovered by breaking the emulsion with chloroform, purified and re-amplified, providing sufficient
assembled DNA for downstream applications.
Optimization of DropSynth
Significant optimization of the oligo processing and bead capture was required to achieve sufficiently
high specificity to allow large multiplexing. Initial attempts to capture fully single-stranded oligos,
generated using USER / λ exo / DpnII treatment [10], followed by primer extension of the missing
complementary strand, performed poorly for three-oligo assemblies and failed altogether with four-
oligo assemblies for all four polymerases tested (Kapa Robust, Kapa HiFi, Pfu Turbo, and Phusion).
As an alternative approach, we nicked opposite strands on either side of the BC region with type
IIS enzymes, before melting the microbead barcode strands apart and removing the unwanted
biotinylated strand, leaving a single-stranded overhang along with the rest of the oligo, as shown
in Fig. 4.1A. This eliminated the need for primer extension, and resulted in a 10-fold specificity
improvement in tests on 96-plex assemblies of three to six oligos.
We also optimized the type of bead chemistry, testing both covalent carboxyl coupling and
streptavidin coupling. Briefly, anchor oligos were covalently attached as follows. 100ul Dynabeads
M-270 Carboxylic Acid were washed twice with 25 mM MES (pH 5). Next, 60µ g anchor oligo in 25
mM MES (pH 5) was added to the washed Dynabeads and incubated at room temperature for 30
minutes. EDC was dissolved in cold 100 mM MES (pH 5) to a concentration of 100 mg/ml, after
which 30µ l EDC solution (3 mg) was added to the Dynabead/anchor oligo suspension. Next, 10µ l
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of 25 mM MES (pH 5) was added and the solution was incubated overnight at 4◦C with slow tilt
rotation. Finally, the coated Dynabeads were washed 4 times using PBS (0.1% Tween-20). Despite
successful assembly from carboxyl-coupled beads, we observed significantly higher enrichment factors
in streptavidin-coupled beads. Thus we proceeded using streptavidin-coupled beads in all DropSynth
experiments.
We further optimized the amount of beads, ligation reaction, the ligase used in the capture step,
nicking reaction, presence/absence of size selection after assembly, and different techniques to purify
the emulsion assembly products before re-amplification to achieve an assembly enrichment factor
of 108, relative to the probability of a correct assembly by random chance, for a 288-plex five-oligo
assembly (Fig. 4.1B).
PPAT rescue plasmid and coaD knockout
As PPAT (coaD) is an essential gene, we re-engineered plasmid pTKRED [30] and to constitutively
express bicistronic wild-type (WT) coaD gene followed by sfGFP (Fig. 4.16A). The WT coaD gene
from E. coli MG1655 was amplified with a strong constitutive promoter (TGACGGCTAGCTCAGTC-
CTAGGTACAGTGCTAGC) and RBS (TACGAGTGAAAGAGGAGAAATACTAG) on the 5’ end,
and BamHI site on the 3’ end. This was ligated to a fragment containing a 5’ BamHI site, RiboJ self-
splicing element [31], sfGFP [32], and a transcriptional terminator to create coaD_sfGFP. pTKRED
was digested with BsaI and the larger fragment (8,391 bp) containing the λ−red genes was gel
extracted. The coaD_sfGFP DNA fragment was then ligated into the larger pTKRED BsaI fragment
to create pTKcoaD. This ligation was transformed into NEB 5-alpha electrocompetent E. coli and
colonies were sequence verified. The pTKcoaD plasmid expresses PPAT and GFP constitutively
while the λ−red recombinase genes are under IPTG induction. The temperature sensitive origin of
replication can be used to heat cure the plasmid at 42◦C, which can be confirmed through the loss
of GFP fluorescence (Fig. 4.16E).
Knockout of the coaD gene in E. coli was carried out using standard techniques [30, 33]. Briefly
pTKcoaD was transformed into both E. coli DH10B electrocompetent cells (ThermoFisher Sci-
entific). Individual colonies were chosen and made electrocompetent. These were transformed
with a recombination template containing a Kanamycin cassette flanked by homology arms to
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the regions immediately adjacent to the coaD gene. This template was made by first amplify-
ing the Kanamycin cassette from pZS2-123 [34] using primers coaD_KO_KAN_FWD_1 and
coaD_KO_KAN_REV_1 (Table 4.7). The resulting amplicon was purified and further amplified
using the primers coaD_KO_KAN_FWD_2 and coaD_KO_KAN_REV_2 (Table 4.7). The
knock-in targeted only the PPAT coding region so as to not interfere with the essential waaA gene
immediately upstream of coaD. Knock out strains were verified by Sanger sequencing and colony
PCR (Fig. 4.16, C and D). We further verified that heat curing of the rescue plasmid suppressed
cell growth and characterized the escape frequency.
pEVBC expression plasmid
The barcoded plasmid used to express PPAT homologs is a derivative of high-copy pUC19 with a
pLac-UV5 promoter, NdeI and KpnI restriction sites for cloning, an in-frame stop codon, and a
20-mer random assembly barcode. This was made by first double-digesting pUC19 with AatII +
BspQI and gel extracting the larger fragment. A gBlock DNA fragment was synthesized containing
the promoter, several restrictions sites, and an in-frame chloramphenicol acetyltransferase before the
stop codon. We initially tried using this in-frame chloramphenicol resistance as a way to screen the
library against frame-shifted products, but we found this highly biased the resultant libraries (data
not shown) and thus we did not use this in-frame selection for the results presented here. This was
ligated into the pUC19 AatII-BspQI backbone fragment to create plasmid pEV_CMR. The plasmid
pEV_CMR was double digested with NcoI + KpnI and the long 2,209 bp fragment was gel extracted.
Round-the-horn PCR was carried out using 1 ng of the pEV_CMR digest as template, a forward
primer pEVBC_FWD with a 5’ biotin and a NdeI site, and a reverse primer pEVBC_REV1 with a
5’ biotin (Table 4.7), a 20 N-mer random assembly barcode, and a KpnI site, for 5 cycles. This PCR
product was further amplified with outer primers pEVBC_FWD and pEVBC_amp_FWD for 15
cycles (Table 4.7). This amplicon was column purified, digested with NdeI + KpnI, treated with
rSAP, cleaned up with Streptavidin coated Dynabeads to remove the small fragments, and column
purified again to create the vector pEVBC (Fig. 4.16B).
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Barcoded PPAT library in pEVBC
Assembled PPAT homolog genes for each library were digested with NdeI + KpnI and column
purified. A ligation was then carried out for each PPAT library using 150 ng of NdeI + KpnI
digested pEVBC vector and 100 ng of digested PPAT homolog genes using 3,000U of T7 ligase in
a total volume of 30 uL. This reaction was column purified and concentrated to a volume of 16
uL. NEB 5-alpha electrocompetent E. coli cells were then transformed using 3-4 uL of the purified
ligation, resulting in over 10 million cfus per transformation. Overnight cultures grown in LB with
Carbenicillin were miniprepped, quantified, and an equimolar pool from all three PPAT homolog
libraries was created, henceforth referred to as sample S0.
Barcoded DHFR library in pEVBC
Analogous to PPAT, assembled DHFR homolog genes for each library were digested with NdeI +
KpnI and column purified. A ligation was then carried out for each library using 150 ng of NdeI
+ KpnI digested pEVBC vector and 100 ng of digested DHFR homolog genes using 3,000U of T7
ligase in a total volume of 30 uL. This reaction was column purified and concentrated to a volume of
8 uL. In order to overcome known DHFR overexpression issues in E. coli, we directly PCR-amplified
ligation products using primers mi3_FWD and mi3_REV_N7## (Table 4.7) to add p5 sequencing
adapters and library indexes, rather than transforming and miniprepping.
Assembly barcode mapping
The assembly barcoded PPAT libraries were sequenced on two Illumina Miseq paired end 600-
cycle runs, and DHFR libraries were sequenced on three Illumina Miseq paired end 600-cycle runs.
Each library was PCR amplified using primers mi3_FWD and mi3_REV_N7## (Table 4.7) to
add p5 sequencing adapters and library indexes. The resulting amplicons were size-selected using
gel-extraction and quantified using an Agilent 2200 Tapestation. Samples were then pooled and
sequenced on a Miseq using custom primers mi3_R1, mi3_R2, and mi3_index (Table 4.7). This
resulted in 27,822,356 total reads (for PPAT) after merging the runs together. Barcode read counts
for the S0 (unselected) library were generated by extracting the 20 bp sequence corresponding to
the barcode region from the Read 2 sequences and using Starcode [35] to collapse barcodes within
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a Levenshtein distance of 1 (Fig. 4.10). Sequencing data are available from the sequencing read
archive (SRA) under BioProject PRJNA421181.
Briefly, the subsequent data processing was carried out as follows. All Fastq files had adapters
trimmed in bbduk followed by paired-end read merging using bbmerge (from the BBTools package
version 36.14). All reads were then concatenated and piped into a custom python script which
generated a consensus nucleotide sequence for each barcode. The script works as follows. First, we
split reads into the 20 nt assembly barcode and the corresponding variant, and generate dictionary
that maps every assembly barcode to a list of variants associated to it. To eliminate assembly
barcodes that are associated with two different variants, we calculate the pairwise Levenshtein
distance of every variant associated with a given assembly barcode. If a certain percentage of these
assembly barcodes (5%) are greater than a distance cutoff (10) then we consider the assembly barcode
contaminated and drop it from further analysis. Finally, we generate a consensus sequence by taking
the majority basecall at every position. Mapped consensus sequences were then translated until the
first stop codon and sequences perfectly matched to any designed homologs were annotated.
Analysis of the number of reads per assembly barcode as a function of dilution revealed a small
number of assembly barcodes with very high number of reads, as many as 300,000 by the fourth
dilution, attributed to the emergence of adaptive mutations conferring a growth advantage at 42◦C,
which occur stochastically. We also deduce from the lack of GFP positive colonies in the plates at
various steps in the dilution that these adaptive mutations did not occur in cells still harboring
the rescue plasmid. A total of 18 barcodes from serial dilution replicate A and 16 barcodes from
replicate B were removed from further analysis.
Mutant homolog sequences were annotated by first aligning the consensus nucleotide sequence
for each barcode against the 1,152 designed PPAT homologs using bbmap. The resulting SAM file
was parsed to extract the closest alignment match. A pairwise alignment of the amino acid sequence
was carried out for each mapped barcode sequence (until the first stop codon) against its best PPAT
homolog alignment match. Mutants within a distance of 5 amino acids from the designed sequence
had their individual a.a. mutations annotated for further analysis downstream.
We estimated the number of chimeric assemblies computationally. First, we used a custom
python script to divide our merged reads into 5 equally sized chunks. We then used BBMap (v
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36.xx) to perform a pseudo-local alignment to a reference fasta containing all of our designed
constructs. We refer to these alignments as pseudo-local as BBMap first searches for an optimal
global alignment, and clips the reads if they return a higher score. We then tallied the number of
chunks successfully aligned, as well as the number of different unique references each chunk aligned
to. We then categorized each construct as follows:
• Perfect - all 5 chunks align to the same reference
• Chimeric - all 5 chunks align, but to more than one reference
• Possibly Chimeric - any number of chunks (not necessarily 5) align to more than one reference
• Junk - less than 5 chunks successfully aligned
BMS analysis
Briefly, we aligned all complementing homologs using MAFFT and created a lookup table for each
residue of each homolog. For perfect homolog sequences we scanned through all residues and placed
the homologs fitness into a BMS data table with the corresponding residue and E. coli position based
on the alignment. For the mutants up to distance 5 a.a. from the perfect, we took only the mutated
residues and added the fitness of the mutant into the BMS data table with the mutated residue and
the corresponding E. coli position based on the alignment. For each residue and position in the BMS
data table, the BMS fitness was determined as the median value of all of the corresponding data
point at that position.
Classifier
We implemented a simple classifier to predict how different variants would perform in our assay.
First, we categorized each variant into two bins based on whether or not their measured fitness score
was greater than 0. We then selected 6 features for our model - the amino acid mutation, secondary
structure class as assigned by DSSP (loop, beta-sheet, or alpha-helix), relative solvent accessibility
as assigned by DSSP, sequence conservation, evolutionary coupling as predicted by EVMutation, and
the frequency of residue substitution from the sequence alignment used for EVMutation’s prediction.
We used the R package Caret to perform a simple logistic regression using these features. To assess
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the performance of our classifier, we performed 10 repeats of 5-fold cross-validation on our dataset
and measured the precision and recall of each model on its respective hold-out set. We then used
the R package precrec to plot both the receiver operating characteristic (ROC) and precision recall
curves [36].
Complementation assay
The complementation of synthesized homologs was carried out using a serial batch culture. After
ligation into pEVBC, homologs from all three libraries were pooled together to create sample S0.
Supercoiled S0 plasmid was then electroporated into electrocompetent E. coli DH10β ∆ coaD
pTKcoaD. The serial batch cultures, consisting of two biological replicates, were initiated by making
10 transformations using 1 ng of S0 plasmid into 40 uL of cells and recovered at 30◦C in 1 mL SOC
+ 1 mM IPTG for 1 hour. For each replicate, 5 transformations were pooled together and used to
seed a fresh culture with between 7 million and 17 million cfus. Cells were grown in 1 L LB media
supplemented with Kanamycin + Carbenicillin + 0.05 mM IPTG and grown to saturation at 42◦C
(8-10 generations) between each bottleneck. Cells were propagated through 3 bottlenecks for a total
of 4 samples for each replicate, with 1000x dilutions at each bottleneck. DNA was miniprepped from
each sample and cells were plated to ensure proper curing of the rescue plasmid, by screening for
GFP+ colonies.
The barcodes from each of the 8 complementation samples were amplified using primers mi4_FWD
and mi4_REV_N7## (Table 4.7) to add sequencing adapters and library indexes. The resulting
294 bp amplicon was size-selected using gel-extraction, purified, pooled, and loaded onto a Hiseq
2000 single-end 50 cycle run using custom sequencing primers mi4_R1 and mi4_index (Table 4.7),
resulting in 138 million total reads. The barcodes for each sample were clustered using Starcode [35]
to collapse barcodes within a Levenshtein distance of 1 (Table 4.1).
Complementation data analysis
In order to reduce noise in calculating the fitness change we pruned the barcodes leaving only those
with at least 10 reads in S0 or at some point in the serial dilution. This reduced the total number of
unique barcodes from 7,038,274 to 627,302. We calculated fitness scores for each mapped sequence
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with at least one barcode. First, the read counts at each dilution were normalized based on the
total sequencing depth of the sample relative to S0. The log2 fold change between each dilution and
sample S0 was then determined for each barcode using
fx0 = log2(rx + 1)− log2(r0 + 1) ,
where rx is the number of normalized reads in the corresponding dilution. We then took the
median value (to minimise effects of outliers) of the log2 fold change over all of the dilutions to
determine the fitness for that barcode
fBC = median(f10, f20, f30, f40).
The median fitness for each barcode representing a sequence was determined for each replicate
(A and B) individually
fseqA = median(fBC1A, fBC2A, fBC3A, fBC4A, ...),
fseqB = median(fBC1B, fBC2B, fBC3B, fBC4B, ...).
We then selected only those sequences represented in both replicates and took the median
replicate fitness as the final fitness value
fseq = median(fseqA, fseqB).
Data analysis was carried out in R, with visualisations using ggplot2, ggtree [37], and UCSF
Chimera [38]. Residue conservation was determined using Jensen-Shannon divergence [39], secondary
structure and relative solvent accessibilities sourced from DSSP analysis [40, 41] of 1H1T [42]. The
analysis scripts are available at https://github.com/kosurilab.
Assembly Retrieval by Dialout Amplification
The presence of a unique barcode on each assembly allows us to retrieve them from the library
using PCR amplification [13, 15]. We attempted to amplify 48 unique homologs and 12 gain-of
function mutants. As a positive control we also amplified the wild-type E. coli coaD gene from
the pTKcoaD rescue plasmid. The designed primers flanked each construct, with reverse primers
annealing to each gene-specific barcode. We observed correct size amplification products for 59 of
60, with 18 of these using lower complexity post complementation selection libraries as template,
while the rest used the high-complexity sample S0. Individual amplicons were then gel-extracted,
restriction digested with KpnI-HF and NdeI, ligated into empty pEVBC backbone, and transformed
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into chemically competent NEB DH5alpha E. coli cells. Colonies were verified via colony PCR
and Sanger sequencing, and validated colonies were re-inoculated overnight and miniprepped. We
successfully sequence-verified 43 of the 59 constructs (37 homologs and 6 gain-of-function mutants),
in addition to the WT coaD gene (Table 4.2).
Growth Rate Analysis of Dialed-out homologs and Gain-of-function Mutants
Following successful dialout PCR and re-cloning, we transformed 1 ng of each construct in pEVBC
into 7 uL of electrocompetent coaD knockout cells. We analyzed the presence of growth by counting
dilution Carb + Kan plates at both 30◦C and 42◦C (Table 4.2, Fig. 4.21A). Four constructs had
no colonies on the 42◦C plates, of which two were low-fitness homologs, one was a gain-of function
mutant with only one barcode (false positive), and another construct KOS35328 had good fitness
(1.88) in the pooled assay determined using 25 barcodes. The lack of colonies for KOS35328 requires
further investigation, and may be a transformation error. Six constructs had low colony counts on
both plates, of which five correspond to low-fitness homologs (Fig. 4.21A). We noticed a trend in
which homologs with enhanced fitness in the pooled complementation assay gave rise to greater
numbers of colonies on the 42◦C dilution plates. Furthermore, we also noticed that homologs with
enhanced fitness in the pooled complementation assay typically gave rise to 42◦C colonies that
appeared larger than their corresponding 30◦C colonies (Fig. 4.21A). Of the constructs with at least
10 colonies on the 42◦C plates, we picked 3 colonies per homolog and re-inoculated them in 1 mL
LB + Carb + Kan and grew overnight at 42◦C. 2 uL of saturated culture was then diluted in 98 uL
of LB + Carb + Kan in wells of a 96-well plate and loaded into a Tecan M1000 Plate Reader for
12 hours at 42◦C. OD600 values, taken at 30-minute intervals, were measured at 9 points within
each well and averaged. Resultant growth curves were plotted for all colonies and averaged on the
construct level. Maximum slopes of each growth curve were calculated and plotted against fitness
scores determined from the complementation assay (Fig. 4.21B). A strong correlation (Spearman
rs = 0.86, p-value 5.9E-12) was observed comparing homolog growth rate to fitness, validating our
assay and analysis pipeline. Examining the residual errors of the fit of growth rate to fitness we
observe that constructs with fewer barcodes tend to have larger errors (Fig. 4.21C) which agrees
with the reproducibility of the fitness value among replicates as a function of the number of barcodes
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(Fig. 4.18B).
DropSynth bead barcoding protocol
Prepare 2X Binding and Wash buffer (2M NaCl, 1mM EDTA, 10mM Tris)
2X B&W 40mL:
• 4.675g NaCl salt
• 400 uL UltraPure 1M Tris-HCl, pH 7.5 (Invitrogen)
• 80uL UltraPure 0.5M EDTA, pH 8.0 (Invitrogen)
• UltraPure Distilled Water (Invitrogen) to 40 mL
This protocol can be done on a single 384 well plate or 4x 96 well plates, the latter protocol is
provided. Reagents required:
• 384 uL 100 uM anchor oligo (Integrated DNA Technologies)
• 384 uL 100 uM ligation oligo (Integrated DNA Technologies)
• 1 uL 100 uM of each barcode oligo (Integrated DNA Technologies)
• 1,576 uL 10X T4 ligase buffer (New England Biolabs)
• 384 uL T4 PNK (10,000 U/mL) (New England Biolabs)
• 40 uL T4 ligase (concentrated 2,000,000 U/mL) (New England Biolabs)
• 1,920 uL stock Dynabeads M270 Streptavidin (Invitrogen)
For each of the four 96-well plates:
1. Mix 96 uL 100 uM anchor oligo and 96 uL 100 uM ligation oligo.
2. Prepare the 96 well plate. In each well add:
• 2 uL of mixed anchor and ligation oligo
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• 1 uL 100 uM barcoded oligo
• 4 uL 10X T4 Ligase buffer
• 33 uL UltraPure Distilled Water
• TOTAL: 40 uL
3. Anneal the mixed oligos on each plate using using the following conditions (30 min total):
• 3 min at 70◦C
• Ramp down to 60◦C for 1 min, 0.1◦C/sec
• Ramp down to 50◦C for 1 min, 0.1◦C/sec
• Ramp down to 40◦C for 1 min, 0.1◦C/sec
• Ramp down to 30◦C for 1 min, 0.1◦C/sec
• Put plate on ice
4. Ligate the barcoded oligo to the ligation oligo:
• Make a 1:10 T4 Ligase dilution:
10 uL T4 Ligase (concentrated 2,000,000 U/mL)
10 uL 10X T4 ligase buffer
80 uL H2O
TOTAL: 100 uL
• Add 1 uL T4 Ligase (1:10 dilution) to each well
• Incubate plate at 16◦C for 1 hr or longer, followed by 65◦C for 20 min to heat inactivate the
ligase
5. Phosphorylate the barcoded oligo:
• Add 1 uL T4 PNK into each well
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• Incubate the plate at 37◦C for 40 min (or longer), followed by 65◦C for 20 min to heat
inactivate the PNK
5. Bind to beads:
• Prepare 480 uL stock Dynabeads M270 Streptavidin, washed, and resuspended in 960 uL
B&W buffer
• Add 10 uL resuspended beads to each well. (∼3.25E6 beads/well and∼18.5E6 molecules/bead)
• Mix overnight with shaking (2000 RPM) at room temperature.
7. Pool beads:
• Wash each well with 150 uL B&W buffer 5 times.
• Resuspend in 10 uL B&W buffer
• 1 uL of each well is mixed together, making a 96 uL mixed barcoded bead pool for each
plate.
• Mix 96 uL from each plate to make a full 384 uL mixed barcoded bead pool. Store these
at 4◦C when not in use.
DropSynth emulsion synthesis protocol
The following protocol was used to assemble the PPAT library. All PCR steps were performed on a
Bio-Rad C1000 Touch Thermal Cycler (Bio-Rad Laboratories).
1. Prepare the OLS pool
• Make 1/5, 1/10, and 1/20 dilutions of the OLS chip pool.
• Prepare mixtures of forward and reverse subpool amplification primers for each subpool,
with 10µ M final concentration of each primer.
2. Amplify subpools.
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• For each subpool run a qPCR to determine the number of cycles required for amplification.
Amplifications are stopped several cycles before plateauing to prevent over-amplification
of the libraries.
• Amplify each subpool.
– 1 uL template (test 1/5, 1/10, 1/20 OLS pool dilutions)
– 1.25 uL subpool specific primer mix (10 uM FWD + 10 uM REV)
– 22.75 uL UltraPure Distilled Water (Invitrogen)
– 25 uL Kapa HiFi HotStart ReadyMix (2X) (KAPA Biosystems)
– TOTAL: 50 uL
– PCR protocol:
1. 3 min 95◦C initial denaturation
2. 45 sec 98◦C denaturation
3. 15 sec 58◦C annealing
4. 15 sec 72◦C extension
5. Go to step 2, repeat based on the number of cycles determined by qPCR.
6. 1 min 72◦C final extension
• Column purify amplified oligos using a Zymo Clean & Concentrator -5 (Zymo Research).
• Run PCR products on gel. Look for higher MW products, indicative of overamplification.
Excessive low MW products may indicate chip synthesis issues.
• Size select, using gel extraction, if necessary.
• Create 20 pg/uL dilutions of each amplified subpool. (∼91 million/uL)
3. Bulk amplify subpools.
• Run a second PCR using a biotinylated FWD amplification primer, with sufficient tubes
to make 4.5 ug to 9 ug of PCR product.
– 1 uL of 20 pg/uL subpool dilution
– 1.5 uL subpool specific primer mix (10 uM biotinylated FWD + 10 uM REV)
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– 22.5 uL UltraPure Distilled Water (Invitrogen)
– 25 uL Kapa HiFi HotStart ReadyMix (2X) (KAPA Biosystems)
– TOTAL: 50 uL
– PCR protocol:
1. 3 min 95◦C initial denaturation
2. 20 sec 98◦C denaturation
3. 15 sec 58◦C annealing
4. 15 sec 72◦C extension
5. Go to step 2, 18X
6. 1 min 72◦C final extension
• Pool and column purify PCR reactions using a Zymo Clean & Concentrator -5 (Zymo
Research).
4. Nicking.
• Nick the bulk amplified subpools. Split the following accross multiple tubes depending on
the amount of DNA to be processed. In each 1.5 mL tube add:
– 4.5 uL Nt.BspQI (10U/uL) (New England Biolabs)
– 2 to 2.5 ug of DNA (final concentration ∼16ng/uL)
– 15 uL NEBuffer 3 (New England Biolabs)
– UltraPure Distilled water (Invitrogen) to 150 uL
• Leave at 50◦C overnight with shaking >1500 RPM.
5. Capture and remove the short biotinylated fragment.
• Wash 50 uL Dynabeads M-270 Streptavidin (Invitrogen) for each 1.5 mL tube in the
nicking reaction, as per manufacturer’s instructions and resuspend in 2X B&W buffer.
• Add 50 uL of washed beads to the 150 uL nicking reaction in each tube.
• Incubate at 55◦C with 800 RPM shaking for at least 1 hour.
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• Move all 1.5 mL tubes to a 55◦C water bath.
• Place the tube so that solution is just below the surface of the water. Hold a strong
magnet underwater against the side of the tube to magnetically separate Dynabeads.
Pipette the supernatant, which contains the processed oligos and save them in a new
container. Remove the tube with the Dynabeads from the magnet. Add 100 uL of
UltraPure Distilled water (Invitrogen) to the tube and resuspend the beads. Incubate
these at 55◦C for another 30 min and then repeat the procedure to recover the supernatant
again while leaving the Dynabeads behind.
• Repeat this procedure for all tubes as necessary.
• Pool processed oligos (supernatant) for each subpool and column cleanup using a Zymo
Clean & Concentrator -5 (Zymo Research).
6. Capture processed oligos with barcoded beads.
• Take 18 uL of the pooled barcoded beads. These are in stored in B&W buffer (high ionic
concentration) which may interfere with ligation reaction. Resuspend them in 18 uL 10
mM Tris-HCl buffered solution.
• Mix the processed DNA with the barcoded beads:
– 40 uL processed DNA (∼1.3 ug,∼12 pmol)
– 18 uL pooled barcoded beads (∼5 million beads, binding capacity 1.2 ug DNA)
– 10 uL 10X Taq ligase buffer (New England Biolabs)
– 4 uL Taq ligase (40 U/uL) (New England Biolabs)
– 28 uL UltraPure Distilled water (Invitrogen)
– TOTAL: 100uL
• Overnight cycling (>2 hr incubation at each of the following temperatures) (13 hr), while
shaking using an Eppendorf ThermoMixer C (Eppendorf):
– 3 hours @ 50◦C
– Ramp to 40◦C for 3h, 0.1◦C/sec
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– Ramp to 30◦C for 3h, 0.1◦C/sec
– Ramp to 20◦C for 2h, 0.1◦C/sec
– Ramp to 10◦C for 2h, 0.1◦C/sec
• Wash 3 times at 4◦C using B&W buffer. This is important for removing unbound oligos
in order to increase specificity.
• Wash twice at RT using B&W buffer
• Re-suspend in 100 uL Elution Buffer (Qiagen) (∼50k beads/uL)
7. Emulsion assembly (ePCA).
• Setup emulsion. All of this procedure should be done in cold room on ice. Add Bts α I
only at very last step. Try to minimize the time between adding the Bts α I and vortexing
the emulsion.
– 10 uL of loaded beads (∼130 ng DNA)
– 0.5 uL 100 uM FWD assembly primer
– 0.5 uL 100 uM REV assembly primer
– 50 uL Kapa2G Robust HotStart ReadyMix (2X) (KAPA Biosystems)
– 1 uL BSA (New England Biolabs)
– 31 uL UltraPure Distilled water (Invitrogen)
– 7 ul Bts α I (New England Biolabs) (add last)
– TOTAL: 100 uL
• Mix at low speed in vortexer to resuspend beads.
• Add 600uL Droplet Generation Oil for EvaGreen (Bio-Rad Laboratories) to a 1.5mL
non-stick tube.
• Add 100uL aqueous phase to the bottom of the oil phase.
• Vortex at Max Speed in foam holder taped down for 3-4 minutes. If doing multiple
emulsions, do this one at a time. We use a Vortex Genie 2 (Scientific Industries) at max
speed.
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• After vortexing all emulsions, place each emulsion into PCR tubes with 100 uL in each
tube. Use a P1000 tip to avoid disturbing the emulsion. Most of the droplets will float to
the top of the tube, try to get as much of this as possible and distribute this over multiple
PCR tubes.
• PCR Cycling
– 55◦C for 90 min (allow Bts α I to cleave DNA from the beads)
– 94◦C for 2 min (initial denaturing)
– 94◦C for 15 sec (denaturing)
– 57◦C for 20 sec (annealing)
– 72◦C for 45 sec (extension)
– Go to step 3 for additional 60 cycles
– 72◦C for 5min (final extension)
– 4◦C forever
8. Break the emulsion. Adapted from pg 69 of the Bio-Rad Droplet Digital PCR Applications
Guide:
• After ePCA, pipet out the entire volume of droplets from each PCR tube into a 1.5 mL
tube. Combine up to 400 uL, in each tube. Note: phase-lock tubes can also be used here
to improve recovery.
• Carefully pipet and discard bottom oil phase after droplets float to the top. Press a P1000
down to its first stop, push through the droplets to the bottom of the tube, press down
to the second stop to expel any droplets, then wait several seconds for the droplets to
float back up to the droplet layer, and finally aspirate out the oil. You do not need to
remove every last bit of oil - just remove most of it.
• Add 50 uL of TE buffer for each 100 uL of PCR reaction combined in the 1.5mL tube.
• In a fume hood, add 175 uL of chloroform for each PCR reaction in the tube. (If there
are 4 PCR reactions in a tube than contents will be: <400uL PCR reactions, 200uL TE,
700 uL chloroform).
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• Vortex at maximum speed for 1 min.
• In a centrifuge, spin down at 15,500 x g for 10 min.
• Remove upper aqueous phase by pipetting, avoiding the chloroform phase.
• Transfer this to a clean 1.5mL tube (this is the DNA).
• Proceed to column or SPRI bead cleanup (Beckman) for the recovered DNA.
9. Size selection.
• The amplicons will often be mixed with undesired lower-molecular weight assemblies.
Removing these using size selection will increase final yield. Choose of of the following
three approaches, ordered from highest yield to lowest yield:
– Pippin Prep (Sage Science).
1. Follow manufacturer’s protocol (calibration, checking currents, loading, etc. . . )
2. Make sure to allow for a range broad enough to include every member of the
library, yet narrow enough to exclude some of the shorter non-specific products
(+/- 100 bp is usually fine).
3. Collect the eluted product and column cleanup using a Zymo Clean & Concen-
trator -5 (Zymo Research).
– or Gel extraction.
1. Run amplicons on a gel and extract the correct range and purify.
2. Note: Typically there is not enough DNA after the ePCA to visualize on a gel,
so this is often a blind extraction.
– or No size selection.
1. Make a dilution of ePCA and use this as template for the re-amplification.
10. Re-amplification.
• Amplify ePCA products using Kapa HiFi HotStart ReadyMix (2X) (KAPA Biosystems).
– 0.2 - 2 uL template
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– 1 uL 10 uM FWD assembly primer
– 1 uL 10 uM REV assembly primer
– 25 uL Kapa HiFi HotStart ReadyMix (2X) (KAPA Biosystems)
– UltraPure Distilled Water (Invitrogen) to 50 uL
– TOTAL: 50 uL
– PCR protocol:
1. 3 min 95◦C initial denaturation
2. 15 sec 98◦C denaturation
3. 20 sec 58◦C annealing
4. 45 sec 72◦C extension
5. Go to step 2, determine cycles using qPCR.
6. 3 min 72◦C final extension
• Column purify re-amplified products using a Zymo Clean & Concentrator -5 (Zymo
Research).
• Check size distribution on gel or tapestation.
• Quantify DNA and proceed to downstream applications.
Supplementary Text
PPAT complementation assay
There are several reasons homologs could have low fitness including environmental mismatches,
improper folding, mismatched metabolic flux, interactions with other cytosolic components, or gene
dosage toxicity effects resulting from improperly high expression. Of the homologs from extremophilic
bacteria, only alkaliphiles showed slightly reduced fitness values which is not significant (p-value =
0.059 Wilcoxon) (Fig. 4.23B). Metabolic mismatch is unlikely since so many homologs were able
to complement well and both CoA and dephospho-CoA act as inhibitors implementing negative
feedback loops to control the metabolic flux through the pathway [17]. Control experiments revealed
that high expression levels of wild-type E. coli PPAT result in growth defects, while similar levels of
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expression for many other homologs had no impact (Table 4.2). This observation parallels similar
findings for E. coli DHFR where wild-type overexpression was toxic while overexpression of homologs
had no detrimental effects [19], an effect linked to evolved protein-protein interactions that confer
benefits at physiological concentrations. PPAT interaction partners include several enzymes encoded
by essential genes such as leuS, murE, and rplD [42, 43].
Broad Mutational Assay (BMS)
Although 87% of the 3,180 possible mutations are covered, the coverage is strongly correlated with
position fitness (ρ=0.76; Pearson, p-value <2.2E-16) (Fig. 4.24C), implying that many mutations
that are depleted in the pooled assay (and typically represented by a only a few assembly barcodes),
never pass the 10-read threshold used to filter assembly barcodes, an issue that can be resolved by
sequencing the initial library to a greater depth. Unlike traditional mutagenesis approaches, the
presence of multi-bp deletions from the oligo synthesis process also allows us to evaluate the effect of
removal of entire residues from the sequence (Del. in Fig. 4.4A).
Gain-of-Function Mutants
In E. coli, residue Glu-134 and proximal Leu-102 have hydrophobic interactions with the cysteamine
moiety of CoA [42], suggesting that some GoF mutations play roles in tuning CoA inhibition, while
Ala-103 participates in hydrophobic interactions contributing to dimer formation [17]. Residues
64, 68, 69 are surface-exposed in the hexameric PPAT complex and are possible candidates for
interactions with other proteins. As many of these mutations had only a single assembly barcode,
we estimated a false positive rate of 0.9% derived from the number of positive fitness mutants for
negative controls (Fig. 4.19A).
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4.4 Supplementary Information
Figure 4.5: The histogram of read distributions for six of the 96-plex 4-oligo assemblies shown
in Fig 1B. A. T7 ligase and 20 ug beads. B. T4 and 20 ug beads. C. Taq ligase and 20 ug beads. D. T7
ligase and 100 ug beads. E. T4 ligase and 100 ug beads. F. Taq ligase and 100 ug beads.
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Figure 4.6: A. A maximum likelihood phylogenetic tree for all 1,152 PPAT homologs as well as E. coli
MG1655. Color scale represents percent amino acid sequence identity relative to E. coli PPAT (NP_418091.1).
B. The gene length distribution for the 5,775 DHFR homologs assembled using either four or five 230-mer
oligos with median gene lengths of 489 bp and 564 bp respectively.
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Figure 4.7: A. Histogram of protein sequence lengths for all 1,152 PPAT library members. Lengths do not
include start or stop codon. The longest, shortest, and median lengths are 516, 381, and 483 bp respectively.
B. Although they share the same function, PPAT homologs have evolutionarily divergent sequences. The
662,976 pairwise percentage identities between the 1,152 members of the PPAT library at the amino acid
level have a distribution with a median of 50% (σ = 5%). C. Without oligo isolation, amplification in bulk
fails to produce the correct product [11]. A 4% agarose gel comparing the assembly products of a 24-member
library of PPAT homologs (120 oligos) when the polymerase cycling assembly is done in bulk (BA) and in
emulsion (EA). The expected product size upon correct assembly is between 520 bp to 550 bp. D. Each of
the three 384-member PPAT libraries (1,920 oligos each) produced correct assembly products. A 4% agarose
gel showing amplified assembly products, with the expected size for most amplicons around ∼530 bp. Lane
1 and 2: High- and low-template PCR products for Lib 1. Lane 4 and 5: High- and low-template PCR
products for Lib 2. Lane 7 and 8: High- and low-template PCR products for Lib 3. High- and low-template
concentrations refer to either 2 uL or 0.2 uL of the purified assembly products from an emulsion used in a 50
uL PCR reaction.
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Figure 4.8: Agilent TapeStation gel image of DropSynth assembly of 28 384-member libraries
of DHFR. A total of 3 libraries of length 610bp (14, 15, 29) are assembled using 5 oligos while the remaining
libraries of length 510bp are assembled using 4 oligos. Another 2 libraries (13, 30) are not shown with one
having low yield on the oligo processing steps and another failing to amplify at the oligo stage.
Figure 4.9: Agilent TapeStation gel image of 25 4-oligo DHFR libraries after assembly, digestion,
ligation into barcoded plasmid and library preparation for sequencing. 5-oligo libraries (14, 15,
29) were not prepared for sequencing due to limitations on Illumina read length capabilities.
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Figure 4.10: Sequencing statistics from sample S0. These data are a set of paired end 600-cycle Miseq
runs which read through the entire assembled gene and its assembly barcode for all three 384-member libraries.
A. The number of reads per assembly barcode, with a median value of 2. S0 contains 7,038,274 unique
assembly barcodes across 20,263,445 reads. Of these, 209,868 assembly barcodes 2.98% (739,771 reads 3.65%)
mapped to the designed protein sequences without any amino acid mutations, of which 199,208 assembly
barcodes contained at least one synonymous mutation. A total of 2,982,539 (42%) of the mapped assembly
barcodes correspond to sequences containing a premature stop codon in the reading frame, of which the large
majority (2,404,348) were due to indel mutations causing a frameshift while the rest were due to nonsense
mutations. B. The long tail distribution of assembly barcodes per homolog, for assembly barcodes mapped
to a perfect sequence. Median value is 56 and a total of 872 out of 1152 homologs are represented with at
least one assembly barcode. C. The percentage of perfect protein sequences for constructs with at least 100
assembly barcodes. The solid line is the median value of 1.9%. D. Individually rank-ordered plots showing
the number of barcodes with perfect assemblies, barcodes with assemblies within distance of 2 a.a., and all
barcodes with an aligned homolog. E. The distribution of sequencing reads for the PPAT libraries. F. The
coverage of the PPAT homologs as a function of the minimum percent identity. Most of the library members
have assemblies with high identity to the respective designed homologs.
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Figure 4.11: A. The library coverage shows strong correlation (ρ=0.73 (Pearson), p-value=3.4E-5) with the
amount of DNA used to load the DropSynth beads prior to assembly. The coverage is defined as the number
constructs with at least one perfect assembly. B. The number of constructs with the same barcode which
dropout among different libraries. The red line is the level with an expectation value close to one for libraries
of size 384 given a uniform dropout distributions. Values above this line are higher than would be expected
by chance. About a dozen barcodes fall in this region.
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Figure 4.12: DropSynth assembly of 10,752 genes. We used DropSynth to assemble 28 libraries of
10,752 genes representing 1,152 homologs of PPAT and 4,992 homologs of DHFR. The number of barcodes per
million representing assemblies within 5 a.a. of each gene is shown alongside the number of library members
with at least one perfect assembly and the percent perfects determined using constructs with at least 100
barcodes.
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Figure 4.13: A. The expected percentage of perfect assemblies for a given number of oligos and the amount
of perfect oligos. B. The maximum gene assembly length possible for a given number of oligos and an oligo
size ranging from (200 to 300bp).
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Figure 4.14: Error analysis of DropSynth Assemblies. Using the error analysis pipeline developed by
Lubock et. al [16], we randomly sampled one million reads from Miseq paired-end 600-cycle assembly barcode
mapping data, performed an exhaustive alignment of each read against every perfect assembly and returned
the best scoring alignment. A. Mismatches are the most common form of error, followed by multiple base
deletions, single base deletions, and single base insertions. In particular, mismatches appear to be localized to
the overlap regions. B. Raw counts of mismatches. A higher number of transitions than transversions were
measured - in agreement with previous experiments where Taq-mediated amplification errors. This suggests
that the majority of mismatches were likely introduced by KAPA2G Robust polymerase during assembly
(evolved Taq variant).
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Figure 4.15: Phosphopantetheine adenylyltransferase (PPAT) metabolic pathway. PPAT shown
in red, catalyzes the second to last step in the five step biosynthesis of coenzyme A. It produces dephospho-
coenzyme A from 4’-phosphopantetheine by transferring a adenylyl group from ATP [17], as shown. Either
Mn2+ or Mg2+ acts as a cofactor. E. coli PPAT is hexameric and encoded by the 477 bp gene coaD. Several
gene knockout [44, 45] and genetic footprinting [46] studies have confirmed coaD to be essential for growth on
rich media in E. coli K-12 strains MC1061, MG1655, and DH10β. Both coenzyme A and dephospho-coenzyme
A act as inhibitors of the forward reaction. PPAT’s low homology to its mammalian counterpart, which is
encoded as one of the two domains on the bifunctional CoASy (CoA Synthase) enzyme, makes it a potential
target for new antimicrobials [18]. At least a dozen different PPAT homologs have crystal structure data
available.
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Figure 4.16: A. Rescue plasmid pTKcoaD allows λ−red recombination of the essential coaD gene. Wild-type
E. coli coaD is expressed constitutively along with GFP, which allows for confirmation of plasmid loss upon
heat curing. B. High-copy expression plasmid pEVBC allows for IPTG-inducible expression of an homolog
PPAT gene cloned in between the NdeI and KpnI sites. A 20-mer random assembly barcode is present
downstream. C. Verification of the coaD gene knockout using colony PCR with two sets of internal primers.
Four 42◦C heat-cured colonies (c1-c4) are shown as well as four colonies (c5-c8) grown at 30◦C which still
contain the rescue plasmid. Red arrows indicate expected amplicon size when coaD gene sequence is present.
D. Colony PCR verification of the coaD genomic knockout using external genomic primers for 9 knockout
colonies and one wildtype control. Wildtype (no knockout) amplicon length is 590 bp while the knockout
(KAN cassette knockin) amplicon length is 1150 bp, as marked by the red arrows. E. Comparison of E. coli
DH10β ∆ coaD pTKcoaD cells grown at 30◦C (left) and 42◦C (right). Cells were grown in LB+Kan for 15
hours at the corresponding temperature, to allow for sufficient outgrowth, before plating on LB+Kan and
incubating at the corresponding temperature. By comparing the number of GFP-positive colonies seen in
each case we estimated an escape frequency of 1 in 16,500 (σ = 1,600). We also tracked the escape frequency
of cells after transformation with PPAT homologs and growth at 42◦C, by determining the ratio of GFP
negative to GFP positive cells, finding an escape frequency of 1 in 20,200 (σ = 9500) as determined by 8
independent transformations. These escape frequencies are similar to those previously reported for coaD
(a.k.a. kdtB) upon heat curing of coaD expressing pMAK705 plasmid in a conditional knockout [44].
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Figure 4.17: PPAT complementation assay. A. The fitness values for 651 homologs across two inde-
pendent biological replicates shows strong correlation (ρ=0.94; Pearson). Six negative controls lacking the
H/TxGH motif required for nucleophilic attack on the α phosphate of the ATP have very low fitness values
(<3) in the assay. We colored each point based on the number of assembly barcodes that corresponded
to errorless constructs, and find that reproducibility among replicates improves with increasing number of
assembly barcodes (Fig. 4.18B). C. Despite having a median 50% sequence identity, distant homologs are
typically still able to complement the function of the native E. coli PPAT (bottom row). This multiple
sequence alignment table shows the fitness scores, percent sequence identity to E. coli PPAT, and source
organism.
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Figure 4.18: A. Fitness values of 329,897 individual assembly barcodes in each biological replicate, with
a correlation of 0.948. A large number of low-fitness assembly barcodes correspond to assemblies with
frameshifts due to indels. B. We see the reproducibility of the fitness values increase with the number of
assembly barcodes. The absolute difference in homolog fitness values between the two biological replicates as
a function of their number of assembly barcodes (ρ=-0.34; Spearman, p-value <2.2E-16). C. Fitness values
are noisy with a median standard deviation of around 2.4. Box plots of individual assembly barcode fitness
values for homologs in replicate A which have at least 50 assembly barcodes. Homologs are rank-ordered by
their final fitness value.
124
Figure 4.19: A. Assembly barcode fitness for six of the homologs missing the H/TxGH motif required for
catalytic activity. No simple mutation would be able to restore catalytic activity to these homologs, so they
serve as a useful measure of the false positive rate for individual assembly barcodes. Of the 994 assembly
barcodes only 9 assembly barcodes (0.9%) have a positive fitness value, indicating a low rate of false positives
at the individual barcode level. B. Mean sequence fitness is reduced with increasing number of mutations
(ρ=-0.38; Spearman, p-value <2.2E-16). Analysis of 144,573 sequences’ fitness as a function of their a.a.
distance from the designed homolog sequence. C. Very few sequences with less than ∼94% sequence identity
show high fitness. For sequences represented by at least 2 assembly barcodes, we plot their fitness as a
function of their sequence identity (relative to their corresponding designed sequences), within bins of 1%.
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Figure 4.20: The population of perfect and low mutational distance sequences expand as a function of time,
while sequences with low sequence identity (primarily due to indels) are depleted. We see that non-functional
assemblies are lost from the population primarily between the first two dilutions. Distribution of mapped
assembly barcodes (top. and mapped reads (bottom., for each replicate (left & right., based on distance
from the designed sequence.
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Figure 4.21: Synthesis verification. Sequence-verified clones were obtained for 37 of 49 homologs. A.
The amount of colonies observed after transformation of amplified constructs into E. coli DH10β ∆ coaD
pTKcoaD cells grown at 30◦C (positive control) and 42◦C (complementation). Symbol indicates 42◦C colony
size relative to 30◦C colonies. Dashed line shows slope of one and is not a fit. The presence of a cluster with
low colony counts in both conditions made up primarily of low-fitness homologs suggests possible toxicity
effects. Two false positives are observed which had positive fitness in the pooled assay but produced no colonies
in this transformation. Both of these had a low number of assembly barcodes (1 and 25). The majority of high
fitness homologs produced large numbers of colonies in both conditions with high correspondence between
the two. B. Comparison of growth rate of individual homologs (log-scale) and gain-of-function mutants as
determined on a plate reader with experimentally-determined fitness from pooled complementation assay,
with a Spearman’s correlation of rS=0.86. Growth rate (hr−1) is defined as the maximum slope of OD600 vs.
time on a log/linear plot. Fit is carried out using log growth rate and does not include the eight homologs
with a growth rate of zero. Wildtype PPAT E. coli had a growth rate of 0.132 indicative of gene dosage
toxicity effects due to overexpression. C. Correlation between the residual error of the fit of growth rate to
fitness and number of assembly barcodes in homologs (rs=-0.50, Spearman, p-value 1.7E-3). Constructs with
fewer assembly barcodes tend to have higher error between individual growth rate and fitness in the pooled
assay, highlighting the need for many assembly barcodes to determine fitness.
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Figure 4.22: PPAT phylogenetic tree. The majority of homologs listed complement wildtype E. coli,
with low-fitness homologs randomly dispersed throughout the tree with minimal clustering. A phylogenetic
tree of 451 homologs labeled, similar to Fig. 4.3D, with each leaf labeled with the organism name and shaded
by fitness.
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Figure 4.23: A. Phylogenetic tree of 411 homologs based on NCBI taxonomy rather than PPAT sequence,
generated using phyloT (http://phylot.biobyte.de). The median fitness was used when multiple sequences
were annotated with the same taxonomic ID. B. Fitness of PPAT homologs from organisms annotated as
extremophiles. Of the different classes, alkaliphiles show a weak shift to lower fitness values (p=0.059 Wilcoxon
rank sum test). Previous characterization of E. coli PPAT showed a maximum activity at pH 6.9 which was
reduced to 68% of the maximum by pH 8 [47].
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Figure 4.24: A. The average BMS position fitness compared to the conservation (Jensen-Shannon divergence).
As expected mutations tend to be more constrained at highly conserved sites (ρ=-0.64; Pearson, p-value
<2.2E-16). B. The average BMS position fitness compared to the relative solvent accessibility based on
a DSSP analysis of the 1H1T crystal structure (dimer not hexamer). Buried residues tend to be more
constrained (ρ=0.42; Pearson, p-value 3.9E-8). C. Mutational scanning coverage decreases at site of low
fitness (ρ=0.76; Pearson, p-value <2.2E-16). This effect is due to assembly barcodes with low read numbers
which, due to their low fitness, never pass the minimum 10 read threshold. D. Residues appearing in wildtype
E. coli PPAT are associated with higher fitness values. The distribution of fitness values for residues present
in the E. coli PPAT sequence (median = 2.16, σ = 0.24) compared to all others (median = 1.86, σ = 2.16).
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Figure 4.25: Variant classifier. We implemented a classifier to predict how different BMS variants would
perform in our assay. Each BMS variant was categorized into two bins based on whether or not their measured
fitness score was greater than 0. We then performed a logistic regression using 6 features for our model -
the amino acid mutation, secondary structure class as assigned by DSSP (loop, beta-sheet, or alpha-helix),
relative solvent accessibility as assigned by DSSP, sequence conservation, evolutionary coupling as predicted
by EVMutation, and the frequency of residue substitution from the sequence alignment used for EVMutation’s
prediction. To assess the performance of our classifier, we performed 10 repeats of 5-fold cross-validation on
our dataset and measured the precision and recall of each model on its respective hold-out set. We found
that on average, our simple classifier has A. an average accuracy of 0.825 +/- 0.013, B. a precision of 0.853
+/- 0.009, and an average recall of 0.931 +/- 0.014.
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Figure 4.26: A. The relative solvent accessibility and conservation of each of the eight gain of function
positions. B. Weblogo showing the probability of each residue at the gain-of-function positions for low-fitness
homologs. C. Weblogo of GoF residues for homologs which complemented. D. The mean fitness of each GoF
mutation at the significant positions, with the number of mutants observed at each a.a. E. The same plot
with the data derived from the broad mutational scan using complementing homologs and their mutants.
F. E. coli PPAT structure with the eight GoF residues shaded in red. Glu-134 is involved in hydrophobic
interactions with coenzyme A [42], suggesting a role for GoF mutations in modulating the inhibitory feedback,
while Ala-103 participates in hydrophobic interactions between the PPAT dimers.
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1. Select protein amino acid sequence to synthesize:
2. Assign random weighted codons:
5a. Split sequence with overlaps for assembly:
5b. If split fails assign new codons
      If split successful
3. Add restriction sites for cloning (NdeI and KpnI):
4. Add 20-mer assembly primers:
6. For each part of the split:
6i. Add flanking restriction sites (BtsI):
6ii. Add ATGC repeat to pad length:
6iii. Add barcode flanked by nicking sites (Nt.BspQI):
6iv. Add 15-mer amplification primers, unique to each pool:
Ligation oligo (20 mer) [5’ phosphorylation, 3’ biotin]
pTCCGCGAGTAAACCTAACAA
Anchor oligo (40 mer) [5’ dual biotin]
TTGTTAGGTTTACTCGCGGAACACGTGCTATTAGATGCCT
384 Barcode oligos (32 mer)
NNNNNNNNNNNNAGGCATCTAATAGCACGTGT
1. Individually mix, hybridize, ligate, and phosphorylate all 384:
pTCCGCGAGTAAACCTAACAA
TTGTTAGGTTTACTCGCGGAACACGTGCTATTAGATGCCT
NNNNNNNNNNNNAGGCATCTAATAGCACGTGT
  NNNNNNNNNNNNAGGCATCTAATAGCACGTGTTCCGCGAGTAAACCTAACAA
TTGTTAGGTTTACTCGCGGAACACGTGCTATTAGATGCCT
T4 ligase
T4 PNK
  pNNNNNNNNNNNNAGGCATCTAATAGCACGTGTTCCGCGAGTAAACCTAACAA
TTGTTAGGTTTACTCGCGGAACACGTGCTATTAGATGCCT
2. Individually bind duplexes to M270 streptavidin Dynabeads:
Wash
unbound
3. Pool all 384 barcodes together:
A
B
Figure 4.27: A. The oligo design process. Briefly, a.a sequences are assigned random weighted codons and
appended with restriction and primer sites used in DropSynth assembly. Sequences are then split into five
oligos with ∼20-nt overlap regions. Individual oligo sequences are appended with restriction sites, padding
sequences, gene-specific microbead barcodes flanked by nicking sites, and amplification primer sites leading to
a library of 200-nt sequences. B. The DropSynth microbead barcoding process. Microbead barcode oligos are
individually mixed with 3’ biotinylated ligation oligos and dual 5’ biotinylated anchor oligos, ligated using T4
ligase and phosphorylated with T4 PNK, exposing the microbead barcode sequence (NNNNNNNNNNNN).
Biotinylated duplexes are then individually bound to M270 streptavidin Dynabeads and pooled together.
133
Figure 4.28: Nick processing to generate single-stranded microbead barcode overhang. A. A
10% TBE-Urea denaturing gel highlighting the steps in nick processing. Lanes 1, 5, 7: a 10 bp ladder. Lane
2: Before processing, all oligos should be 200 nt. Lane 3: After nick processing we expect fragments of 165 nt,
177 nt, 35 nt, and 23 nt. Lane 4: After streptavidin Dynabead cleanup of nick processed oligos we expect
fragments of 165 nt and 177 nt. Lane 6: The captured Dynabead fraction after boiling at 90◦C for 10 min in
10 mM EDTA pH 8.2. B. A non-denaturing 4% agarose gel showing the nick processing which takes a 200 bp
duplex and leaves a 12-nt single-stranded microbead barcode overhang on a 165 bp dsDNA fragment. Lanes
p1-p4 showing several samples after nick processing and also one before processing (NP). Lanes b1-b4 show
the corresponding Dynabead fractions after denaturing at 80◦C for 3 min. Full length oligos containing errors
in the nt.BspQI sites will not have both strands nicked and are likely to be pulled down by the Dynabeads
together with the short fragment.
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Figure 4.29: Characterization of the distribution of droplet sizes for the vortex emulsions.
Briefly, 100 uL of Kapa Robust buffer was added to an eppendorf tube with 600 uL of Bio-Rad Droplet
Generation Oil and vortexed upright for 4 minutes on the highest setting of a Vortex-Genie 2. Samples were
then taken from the bottom, middle, and top of the resulting emulsion and imaged under 40X magnification.
The mode of the droplet diameter distribution peaks below 5 um. Scale bars are 100 um. Bottom right:
Histogram of droplet diameters as determined by image analysis. Median droplet diameter is below 5 um.
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Table 4.1: Assembly barcode statistics for each serial dilution in the two biological
replicates. Barcodes for each sample were clustered using Starcode [35] to collapse barcodes within
a Levenshtein distance of 1.
Biological
replicates
Serial dilution Total reads Total baracodes Total clutered
barcodes
A 1 9,051,752 4,317,940 4,289,165
2 9,790,924 2,319,457 2,231,361
3 8,222,783 1,346,284 1,263,430
4 7,947,874 970,291 892,753
B 1 9,136,919 4,259,319 4,228,531
2 8,319,364 1,919,591 1,843,449
3 10,036,601 1,393,886 1,292,371
4 9,437,037 993,877 907,884
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Table 4.2: Homologs and GoF mutants retrieved from the assem-
bled library and individually tested in knockout (KO) PPAT cells.
Growth rate (hr−1) is defined as the maximum slope of OD600 vs. time on a
log/linear plot. Wildtype E. coli PPAT and 3 catalytically inactive wildtype
mutants were also prepared and tested.
Type Construct ID Assembly
barcodes
42◦C
CFU
30◦C
CFU
Growth rate
(hr-1.
Fitness
Homolog CDD12392 699 312 234 0.198 2.02
Homolog WP_041531153 63 343 334 0.178 -0.94
Homolog CDA36762 834 324 237 0.205 2.76
Homolog WP_051012154 63 0 281 0 -3.46
Homolog WP_012984121 1302 372 315 0.205 1.83
Homolog WP_028874703 462 357 371 0.208 1.69
Homolog WP_009532117 220 349 313 0.218 3.15
Homolog CDC50010 429 361 406 0.216 3.39
Homolog WP_025936372 1150 207 168 0.215 2.53
Homolog WP_050330521 89 20 24 0 -3.58
Homolog WP_028844278 38 174 166 0.146 -3.03
Homolog WP_012096847 710 383 383 0.214 2.49
Homolog WP_050708028 1154 362 300 0.212 4.05
Homolog WP_027397238 40 20 44 0.131 -2.99
Homolog WP_007413164 172 497 300 0.176 1.68
Homolog KOS35328 25 0 41 0 1.88
Homolog KHS64893 506 96 210 0.218 2.49
Homolog KGB86419 185 585 491 0.233 2.94
Homolog WP_025369197 131 0 305 0 -3.70
Homolog WP_021271192 256 10 360 0.178 1.81
Homolog KJF18279 242 10 36 0 -3.52
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Homolog WP_029522041 128 2 640 0.124 -1.77
Homolog WP_014806494 143 523 451 0.177 -1.90
Homolog WP_038558636 938 18 24 0.193 0.58
Homolog CDC19414 310 638 541 0.236 3.78
Homolog WP_029455214 49 43 35 0.167 -3.49
Homolog BAN02173 56 290 487 0 -3.46
Homolog WP_008711239 693 787 642 0.229 3.28
Homolog WP_039669974 51 5 41 0 -3.52
Homolog WP_013656808 167 326 403 0.147 -3.46
Homolog KJS87341 2691 220 172 0.215 -0.70
Homolog WP_005674855 1059 305 290 0.256 3.84
Homolog WP_011140849 4757 278 216 0.214 1.68
Homolog WP_009360218 2986 281 77 0.222 3.25
Homolog EUC78355 317 413 388 0.217 1.84
Homolog WP_011433776 828 206 170 0.191 0.24
Homolog WP_006440043 20 297 174 0 -3.55
GOF WP_013656808_S69R 1 148 124 0.209 3.31
GOF WP_029455214_K69T 1 361 394 0.184 3.34
GOF WP_023508997_A104V 1 179 141 0.217 2.41
GOF WP_049662705_A101V 1 415 404 0.204 3.82
GOF WP_054252071_D66E 1 0 319 0 4.06
GOF WP_044825986_V134F 1 211 264 0.211 4.40
Wildtype NP_418091 196 207 0.132 ND
Inactive NP_418091_H18Y 95 142 0.105
Inactive NP_418091_H18D 0 130 0
Inactive NP_418091_H18W 0 113 0
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Table 4.3: Cost to create pool of 384 barcoded DropSynth microbeads. Creating the pool
of barcoded beads is a one time cost and produces enough beads to carry out at least 210 assemblies
of 384 genes, or over 80,000 genes, using the current protocol.
Item Cost
38.4 nmol anchor oligo (5’ dual biotin modification) $300
38.4 nmol ligation oligo (5’ phosphorylation and 3’ biotin modifications) $540
0.1 nmol of each of the 384 barcoded oligos $1656
1,575 uL 10X T4 ligase buffer $5
80E9 Units of T4 ligase (concentrated) $40
1,920 uL stock M270 streptavidin Dynabeads $456
3.84E9 Units T4 PNK $344
TOTAL $3341
Cost per assembly $15.69
Cost per construct $0.04
Table 4.4: DropSynth assembly costs per 384 gene library.
Item Cost
Microarray derived OLS pool (Agilent Technologies; ∼$0.10/oligo) $192
3x 50uL rxn KAPA Real-time Library Amplification Kit (KAPA Biosystems) $8.4
8x 50uL rxn KAPA HiFi HotStart ReadyMix (KAPA Biosystems) $33.6
2x columns Zymo Clean & Concentrator -5 (Zymo Research) $2.5
1 biotinylated primer (Integrated DNA Technologies) $40
3 primers (Integrated DNA Technologies) $10
2x SPRI cleanup (Beckman) $1
1,200 uL Dynabeads M-270 Streptavidin (Invitrogen) $285
50 uL Nicking enzyme (Nt.BspQI) (New England Biolabs) $27
50 uL Kapa2G Robust HotStart ReadyMix (KAPA Biosystems) $2.7
7 uL BtsI (New England Biolabs) $7.3
600 uL BioRad Droplet Generation Oil for EvaGreen (Bio-Rad Laboratories) $2.3
TOTAL $612
Cost per Construct $1.59
Cost per Construct with Barcoded Beads $1.63
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Table 4.5: Nick processing efficiencies for various conditions.
Sample nt.BspQI
digest (min)
[nt.BspQI]
(U/uL) in
150 uL digest
[DNA]
(ng/uL) in
digest
M270
Dynabead
incubation
(min)
[M270
Dynabead]
(ug/uL)
Molar
Yield (%)
i 190 0.266 9.5 200 2.2 56%
ii 240 0.266 14.4 280 1.2 35%
iii 985 0.3 16 375 2.2 46%
iv 985 0.32 14.4 375 1.2 40%
v 390 0.3 15.7 35 2.2 47%
vi 390 0.34 18.7 50 2.2 44%
vii 390 0.32 17.6 70 2.2 36%
Table 4.6: The oligos required for the bead barcoding process. All oligos were ordered from
Integrated DNA Technologies.
Oligo Name Sequence Modifications Amount
Ligation oligo TCCGCGAGTAAACCTAACAA 3’ biotin
5’ phosphorylation
38.4 nmol
Anchor oligo TTGTTAGGTTTACTCGCGGAA-
CACGTGCTATTAGATGCCT
5’ dual biotin 38.4 nmol
384X
barcoded oligos
12-mer microbead barcode
reverse complement +
AGGCATCTAATAGCACGTGT
0.1 nmol each
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Table 4.7: Primer sequences used in this study.
Name Sequence
coaD_KO_KAN_FWD_1 AACGCATTGAGGTTGTTGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGG-
AATAGGAACTTCTTTCTTAGACGTCGGAATTGCCAGC
coaD_KO_KAN_REV_1 ATACCATCCGGCATAAACGAGTTCCTATTCCGAAGTTCCTATTCTCTAGAAAG-
TATAGGAACTTCGCTCAGAAGAACTCGTCAAGAAGGC
coaD_KO_KAN_FWD_2 GCTTCAACTGCTGGAACCTTACCTGCCACCGAAAACGCATTGAGGTTGTT-
GAAGTTCC
coaD_KO_KAN_REV_2 TGCCAGAAGTAATTCATGCGCGCCGGATGGCATACCATCCGGCATAAACG-
AGTTCC
pEVBC_FWD Biotin-GCCGTCATATGAGCTGTTTCCTGTGTGAAATTG
pEVBC_REV1 Biotin-GTGGGTACCTAAGTGTGGCTGCGGAACNNNNNNNNNNNNNNNNNNNN-
GCACGACGTCAGGTGGCACTTTTCG
pEVBC_amp_FWD Biotin-GTGGGTACCTAAGTGTGGCTGCGGAAC
mi3_FWD AATGATACGGCGACCACCGAGATCTACACGTGGAATTGTGAGCGGATAACAA-
TTTCACACAGGAAACAGCTCATATG
mi3_REV_N70# CAAGCAGAAGACGGCATACGAGATNNNNNNNNCGCACATTTCCCCGAAAA-
GTGCCACCTGACG
mi3_R1 GTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTCATATG
mi3_R2 CGCACATTTCCCCGAAAAGTGCCACCTGACGTCGTGC
mi3_index GCACGACGTCAGGTGGCACTTTTCGGGGAAATGTGCG
mi4_FWD AATGATACGGCGACCACCGAGATCTACACGCTAGACGGTACCTAAGTGTGGCTG-
CGGAAC
mi4_REV_N7## CAAGCAGAAGACGGCATACGAGATNNNNNNNNCCTGACGTCAGGCAAGTGCCAC-
CTGACGTCGTGC
mi4_R1 GGCTAGACGGTACCTAAGTGTGGCTGCGGAAC
mi4_R2 CCTGACGTCAGGCAAGTGCCACCTGACGTCGTGC
mi4_index GCACGACGTCAGGTGGCACTTGCCTGACGTCAGG
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Chapter 5
A Scalable, Multiplexed Assay for
Decoding Receptor-Ligand Interactions
5.1 Abstract
G-protein coupled receptors (GPCRs) are the primary means by which mammalian cells sense and
respond to chemicals. Using next-generation sequencing of barcoded genetic reporters in engineered
human cell lines, we developed a platform to screen large chemical panels against multiplexed GPCR
libraries. We used this platform to map 39 mammalian olfactory receptors against 181 odorants,
revealing many new associations and deorphanizing 15 receptors.
5.2 Introduction
Interactions between small molecules and receptors underpin an organism’s ability to sense and
respond to its internal state and the environment. For many drugs and natural products, the
ability to modulate many biological targets at once is crucial for their efficacy [1, 2, 3]. Thus,
to understand the effect of many small molecules, we need to comprehensively characterize their
functional interactions with biological targets. This many-on-many problem is laborious to study
one interaction at a time, and is especially salient in the mammalian sense of smell [4, 5].
† This work has been published as: E. M. Jones and R. Jajoo, D. Cancilla, N. B. Lubock, J. Wang, M. Satyadi, R.
Cheung, C. de March, J. Bloom, H. Matsunami, S. Kosuri. “A scalable, multiplexed assay for decoding receptor-ligand
interactions” bioRxiv pp. 348739, 2018
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Olfaction is mediated by a class of G protein-coupled receptors (GPCRs) known as olfactory
receptors (ORs)[6]. GPCRs are a central player in small molecule signaling and are currently targeted
by 34% of US Food and Drug Administration (FDA) approved drugs [7]. ORs are a large family
of class A GPCRs with approximately 396, 1130, and 1948 intact receptors in humans, mice, and
elephants respectively [8]. Each OR can potentially interact with many odorants, and inversely, each
odorant with many ORs. The majority of ORs remain orphan– i.e.have no known ligand– because
of this vast combinatorial space, further compounded by the fact that recapitulating mammalian
GPCR function in vitro is challenging [9, 10]. In addition, no experimentally determined structure
for any mammalian OR is available, hindering computational efforts to predict which odorants can
activate each OR [11].
Most GPCR and OR assays test chemicals against each receptor individually [12, 13]. Multiplexed
assays, where the activities of multiple receptors – often referred to as a library of receptors – are
measured in the same well, would increase the throughput but have remained technically challenging.
In such an assay, each cell expresses a single type of receptor and, upon activation, transcribes a short
barcode sequence that identifies the particular receptor expressed in that cell. The enrichment of
barcoded transcripts corresponding to each receptor’s activation are then measured by microarrays or
next-generation sequencing. Such multiplexed GPCR activity assays have previously been attempted
by transient transfection of individual receptors and subsequent pooled screening [14, 15]. However,
these assays are difficult to perform, especially in olfaction, for several reasons. First, ORs, like many
GPCRs, are difficult to express in their non-native contexts and often require specialized accessory
factors and signaling proteins to function heterologously [16]. Second, transient transfection must
be performed for tens to hundreds of individual cell lines each time an assay is performed. Thus,
experimental protocols for such multiplexed screens are expensive, labor intensive, and often carried
out in a low-throughput manner. Using stable lines would alleviate these burdens, but building
stable OR reporter lines is challenging and has only worked in two reported cases [17, 18].
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Figure 5.1: A Genomically Integrated Synthetic Circuit Allows Screening for Mammalian
Olfactory Receptor Activation. A. Schematic of the synthetic circuit for stable OR expression and
function in an engineered HEK293T cell line (ScL21). Heterologous accessory factors expressed include (pink):
RTP1S, RTP2, Gαolf, and Ric8b. B. MOR42-3 reporter activation expressing the receptor transiently (left) or
genomically integrated (right) at varying copy number, under constitutive or inducible expression in HEK293T
cells. C. MOR258-5 reporter activation with/without accessory factors (A.F.s), RTP1S and RTP2, transiently
coexpressed in HEK293T cells compared to stable receptor expression in ScL21. D. Reporter activation
response curves for MOR258-5 and MOR41-1 genomically integrated in ScL21 with/without doxycycline
induction of receptor expression.
5.3 Results
Here we report a new high-throughput screen to characterize small molecule libraries against mam-
malian OR libraries in multiplex. To do this, we developed both a stable cell line capable of
functional OR expression (ScL21) and a multiplexed reporter for OR activity (Fig. 5.1a, Supple-
mentary Fig. 5.3). Activation of each OR leads to the expression of a reporter transcript with a
unique 15-nucleotide barcode sequence. Each barcode identifies the OR expressed in that cell; this
enables OR activation to be measured by quantifying differential barcode expression with RNA-seq.
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This technology enables the simultaneous profiling of a single chemical’s activity against a library of
receptors in a single well.
We first engineered a stable cell line, ScL21, capable of functionally expressing ORs and responding
to odorant stimuli by transcribing an RNA barcode. First, we found that multi-copy integration
and inducible receptor expression are both essential for reporter activation, but individually neither
of these features is sufficient to generate a response (Fig. 5.1b, Supplementary Fig. 5.4). Then,
to allow larger OR repertoires to be assayed, we added features known to improve OR function
[16, 19, 20]. We stably integrated a pool of 4 accessory factors at multi-copy under inducible
expression: Gαolf and Ric8b for signal transduction, and RTP1S and RTP2 to promote surface
expression (Fig. 5.1c, Supplementary Figs. 5.3 and 5.4). To select a single line for further use, we
isolated clones and screened for robust activation of two ORs known to require accessory factors
to function heterologously (Supplementary Fig. 5.4). In addition, we then incorporated protein
trafficking tags previously shown to increase surface expression [21, 22], included DNA insulator
sequences to reduce background reporter activation, optimized the cAMP response element (CRE)
to improve reporter signal, and combined these improvements into a single transposable vector to
speed cell line development (Supplementary Fig. 5.5). We validated our system on two murine ORs
with known ligands, and observed induction- and dose-dependent activation (Fig. 5.1d).
To pilot the platform, we chose 42 phylogenetically divergent murine ORs with both known and
unknown chemical specificities and created a library of OR-expressing cell lines (Supplementary
Fig. 5.6). To engineer the individual cell lines, we first cloned and mapped the ORs to their
corresponding barcodes and transposed the plasmids individually into the genomes of HEK293T
cells [23]. After selection we pooled the cell lines together, generating assay-ready libraries for
repeated testing (Fig. 5.2a). Unlike a luciferase reporter assay, each well contains the entire OR
library and a single chemical’s activity is measured against the entire library of ORs in a single well.
We seeded the cell library in 6-well culture dishes and screened odorants known to activate ORs
in our library (Supplementary Fig. 5.7); all but 3 ORs passed quality filtering to obtain reliable
estimates of activation (See Methods). Analysis of the sequencing readout recapitulated previously
identified odorant-receptor pairs, and chemical mixtures appropriately activated multiple ORs [12]
(Supplementary Fig. 5.7). We found the assay was robust to chemicals such as the adenylate cyclase
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stimulator, forskolin, which non-specifically induces barcode transcription independent of the OR
each cell expresses. This is likely because our library-based approach measures the relative activation
of ORs to each other, normalizing any global effects due to off-target reporter activation.
Next, we adapted the platform for high-throughput screening in 96-well format. To decrease
reagent cost and assay time, we optimized an in-lysate reverse transcription protocol and used dual
indexing to uniquely link barcode reads to the correct well once samples were mixed for sequencing
(see Methods). With these improvements, the assay is able to recapitulate dose-response curves for
known odorant-receptor pairs (Supplementary Fig. 5.7). We observed reproducible results between
identically treated but biologically independent wells (Supplementary Figs. 5.8 and 5.9).
We subsequently screened 181 odorants with both known and unknown receptor specificity at
three concentrations in triplicate against the 39-member OR cell library, or 81,012 wells if each
combination had been tested individually including controls (Fig. 5.2a and Supplementary Tables
5.1 and 5.2). Each 96-well plate in the assay contained independent positive control odorants and
solvent (DMSO) for normalization (Supplementary Fig. 5.9). We used a generalized linear model
to determine OR-odorant interactions (see Methods)[24]. We found 112 significant interactions
(out of > 7, 000 combinations), of which 79 are novel, and 24 that target 15 orphan receptors
(Benjamini-Hochberg corrected FDR = 1%; Fig. 5.2b, Supplementary Fig. 5.10a, and Supplementary
Table 5.3)[25]. Overall, 28 of 39 receptors were activated by at least one odorant, and 67 of 181
odorants activated at least one OR (Supplementary Table 5.3).
To validate our assay, we compared results to a previous study and also analyzed individual
interactions in a different experimental context. First, we chose 36 interactions with at least 1.2-
fold induction to retest individually in a previously developed transient OR activation system [26]
(Supplementary Fig. 5.11). Of the 27 significant interactions at an FDR of 1%, 20 of them replicated
in this orthogonal system (Supplementary Fig. 5.10). Notably, some of the seven interactions which
did not replicate in this orthogonal system, appear to be true hits. For instance, our assay registered
two hits for MOR19-1 with high chemical similarity (methyl salicylate and benzyl salicylate),
suggesting they are likely not false positives (Supplementary Fig. 5.11). Additionally, three of nine
interactions not passing the 1% FDR threshold showed activation in the orthogonal assay, indicating
that a conservative FDR threshold likely generated some false negatives. A previous large-scale OR
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deorphanization study screened some of the same receptors and chemicals, and we found that 9/12
of their reported interactions with EC50 below 100µM were also detected in our platform, though
we did not identify most of the previous low affinity interactions [12] (Supplementary Fig. 5.12).
Conversely, we also detected 14 positive interactions absent from the previous study. Finally, our
assay replicated the vast majority of non-interacting odorant-OR pairs (493/507).
Using the data generated by this high throughput assay, we found that chemicals with similar
features activate the same ORs, including those receptors we deorphanize in this study (Fig. 5.2c).
For example, the previously orphan MOR19-1 has clear affinity for the salicylate functional group,
while MOR13-1 is activated by four chemicals with hydrogen bond accepting groups attached and–
in three cases– to stiff non-rotatable scaffolds (Supplementary Data 1). We also detect ORs with
partial overlap in chemical specificity; MOR13-1 detects compounds with terminal carbonyls while
MOR258-5 detects cyclic conjugated molecules (Fig. 5.2d). Benzaldehyde, an intermediate size
carbonyl, activates both ORs.
To more systematically understand how chemical similarity relates to receptor activation, we
used a recently developed molecular autoencoder to computationally map each tested chemical
onto a 292-dimensional continuous representation of chemical space and visualized the results with
Principal Components Analysis [27] (Supplementary Fig. 5.13). Chemicals for 11/17 multi-hit
receptors cluster together across the first two principal components (Supplementary Fig. 5.14). For
instance, of 13 aliphatic aldehydes or carboxylic acids with >5 carbons in our chemical panel, 10
activate MOR5-1 (Fig. 5.2c, Supplementary Data 1). Interestingly, this analysis also highlights the
instances where ORs are sensitive to several distinct sets of chemicals (Fig. 5.2e). For example,
MOR139-1 is activated by compounds that belong to two distinct clusters: one with benzene rings
and the other with cyclohexane rings, hinting at the selective features of these odorants. Similarly,
MOR170-1 exhibits a broad activation pattern: this receptor responds to 50% of all odorants in
our panel that contains both a benzene ring, and either a carbonyl or ether group. Most of these
odorants form a single cluster with the exception of the acetate compounds that form a separate
cluster. Understanding the global chemical space that activates each OR establishes the groundwork
for the prediction of novel odorant-OR interactions.
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Figure 5.2: Large-Scale, Multiplexed Screening of Olfactory Receptor-Odorant Interactions. A.
Experimental workflow for OR library generation and high-throughput screening. To perform assay, we
cloned OR genes and barcodes into plasmids, engineered cell lines via individual transposition of plasmids,
pooled cell lines and performed screen in 96 well plates. We assayed the equivalent of 81,012 wells of a screen
where interactions are tested individually. B. Heatmap of interactions from the screen clustered by odorant
and receptor responses, and shaded by the minimum activating odorant concentration that triggered reporter
activity. Only ORs and chemicals that registered at least one interaction are shown. C. Chemical names and
structures for odorants that activate MOR23-1 and MOR5-1. D. Chemical names and structures for odorants
that activate MOR258-5 and MOR13-1. E. Chemical hits identified for MOR170-1 and MOR139-1 (black)
mapped onto a PCA projection of the chemical space of our odorant panel (grey). Shaded areas highlight
hits that cluster together in chemical space.
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5.4 Discussion
We anticipate that this platform can be scaled to test the 396-member human OR repertoire and
comprehensively define OR response to any odorant of interest. The approximate cost per well is on
par with existing assays, but per receptor-ligand interaction interrogated, multiplexing dramatically
reduces cost and labor. Our incomplete understanding for how ligands [28], drugs [1], hormones,
natural products [29] and odors [12] interact with potential cellular targets limits our ability to
rationally develop new molecules to modulate receptor activity. Multiplex methods like this platform
offer a scalable solution to generate large-scale datasets that will help guide both empirical and
algorithmic efforts to better dissect the complex interactions between small molecules and biological
targets [30].
5.5 Materials and Methods
Odorant-Receptor Activation Luciferase Assay (Transient)
The Dual-Glo Luciferase Assay System (Promega) was used to measure OR-odorant responses
as previously described26. HEK293T cells (ATCC #11268) were plated in poly-D-lysine coated
white 96-well plates (Corning) at a density of 7,333 cells per well in 100 ul DMEM+10% FBS
(Thermo Fisher Scientific). 24 hours later, cells were transfected using lipofectamine 2000 (Thermo
Fisher Scientific) with 5 ng/well of plasmids encoding ORs and 10 ng/well of luciferase driven by a
cyclic AMP response element or 10 ng/well of a plasmid encoding both the OR and the luciferase
gene, and in both cases 5 ng/well of a plasmid encoding Renilla luciferase. Experiments conducted
with accessory factors included 5 ng/well of plasmids encoding RTP1S (Gene ID: 132112) and
RTP2 (Gene ID: 344892). Inducibly expressed ORs were transfected with 1 ug/ml doxycycline
(Sigma-Aldrich) added to the transfection media. 10-100 mM odorant stocks were established in
DMSO or ethanol. 24 h after transfection, transfection medium was removed and replaced with 25
ul/well of the appropriate concentration of odorant diluted from the stocks into CD293 (Thermo
Fisher Scientific). Four hours after odorant stimulation, the Dual-Glo Luciferase Assay kit was
administered according to the manufacturer’s instructions. Luminescence was measured using the
M1000 plate reader (Tecan). All luminescence values were normalized to Renilla luciferase activity
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to control for transfection efficiency in a given well. Data were analyzed with Microsoft Excel and R.
Odorant-Receptor Activation Luciferase Assay (Integrated)
HEK293T and HEK293T derived cells integrated with the combined receptor/reporter plasmids
were plated at a density of 7333 cells/well in 100 µL DMEM+10in poly-D-lysine coated 96-well
plates. 24 hours later, 1 ug/ml doxycycline was added to the well medium. Odorant stimulation,
luciferase reagent addition, and luminescence measurements were carried out in the same manner
as the transient assays. Constitutively expressed ORs were assayed in the same manner without
doxycycline addition. Data were analyzed with Microsoft Excel and R.
Odor Stimulation and RNA Extraction for Pilot-Scale Multiplexed Odorant
Screening
HEK293T and HEK293T-derived cells transposed with the combined receptor/reporter plasmid
were plated at a density of 200k cells/well in a 6 well plate in 2 mL DMEM+10%FBS. 24 hours
later, 1 ug/ml doxycycline was added to the well medium. 10-100 mM odorant stocks were diluted
in DMSO or ethanol. 24 hours after doxycycline addition, odorants were diluted in OptiMEM and
media was aspirated and replaced with 1 mL of the odorant-OptiMEM solution. 3 hours after odor
stimulation, odor media was aspirated and 600 µL of buffer RLT (Qiagen) was added to each well.
Cells were lysed with the Qiashredder Tissue and Cell Homogenizer (Qiagen),and RNA was purified
using the RNEasy MiniPrep Kit (Qiagen) with the optional on-column DNAse step according to the
manufacturer’s protocol.
Pilot Scale Library Preparation and RNA-seq
5 ug of total RNA per sample was reverse transcribed with Superscript IV (Thermo-Fisher) using a
gene specific primer for the barcoded reporter gene (OL003). The reaction conditions are as follows:
annealing: [65◦C for 5 min, 0◦C for 1 min] extension: [52◦C for 60 min, 80◦C for 10 min]. 10% of the
cDNA library volumes were amplified for 5 cycles (OL004F and R) using HiFi Master Mix (Kapa
Biosystems). The reaction and cycling conditions are optimized as follows: 95◦C for 3 minutes, 5
cycles of 98◦C for 20 seconds, 59◦C for 15 seconds, and 72◦C for 10 seconds, followed by an extension
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of 72◦C for 1 minute. The PCR products were purified using the DNA Clean & Concentrator kit
(Zymo Research) into 10 µL and 1 µL of each sample was amplified (OL005F and R) using the
SYBR FAST qPCR Master mix (Kapa Biosystems) with a CFX Connect Thermocycler (Biorad) to
determine the number of PCR cycles necessary for library amplification. The reaction and cycling
conditions are optimized as follows: 95◦C for 3 minutes, 40 cycles of 95◦C for 3 seconds and 60◦C
for 20 seconds. After qPCR, 5 µL of the pre-amplified cDNA libraries were amplified a second time
at the same cycling conditions as the first amplification with the same primers used for qPCR for 4
cycles greater than the previously determined Cq. The PCR products were then gel isolated from a
1% agarose gel with the Zymoclean Gel DNA Recovery Kit (Zymo Research). Library concentrations
were quantified using a TapeStation 2200 (Agilent) and loaded at equimolar ratios onto a HiSeq
3000 with a 20% PhiX spike-in and sequenced with custom primers: Read 1 (OL003) and i7 Index
(OL006).
Pilot Scale Data Analysis
To determine fold activation of each OR treated with each chemical, we first calculated the fraction
of barcodes (composition) corresponding to each OR in the control treatment (DMSO). Then, we
calculated the fold change in the composition of each OR in each a specific condition. As the barcode
reads from activated ORs can dominate the composition of all reads and change the effective library
size, we then normalized the activation of each OR by the median activation for each well. To be
effective, this normalization assumes that fewer than half of the ORs are activated by an odorant.
OR Library Cloning
The backbone plasmid (all genetic elements except the OR and barcode) was created using isothermal
assembly with the Gibson Assembly HiFi Mastermix (SGI-DNA). A short fragment was amplified
with a primer containing 15 random nucleotides to create the barcode sequence (OL007F and R)
using HiFi Master Mix. The reaction and cycling conditions are optimized as follows: 95◦C for 3
minutes, 35 cycles of 98◦C for 20 seconds, 60◦C for 15 seconds, and 72◦C for 20 seconds, followed
by an extension of 72◦C for 1 minute. The amplicon and the backbone plasmid were digested with
restriction enzymes MluI and AgeI (New England Biolabs) and ligated together with T4 DNA ligase
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(New England Biolabs). DH5α E.coli competent cells (New England Biolabs) were transformed
directly into liquid culture with antibiotic to maintain the diversity of the barcode library.
OR genes were received as a gift from Hiro Matsunami. OR genes were amplified individually
with primers (OL008) adding homology to the barcoded backbone plasmid using HiFi Master Mix.
The reaction and cycling conditions are optimized as follows: 95◦C for 3 minutes, 35 cycles of 98◦C
for 20 seconds, 61◦C for 15 seconds, and 72◦C for 30 seconds, followed by an extension of 72◦C for 1
minute. The amplified ORs were purified with DNA Clean and Concentrator Kit (Zymo Research)
and pooled together. The barcoded backbone plasmid was digested with NdeI and SbfI and the
OR amplicon pool was cloned into it using isothermal assembly with the Gibson Assembly Hifi
Mastermix. DH5α E.coli competent cells were transformed with the assembly and antibiotic resistant
clones were picked and grown up in 96-well plates overnight. The plasmid DNA was prepped with
the Zyppy -96 Plasmid Miniprep Kit (Zymo Research). Plasmids were Sanger sequenced (OL109-111)
both to associate the barcode with the reporter gene and identify error-free ORs.
OR Library Genomic Integration
HEK293T cells and HEK293T-derived cells were seeded at a density of 350k cells/well in a 6-well
plate in 2 mL DMEM+10% FBS. 24 hours after seeding, cells were transfected with plasmids
encoding receptor/reporter transposon and the Super PiggyBac Transposase (Systems Bioscience)
according to the manufacturer’s instructions. 1 ug of transposon DNA and 200 ng of transposase
DNA were transfected per well with Lipofectamine 3000 (Thermo Fisher Scientific). 3 days after
transfection, cells were passaged 1:10 into a 6-well plate, and one day after passaging 8 ug/mL
blasticidin were added to the cells. Cells were grown with selection for 7-10 days. The OR library
was transposed individually and pooled together at equal cell numbers.
Accessory Factor Cell Line Generation
HEK293T derived cells were transposed with plasmids encoding the accessory factor genes RTP1S,
RTP2, Gαolf (Gene ID: 2774), and Ric8b (Gene ID: 237422) inducibly driven by the Tet-On promoter
pooled equimolar according to the transposition protocol in the OR Library Integration section.
Cells were selected with 2 ug/mL puromycin (Thermo Fisher). After selection, cells were seeded in a
156
96-well plate at a density of 0.5 cells/well. Wells were examined for single colonies after 3 days and
expanded to 24-well plates after 7 days. Clones were screened for accessory factor expression by
screening them for robust activation of MOR258-5/Olfr62 and OR7D4 with a transient luciferase
assay (Supplementary Fig. 5.3). The clone with the highest fold activation for both receptors and
no salient growth defects was established for the multiplexed screen.
Transposon Copy Number Verification
gDNA was purified from cells transposed with the OR reporter vector and from cells containing the
single copy landing pad with the Quick-gDNA Miniprep kit. 50 ng of gDNA was amplified with
primers annealing to the regions of the exogenous DNA from each sample using the SYBR FAST
qPCR Master Mix (Kapa Biosystems) on a CFX Connect Thermocycler using the manufacturer’s
protocol. The reaction and cycling conditions are optimized as follows: 95◦C for 3 minutes, 40 cycles
of 95◦C for 3 seconds and 60◦C for 20 seconds. Cq values for the transposed ORs were normalized
to the single copy landing pad to determine copy number.
Lentiviral Transduction
Lentiviral vector was produced by transient transfection of 293T cells with lentiviral transfer plasmid,
pCMV∆R8.91 and pCAGGS-VSV-G using Mirus TransIT-293. HEK293T cells were transduced to
express the m2rtTA transcription factor (Tet-On) at 50% confluency and seeded one day prior to
transduction. Clones were isolated by seeding cells in a 96-well plate at a density of 0.5 cells/well.
Wells were examined for single colonies after 7 days and expanded to 24 well plates. Clones were
assessed for m2rtTA expression by screening for robust activation of MOR42-3 (Gene ID: 257926)
with a transient luciferase assay.
High-throughput Odorant Screening
The OR library cell line was thawed from a liquid nitrogen frozen stock into a T-225 flask (Corning)
three days before seeding into a 96-well plate for screening. The library was seeded at 6,666 cells
per well in 100 µL of DMEM+10% FBS. 24 hours later a working concentration of 1 ug/mL of
doxycycline in DMEM+10% FBS was added to the wells. 24 hours after induction, the media was
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removed from each plate and replaced with 25 ul of odorant diluted in OptiMEM. Each odor was
added at three different concentrations (10 µM, 100 µM, 1 mM) in triplicate with the same amount
of final DMSO (1%). Each plate contained two control odorants at a three concentration (10 µM,
100 µM, 1 mM) in triplicate and three wells containing 1% DMSO dissolved in media. The library
was incubated with odorants for three hours in a cell culture incubator with the lids removed.
After odor incubation, media was pipetted out of the plates and cells were lysed by adding 25 µL
of ice-cold Cells-to-cDNA II Lysis Buffer (Thermo Fisher) and pipetting up and down to homogenize
and lyse cells. The lysate was then heated to 75◦C for 15 minutes and flash frozen with liquid
nitrogen and kept at -80◦C until further processing. Then 0.5 µL DNase I (New England Biolabs)
was added to lysate, and incubated at 37◦C for 15 minutes. To anneal the RT primer, 5 ul of lysate
from each well was combined with 2.5 µL of 10 mM dNTPs (New England Biosciences), 1 µL of 2 µM
gene specific RT primer (OL003), and 1.5 µL of H2O. The reaction was heated to 65◦C for 5 min and
cooled back down to 0◦C. After annealing, 1 µL of M-MµLV Reverse Transcriptase (Enzymatics), 1
µL of buffer, and 0.25 ul of RNase Inhibitor (Enzymatics) were added to each reaction. Reactions
were incubated at 42◦C for 60 min and the RT enzyme was heat inactivated at 85◦C for 10 min.
For each batch, qPCR was performed on a few wells (OL005F and OL013) with SYBR FAST
qPCR Mastermix to determine the number of cycles necessary for PCR based library preparation.
The reaction and cycling conditions are optimized as follows: 95◦C for 3 minutes, 40 cycles of 95◦C
for 3 seconds and 60◦C for 20 seconds. After qPCR, 5 µL of each RT reaction was combined with
0.4 µL of 10 µM primers containing sequencing adaptors (OL005F and OL013), 10 µL of NEB-Next
Q5 Mastermix (New England Biosciences) and 4.2 µL H2O, the PCR was carried out according
to the manufacturer’s protocol. The forward primer contains the P7 adaptor sequence and an
index identifying the well in the assay and the reverse primer contains the P5 adaptor sequence
and an index identifying the plate in the assay. PCR products were pooled together by plate and
purified with the DNA Clean and Concentrator Kit. Library concentrations were quantified using a
TapeStation 2200 and a Qubit (Thermo Fisher). The libraries were sequenced with two index reads
and a single end 75-bp read on a NextSeq 500 in high-output mode (Illumina).
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Analysis of Next-Generation Sequencing Data
Samples were identified via indexing by their PCR index adapters unique for each well (5’ end)
and unique for each plate (3’ end). The well barcodes followed the 7bp indexing scheme in Meyer
et al., Cold Spring Harb Protoc, 2010. The plate indexing scheme followed the Illumina indexing
scheme. Sequencing data was demultiplexed, and 15bp barcode sequences were counted with only
exact matches by custom python and bash scripts.
Statistical Methods for Calling Hits
Count data was then analyzed using the differential expression package EdgeR [24]. To filter out
ORs with low representation, we empirically set a cutoff that an OR had to contain at least 0.5% of
the reads from more than 399 of the 1954 test samples. This filtered out 3 of 42 ORs which were
underrepresented in the cell library (MOR172-1, MOR176-1 and MOR181-1).
Normalization factors were determined using the EdgeR package function calcNormFactors,
and glmFit was used with the dispersion set to the tagwise dispersion, since only 39 ORs were
present in the library and trended dispersion values did fit the data well. By fitting a generalized
linear model to the count data to determine if odorants stimulated specific ORs, we were able to
determine both the mean activation for each OR-odorant interaction and the p-value. We then
corrected this p-value for multiple hypothesis testing using the built in p.adjust function with the
Benjamini & Hochberg correction, yielding a False Discovery Rate (FDR)[25]. We set a cutoff of 1%
to determine interacting odorant-OR pairs. For each interaction between an odorant and an OR, we
further required that an OR-odorant interaction was above the cutoff in two different concentrations
of odorant or in just the 1000 µM concentration.
Molecular Autoencoder
We used an autoencoder as described in Gómez-Bombarelli et al. to visualize OR-chemical interactions
in the context of chemical space [27]. Following the authors’ advice, we used a reimplementation of
autoencoder as the original implementation requires a defunct Python package (https://github.
com/chembl/autoencoder_ipython). This model comes pre-trained to a validation accuracy of 0.99
on the entire ChEMBL 23 database with the exception of molecules whose SMILES are longer than
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120 characters. We used this pretrained model to generate the latent representations of the 168
chemicals for which we could find SMILES representations and 250,000 randomly sampled chemicals
from ChEMBL 23. We then used scikit-learn to perform principal component analysis to project
the resulting matrix onto two dimensions [31].
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5.6 Supplementary Information
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Figure 5.3: Schematic of the Synthetic Olfactory Activation Circuit in the Engineered Cell
Line. Full graphical representation of the expressed components for expression/signaling of the ORs and the
barcoded reporter system as shown in Fig. 5.1 of the main text. Receptor expression is controlled by the
Tet-On system (Orange). After doxycycline induction, the OR is expressed on the cell surface with assistance
from two exogenously expressed chaperones, RTP1S and RTP2 (pink). Upon odorant activation, G protein
signaling triggers cAMP production. Signaling is augmented by transgenic expression of the native OR G
alpha subunit, Gαolf, and its corresponding GEF, Ric8b (pink). cAMP leads to activation of the kinase PKA
that phosphorylates the transcription factor CREB leading to expression of the barcoded reporter.
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Figure 5.4: Engineering HEK293T Cells for Stable, Functional OR Expression. A. Comparison
of MOR42-3 activation under inducible receptor expression either transiently transfected (left) or integrated
at single copy into the H11 genomic locus (right). B. Comparison of MOR42-3 reporter activation integrated
at multiple copies in the genome with the PiggyBac Transposon System under constitutive or inducible
receptor expression. C. Relative receptor/reporter copy number determined with qPCR for three transposed
ORs relative to a single copy integrant. D. Comparison of MOR258-5 and MOR30-1 reporter activation
(stimulated with 2-coumaranone and Decanoic Acid respectively) co-transfected with or without Accessory
Factors (AF) Gαolf, Ric8b, RTP1S, and RTP2. E. Cell line generation for stable accessory factor expression.
After transfection, clones were isolated and screened for activation of ORs, MOR258-5 and OR7D4, that
require accessory factors for functional expression. The dark purple bar represents the clone (ScL21) selected
for further experiments.
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Figure 5.5: Design of a Multiplexed Genetic Reporter for OR Activation. A. Annotated Vector
map for the plasmid containing the OR expression cassette and genetic reporter for integration. B. MOR42-3
reporter activation in cells transiently co-expressing the receptor and genetic reporter on separate plasmids
or together. C. Fold activation of MOR42-3 driven by an engineered CRE enhancer (7 CREB binding
sites) compared to Promega’s pGL4.19 CRE enhancer. D. Genetic reporter basal activation upon inducible
expression of MOR42-3 with or without a DNA insulator upstream of the CRE enhancer.
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Figure 5.6: Evolutionary Tree of Mouse ORs. Phylogenetic tree inferred from amino acid sequence of
functional murine ORs. The length of lines indicate degree of divergence between ORs. Red dots indicate
ORs that were selected for inclusion in this study.
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Figure 5.7: Pilot-Scale Recapitulation of Odorant Response in Multiplex. A. Heatmap displaying
39 pooled receptors’ activity against 9 odorants and 2 mixtures. Interactions are colored by the log2-fold
activation of the genetic reporter (see methods). Odorant interactions previously identified are boxed in yellow
[12]. B. Dose-response curves for odorants or forskolin (adenylate cyclase stimulator) at 5 concentrations
screened against the OR library. Curves for ORs known to interact with the odorant are colored. Stimulation
with forskolin does not show substantial differential activity between ORs in our assay.
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Figure 5.8: Library Representation. Representation of individual ORs in the library for the 39/42 ORs
that had sufficient cellular coverage (see Methods). A. Frequency of each OR as a fraction of the library
determined by the relative activation of each reporter stimulated with DMSO. B. The relationship between
frequency of each OR in the library and the average coefficient of variation between biological replicate
measurements of reporter activation for all conditions.
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Figure 5.9: Replicability of the Large-Scale Multiplexed Screen. A. Histogram displaying the
distribution of the coefficient of variation for the OR library when stimulated with DMSO. B. Histogram
displaying the distribution of the coefficient of variation for the OR library against all conditions assayed. C.
Dose-response curves for the control odorants included on each 96-well plate assayed. Each color represents a
different plate.
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Figure 5.10: Significance and Fold Change of High-Throughput Assay Data. A. The False
Discovery Rate (FDR; Benjamini-Hochberg corrected, see Methods) plotted against the fold change for
each OR-odorant interaction. The dashed line represents the 1% FDR, the cutoff used to identify positive
interactions. B. The subset of interactions tested by a follow-up orthogonal luciferase assay (color indicates
whether it was recapitulated in the orthogonal system). Of the interactions passing a 1% FDR, 20 of 27 also
showed interaction in the orthogonal follow-up assay.
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Figure 5.11: Recapitulation of the Screen in a Transient, Orthogonal System. Secondary screen
of chemicals in a transient OR reporter activation system with a luciferase reporter gene readout [26]. Each
plot shows the behavior of a control cell line expressing the reporter gene but no OR (black line), as well as
a cell line expressing a specific OR and reporter gene. In addition, data from the high throughput screen
(labeled as Seq) is plotted for reference.
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Figure 5.12: Assay Correspondence with Previously Screened Odorant-Receptor Pairs. A. FDR
plotted against fold induction for the 540 odorant-OR interactions that were previously tested by Saito
et al.12. Points are colored by the EC50 of the interaction in the previous work. Grey points represent
interactions not identified in the previous screen. Comparing the results from transient versus integrated
luciferase assays revealed that, in some cases, the integrated system required a higher concentration of odorant
to achieve significant activation, likely because of the lower DNA copy number of the CRE-driven luciferase
and receptor. Since the highest concentration of odorant assayed was 1 mM, low affinity interactions may
not have been detectable in this screen. B. The FDR in the assay related to the EC50 of the hit from the
previous screen, colored by the fold activation from the multiplexed screen.
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Figure 5.13: Location of Odors Tested with Respect to a Learned Chemical Space. Locations of
the chemicals tested in this assay in chemical space. The molecular autoencoder was used to generate a
292-dimensional representations of 250,000 randomly sampled molecules from the ChEMBL 23 database (blue)
as well as the chemicals tested in our assay (red) projected onto two dimensions with Principal Component
Analysis (PCA)[27].
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Figure 5.14: Clustering of Odorant Response for Receptors. The locations of any hits (black) with
respect to other chemicals tested (grey) for each OR on the PCA on the 292-dimensional latent representation.
PC1 explains 34.4% of variance and PC2 explains 14.0% of the variance.
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Table 5.1: Olfactory receptors screened in this study.
Mouse OR Convention OR Convention
MOR102-1 Olfr1325
MOR110-1 Olfr812
MOR112-1 Olfr790
MOR119-1 Olfr214
MOR120-1 Olfr459
MOR13-1 Olfr644
MOR131-1 Olfr161
MOR132-1 Olfr24
MOR133-1 Olfr406
MOR8-1 Olfr575
MOR20-1 Olfr613
MOR203-1 Olfr992
MOR206-1 Olfr1098
MOR208-1 Olfr1413
MOR23-1 Olfr599
MOR25-1 Olfr554
MOR30-1 Olfr569
MOR35-1 Olfr686
MOR4-1 Olfr620
MOR5-1 Olfr638
MOR168-1 Olfr916
MOR169-1 Olfr902
MOR170-1 Olfr895
MOR18-1 Olfr558
MOR180-1 Olfr1019
MOR189-1 Olfr1079
MOR19-1 Olfr616
MOR194-1 Olfr1046
MOR199-1 Olfr1032
MOR258-5 Olfr62
MOR134-1 Olfr356
MOR136-1 Olfr340
MOR139-1 Olfr1352
MOR142-1 Olfr1356
MOR144-1 Olfr39
MOR149-1 Olfr828
MOR158-1 Olfr362
MOR165-1 Olfr909
MOR9-1 Olfr609
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Table 5.2: Odorants screened in this study
Pentanoic Acid Hexanoic Acid
1-nonanol Nonanal
4-hydroxycoumarin Dimedone
1-decanol Decanal
4-Chromanone (-)-Menthone
(+)-2-Heptanol Citral
2-Butanone beta-ionone
(+)-2-Octanol Hydroxycitronellal
2-Hexanone Pentyl acetate
(-)-B-Citronellol Lyral
2-Heptanone Allyl heptanoate
Geraniol Acetophenone
3-Heptanone Amyl hexanoate
Linalool Control_1
2-Octanone Nonanoic Acid
1-Undecanol Control_2
3-Octanone Amyl butyrate
Allyl phenylacetate Decanoic_Acid
Propionic Acid Butyl heptanoate
Benzene DMSO
2_coumaranone Heptyl isobutyrate
Benzyl acetate Prenyl_Acetate
2-Nonanone Hexyl acetate
Phenyl acetate Vanillic_Acid
2,3-Hexanedione Butyl formate
Octanethiol a-Amylcinnamaldehyde
3,4-Hexanedione Ethyl isobutyrate
Nonanedioic Acid Eucalyptol
(-)-Carvone 1-butanol
Nonanethiol Pentyl propionate (Amyl propionate)
(+)-Dihydrocarvone Isovaleric Acid
Butanal Dihydro Myrcenol
(+)-Camphor 1-propanol
Pentanal Muscenone
Dihydrojasmone 1-hexanol
Hexanal ethyl maltol
Benzophenone 1-heptanol
Heptanal calone
(+)-Pulegone 1-octanol
Octanal Sandalwood Mysone
Iso E Super w-Pentadecalactone
benzyl benzoate (Pentamethylbenzaldehyde) Ethyl 2-methylbutyrate
Olibanum Coeur MD 2-Phenylethanol
Piperonyl alcohol trans-2-Dodecenal
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Turkish Rose Oil 2-Phenethyl acetate
Piperonyl acetate Cedryl acetate
Angel Eau de parfum (10 uM) Piperonal
Tetrahydrofuran 1-Octen-3-one
a-Hexylcinnamaldehyde Pyrazine
Tetrahydropyran 2-Bromohexanoic acid
Dior Jadone Eau de parfum Sassafras oil
Benzaldehyde dimethyl acetal 6-Bromohexanoic acid
Flowerbomb Viktor and Rolf thymol
2-Methyl-1-propanethiol 2-Bromooctanoic acid
Chanel No 5 Triethylamine
(+)-Dihydrocarveol Furfuryl methyl disulfide
Axe L-Turpentine
(-)-Dihydrocarveol Ethyl isovalerate
Aedione Anisaldehyde
(+)-Perillaaldehyde Bis(2-methyl-3-furyl)disulphide)
Isobornyl acetate [Di]ethyl sulfide
(-)-Perillaaldehyde Dimethyl trisulfide
a-Amylcinnamaldehyde dimethyl acetal Eugenol
Benzyl salicylate trans-2,cis-6-Nonadienal
p-Tolyl isobutyrate Eugenol methyl ether
(+)-Limonene oxide,mixture of cis and trans trans-2-Nonenal
o-Tolyl isobutyrate 4-Ethylphenol
(-)-Limonene oxide,mixture of cis and trans Cinnamyl alcohol
p-Tolyl phenylacetate Ethyl vanillin
(R)-(+)-Limonene n-Decyl acetate
2-Methoxy-3-Methyl-pyrazine Vanillin
(-)-Camphene Dimethyl anthranilate
2-Methoxypyrazine 2-Ethylphenol
(+)-Camphene trans-2-Undecenal
Methyl salicylate Guaiacol
2,3-Diethyl-5-methylpyrazine Neryl isobutyrate
Anethole 2-bromophenol
Ethyl disulfide cis-4-Decenal
Myrcene Benzaldehyde
Methyl disulfide Octyl formate
(±)-2-Butanol 2,3-Diethylpyrazine
trans-2-Methyl-2-butenal (2MB) p-cymene
2-Isopropyl-3-methoxypyrazine 2-Methylbutyric acid
diacetyl helional
2-sec-Butyl-3-methoxypyrazine Cyclobutanecarboxylic acid
galaxolide 1,9-nonanediol
cis-6-Nonenal Isopentylamine (1-Amino-3-methylbutane, Isoamylamine)
isobutyraldehyde octanedioic acid (suberic acid)
Cinnamaldehyde Quinoline (1-Benzazine; 2,3-Benzopyridine)
Ethyl 2-methylpentanoate decanedioic acid (sebacic acid)
beta-Damascone Farnesene
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e,b,Farnesene Anisole (Methoxybenzene, Methyl phenyl ether)
Table 5.3: Odorant-receptor pairs called as hits.
OR Odorant Minimum
Activating
Concentration
(µM)
Previously
Orphan
Receptor?
MOR102-1 Cedryl acetate 1000 YES
MOR112-1 Benzaldehyde 1000 YES
MOR112-1 galaxolide 100 YES
MOR119-1 Axe (10 uM) 1000 YES
MOR119-1 Furfuryl methyl disulfide 1000 YES
MOR119-1 n-Decyl acetate 100 YES
MOR120-1 Cedryl acetate 1000 YES
MOR120-1 Lyral 1000 YES
MOR120-1 Nonanethiol 1000 YES
MOR13-1 Benzaldehyde 1000 YES
MOR13-1 Cyclobutanecarboxylic acid 1000 YES
MOR13-1 Pentanoic Acid 1000 YES
MOR13-1 trans-2-Methyl-2-butenal (2MB) 1000 YES
MOR131-1 (-)-Perillaldehyde 1000 YES
MOR131-1 1-hexanol 1000 YES
MOR131-1 3,4-Hexanedione 1000 YES
MOR131-1 galaxolide 1000 YES
MOR132-1 Cedryl acetate 1000 YES
MOR133-1 3-Octanone 1000 YES
MOR134-1 Chanel No 5 (10 uM) 1000 YES
MOR136-1 (-)-Dihydrocarveol 1000 NO
MOR136-1 (+)-Camphor 100 NO
MOR136-1 (+)-Dihydrocarveol 1000 NO
MOR136-1 2-Ethylphenol 100 NO
MOR136-1 Olibanum Coeur MD 1000 NO
MOR139-1 (-)-Dihydrocarveol 1000 NO
MOR139-1 (+)-Dihydrocarvone 1000 NO
MOR139-1 (+)-Pulegone 1000 NO
MOR139-1 2-sec-Butyl-3-methoxypyrazine 1000 NO
MOR139-1 4-Chromanone 1000 NO
MOR139-1 beta-ionone 1000 NO
MOR139-1 Butanal 1000 NO
MOR139-1 Dihydrojasmone 1000 NO
MOR139-1 Dimethyl anthranilate 1000 NO
MOR139-1 Eugenol 1000 NO
MOR139-1 Eugenol methyl ether 1000 NO
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MOR139-1 helional 1000 NO
MOR139-1 Neryl isobutyrate 1000 NO
MOR139-1 Quinoline (1-Benzazine; 2,3-Benzopyridine) 100 NO
MOR142-1 Bis(2-methyl-3-furyl)disulphide) 1000 YES
MOR142-1 Cedryl acetate 1000 YES
MOR158-1 Iso E Super 1000 YES
MOR165-1 decanedioic acid (sebacic acid) 1000 YES
MOR165-1 Octyl formate 1000 YES
MOR170-1 2-Bromohexanoic acid 1000 NO
MOR170-1 2-Phenethyl acetate 1000 NO
MOR170-1 4-Chromanone 100 NO
MOR170-1 4-Ethylphenol 1000 NO
MOR170-1 Anisaldehyde 1000 NO
MOR170-1 Benzyl acetate 1000 NO
MOR170-1 benzyl benzoate (Pentamethylbenzaldehyde) 10 NO
MOR170-1 Chanel No 5 (10 uM) 1000 NO
MOR170-1 Cinnamyl alcohol 1000 NO
MOR170-1 Dimethyl anthranilate 10 NO
MOR170-1 ethyl maltol 1000 NO
MOR170-1 Eugenol methyl ether 10 NO
MOR170-1 helional 1000 NO
MOR170-1 Piperonal 1000 NO
MOR170-1 Piperonyl acetate 1000 NO
MOR170-1 Quinoline (1-Benzazine; 2,3-Benzopyridine) 100 NO
MOR170-1 Vanillin 1000 NO
MOR180-1 a-Amylcinnamaldehyde dimethyl acetal 1000 NO
MOR180-1 Axe (10 uM) 1000 NO
MOR189-1 4-Chromanone 1000 NO
MOR189-1 benzyl benzoate (Pentamethylbenzaldehyde) 1000 NO
MOR189-1 beta-Damascone 1000 NO
MOR189-1 beta-ionone 1000 NO
MOR189-1 Cedryl acetate 1000 NO
MOR189-1 Eugenol methyl ether 1000 NO
MOR189-1 Quinoline (1-Benzazine; 2,3-Benzopyridine) 1000 NO
MOR19-1 Benzyl salicylate 10 YES
MOR19-1 Methyl salicylate 1000 YES
MOR199-1 ethyl maltol 100 YES
MOR203-1 helional 1000 NO
MOR203-1 Piperonyl acetate 1000 NO
MOR208-1 Cedryl acetate 1000 YES
MOR23-1 2-Bromooctanoic acid 1000 NO
MOR23-1 6-Bromohexanoic acid 100 NO
MOR23-1 Heptanal 1000 NO
MOR23-1 Hexanoic Acid 1000 NO
MOR23-1 Nonanal 1000 NO
MOR23-1 Nonanoic Acid 1000 NO
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MOR23-1 Octanal 100 NO
MOR25-1 (-)-Carvone 1000 NO
MOR25-1 Decanal 1000 NO
MOR25-1 Decanoic-Acid 100 NO
MOR25-1 Nonanoic Acid 1000 NO
MOR30-1 Cedryl acetate 1000 NO
MOR30-1 Decanal 100 NO
MOR30-1 Decanoic-Acid 10 NO
MOR30-1 Nonanal 1000 NO
MOR30-1 Nonanoic Acid 100 NO
MOR4-1 Hexanoic Acid 1000 NO
MOR4-1 Pentanoic Acid 1000 NO
MOR5-1 2-Bromohexanoic acid 1000 NO
MOR5-1 2-Bromooctanoic acid 1000 NO
MOR5-1 6-Bromohexanoic acid 1000 NO
MOR5-1 cis-4-Decenal 1000 NO
MOR5-1 cis-6-Nonenal 1000 NO
MOR5-1 Decanoic-Acid 1000 NO
MOR5-1 Hexanoic Acid 1000 NO
MOR5-1 Nonanal 1000 NO
MOR5-1 Nonanoic Acid 100 NO
MOR5-1 Octanal 1000 NO
MOR5-1 Olibanum Coeur MD 1000 NO
MOR258-5 2-coumaranone 1000 NO
MOR258-5 Benzaldehyde 1000 NO
MOR258-5 Benzophenone 1000 NO
MOR258-5 ethyl maltol 1000 NO
MOR258-5 Piperonal 1000 NO
MOR258-5 Quinoline (1-Benzazine; 2,3-Benzopyridine) 1000 NO
MOR9-1 galaxolide 1000 NO
179
Table 5.4: Primers used in this study.
Primer Sequence Description
OL001 CCCTTTAATCAGATGCGTCG Gene Specific RT, Reporter Gene, for Q-RTPCR
OL002 CTGCCTGCTTCACCACCTTC Gene Specific RT, GAPDH
OL003 AAGTGCCTTCCTGCCCTTTAATCAG-
ATGCGTCG
Gene Specific RT, Reporter Gene, for RNA-seq,
Also NGS Read1 Primer
OL004F CGCCGAAGTGAAAACCACCTA Pilot-Scale RNA-seq Round 1 Library Prep Ampli-
fication
OL004R AAGTGCCTTCCTGCCCTTTAA Pilot-Scale RNA-seq Round 1 Library Prep Ampli-
fication
OL005F CAAGCAGAAGACGGCATACGAGAT-
NNNNNNNN -GAAGTGAAAACCACCTA
P7+i7index+primer for RNAseq library amplifica-
tion
OL005R AATGATACGGCGACCACCGAGATC-
TACACAAGTGCCTTCCTGCCCTTTAA
P5+Read1+primer for pilot-scale RNAseq library
amplification
OL006 CGGGTTTCTTGGCCTTGTAGGTGGT-
TTTCACTTCG
i7 index read primer, pilot-scale experiment
OL007F ggaataACGCGTNNNNNNNNNNNNNNN-
CGACGCATCTGATTAAAGGG
Amplification of fragment containing barcode to
be cloned into reporter plasmid
OL007R ggaaggACCGGTtctagtcaaggcactatacat Amplification of fragment containing barcode to
be cloned into reporter plasmid
OL008F tgctcctggccctgctgaccctaggcctggct-
CATATGAATGGCACAGAAGGCCC
Amplification of fragment containing the OR to be
cloned into the reporter plasmid
OL008R AGTCGGCCCTGCTGAGGAGTCTTT-
CCACCTGCAGGTCTTAT-
CATGTCTGCTCGAA
Amplification of fragment containing the OR to be
cloned into the reporter plasmid
OL009 CTTCTACGTGCCCTTCTC Sequencing and linking barcodes/ORs in the re-
porter vector
OL010 CCTGCAGGTCTTATCATGTC Sequencing and linking barcodes/ORs in the re-
porter vector
OL011 TACAGGCGGAATGGACGAG Sequencing and linking barcodes/ORs in the re-
porter vector
OL012F AAGTGAAAACCACCTACAAGG QPCR of the transposon for copy number analysis
OL012R CCCTTTAATCAGATGCGTCG QPCR of the transposon for copy number analysis
OL013 AATGATACGGCGACCACCGAGATC-
TACACNNNNNNNNAAGTGCCTTCC-
TGCCCTTTAA
P5+i5+Read1+primer, for large-scale library am-
plification
LP001F TGGGCAGTTCCAGGCTTATAGTC Genomic Amplification of the H11 locus with the
landing pad
LP001R GGGCGTACTTGGCATATGATACAC Genomic Amplification of the H11 locus with the
landing pad
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Chapter 6
Deep Mutational Scan of the
β2-adrenergic Receptor
6.1 Abstract
The G protein-coupled receptors (GPCRs) are a uniquely important protein family in human
physiology. Their dynamic structure is critical to their myriad functions, but makes biophysical
characterization challenging. We developed a platform to characterize large libraries of GPCRs in
human cell lines, and use it to functionally assess all possible single amino acid substitutions to the
β2-adrenergic receptor across several agonist concentrations. Cumulatively, we find that residues with
similar mutational profiles reflect their structural and functional organization, and we identify both
known and novel residues critical for function. In addition, we describe a previously uncharacterized,
conserved extracellular “structural latch” maintained in both the inactive and active state of the
receptor. Our approach enables mutational scanning for most GPCRs and other human proteins
where function can be linked to a genetic reporter.
†This chapter is an unpublished manuscript that will be submitted for publication as: E. M. Jones and N. B.
Lubock, AJ Venkatakrishnan, D. Cancilla, J. Wang, M. Satyadi, J. Davis, N. R. Latorraca, J. M. Paggi, A. M. Tseng,
M. M. Babu, R. O. Dror, and S. Kosuri. “Deep Mutational Scan of the β2-adrenergic Receptor,” 2018
183
6.2 Introduction
G protein-coupled receptors (GPCRs) are central mediators of mammalian cells’ ability to sense and
respond to their environment. In humans, the ∼800 GPCRs respond to a wide range of chemical
stimuli such as hormones, odors, natural products, and drugs by modulating a set of prototypical
pathways that affect cell physiology. Their central role in altering relevant cell states makes them
ideal targets for therapeutic intervention, with ∼34% of all U.S. Food and Drug Administration
(FDA)-approved drugs targeting the GPCR superfamily [1]
Understanding GPCR signal transduction is difficult for several reasons. First, GPCRs exist
in a large conformational landscape, making traditional biophysical characterizations difficult.
Consequently, most GPCR structures are truncated, non-native, or artificially stabilized. Even when
structures exist, most are of inactive states, and only ∼18 receptors have active state structures
available [2]. Second, GPCR dynamics are critical for their function. Static structures from both
X-ray crystallography and Cryo Electron Microscopy do not directly probe receptor dynamics
[3]. Towards this end, tools such as spectroscopy and computational simulation have aided our
interpretation [4].
Alternatively, mutagenesis has long been a foundation of protein biochemistry and, when coupled
with a phenotypic screen, provides a robust approach to directly investigate GPCR signaling and
function [5, 6, 7]. Historically, technical constraints restricted the number of mutations that could
be generated and characterized. Recent advancements in DNA synthesis, genome editing, and
next-generation sequencing (NGS) have enabled Deep Mutational Scanning (DMS), a method to
functionally assay all possible missense variants of a given protein [8, 9].
However, deep mutational scans often suffer from not being generalizable across different protein
targets or screen a phenotype that is not informative of protein function. GPCRs are particularly
susceptible to this problem because they bind a variety of signaling effectors that activate distinct
pathways [10, 11, 12]. Here we report a novel platform to globally dissect the functional consequences
of missense variation in GPCRs expressed in human cell lines. By constructing a method to assay
genetic reporters in multiplex, we are able to link GPCR activation to cAMP production, a direct
output of G protein signaling. Furthermore, genetic reporters are modular and can be easily
exchanged to suit DMS targets of disparate function [13].
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Figure 6.1: Platform for Deep Mutational Scanning of GPCRs and Variant-Activity Landscape.
A. Graphical Display of Multiplexed GPCR Activity Assay. ADRB2 variants with their barcoded genetic
reporter are integrated into a defined genomic locus such that one variant is integrated per cell. Upon
isoproterenol agonization, G protein signaling induces transcription of the cAMP-responsive genetic reporter
and the barcode. The barcode sequence in the 3’ UTR of the reporter encodes the identity of the receptor
within the same cell. B. Overview of workflow for Multiplexed GPCR Activity Assay. The variant library is
generated, barcoded, and cloned into a vector with a genetic reporter. The library is then integrated into
HEK293T cells and agonized with various concentrations of isoproterenol. After stimulation, mutant activity
is determined by measuring the relative abundance of each variant’s barcoded cAMP-responsive genetic
reporter transcripts with RNA-seq. C. Top: Secondary structure diagram represents the N and C termini in
black, the transmembrane domains as blocks, and the intra- and extracellular domains in blue and green
respectively. The EVmutation track displays average effect of every mutation as predicted by EVmutation.
The Conservation track displays the sequence conservation of each residue. The shaded guides represent
positions of the protein in the transmembrane domain. Bottom: The heatmap representation of the activity
of every missense mutation and frameshift at each agonist condition. Cells are colored by the relative activity
to the mean frameshift mutation.
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6.3 Results
To comprehensively probe the structure-function relationship of the β2-adrenergic receptor (β2AR),
we developed technology to generate and simultaneously profile the receptor’s 7,828 possible missense
variants for differences in functional activity in HEK293T cells (Fig. 6.1a, b, Supplementary Fig.
6.5, 6.6). The activity of each variant is linked to expression of a cAMP responsive genetic reporter
enabling an accurate depiction of receptor signaling capability. Variant identity is encoded in a short
barcode sequence appended to the 3’ UTR of the reporter gene. Using RNA-seq we read the activity
of the entire variant library in multiplex. We screened the mutant library under four conditions of
the β2AR agonist isoproterenol: vehicle control, an empirically determined EC50, EC100, and beyond
saturation of the WT receptor, and report measurements for 99.6% of possible missense variants.
To validate our assay, we recorded the activity of 6 mutants that are stably and individually
expressed at single copy, the same configuration as the multiplexed assay, with a luciferase reporter
gene [14, 15, 16]. These measurements largely agree with the results of our multiplexed assay
(Supplementary Fig. 6.7). Our variant generation approach, microarray-based oligo synthesis, often
produces single base deletions that introduced a plethora of frameshift mutations into our library
[17]. As expected, frameshift mutations have consistently lower activity than missense mutations.
Furthermore, frameshifts occuring in the C-terminus have a significantly diminished reduction of
activity (Supplementary Fig. 6.7).
The heatmap representation of mutant activity reveals the helices are more sensitive to substitution
than the termini or loops, and this effect becomes more pronounced at higher agonist concentration
(Fig. 6.1c). In general, the transmembrane domain is especially sensitive to proline substitution
(Supplementary Fig. 6.7). In lieu of large-scale functional data, two indications of the effect a
potential mutation will have on protein function are sequence conservation and co-variation. While
conservation is highly correlated (ρ = -0.747) with mutational tolerance, the aggregate fitness for all
substitutions at a given position, it does not apply to specific substitutions([18, 19]). EVmutation,
a a predictor of mutational effects from sequence covariation, correlates well (ρ = 0.521) with our
variant-level data (Fig. 6.1c) [20]. Of note, correlation between our data and both predictors
increases with agonist concentration up to EC100, suggesting our phenotypic screen is evolutionarily
relevant (Supplementary Fig. 6.8).
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Figure 6.2: Unsupervised Learning Elucidates Broad Structural Features and Critical Residues
of the β2AR. A. We averaged amino acid substitutions into classes based on their physicochemical properties.
We then used Uniform Manifold Approximation and Projection (UMAP) to learn a 2D representation of
every residue’s response to these classes of substitutions across all agonist conditions. Each residue is assigned
into one of six clusters using HDBSCAN (see Supplementary Fig. 6.10). B. The class averages of each of
these cluster reveals their distinct responses to mutation. The upper dashed line represents the mean of the
Cluster 6 and the lower dashed line represents the mean activity of frameshifted mutants. C. A 2D snake
plot representation of β2AR secondary structure with each residue colored by cluster.
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Our data spans thousands of mutations of varying severity across multiple agonist conditions.
We hypothesized unsupervised learning methods could reveal hidden regularities within groups’
of residues response to mutation. We applied Uniform Manifold Approximation and Projection
(UMAP) to learn multiple different lower-dimensional representations of our data and clustered
the output with HDBSCAN [21, 22] (Supplementary Fig. 6.9). We found residues consistently
separated into 6 clusters that exhibit distinct responses to mutation (Fig. 6.2a, b). Clusters 1 and 2
are globally intolerant to all substitutions, whereas Cluster 3 is affected by proline and hydrophilic
substitutions. Cluster 4 is particularly inhibited by negatively charged substitutions, while Cluster 5
is uniquely intolerant to proline, and Cluster 6 is unaffected by substitution.
Mapping these clusters onto a 2D snake plot representation shows Clusters 1-5 primarily comprise
the transmembrane helices, while Cluster 6 mainly resides in ICL3 and the termini (Fig. 6.2c)
[2]. These flexible regions are often truncated before crystal structure determination to minimize
conformational variability [23]. Surprisingly, a number of residues from Cluster 5 also map there.
Given that residues in Cluster 5 are uniquely intolerant to proline substitutions, we hypothesize
these regions may become structured in one or more receptor conformations.
Next, we projected the clusters onto the hydroxybenzyl isoproterenol bound structure (Sup-
plementary Fig. 6.10; PDB: 4LDL). The globally intolerant Clusters 1 and 2 segregate to core of
the protein, while Cluster 3, intolerant to polar residue substitution, is enriched in the lipid-facing
portion. This suggested that differential response to hydrophobic and charged substitutions could
correlate with side chain orientation within the transmembrane domain. Indeed, residues that are
uniquely charge sensitive are significantly more lipid-facing than those that are sensitive to both
hydrophobic and charged mutations (Fig. 6.3a; Supplementary Fig. 6.10) [24]. Taken together, DMS
and unsupervised learning methods provide a way to determine patterns of mutational constraint
between cohorts of residues. From this, we can learn structural features, such as side chain orientation
and secondary structure, even without a crystal structure.
Decades of research have revealed many GPCRs couple ligand binding to G protein activation
through a series of conserved motifs [25]. The globally intolerant UMAP clusters (1 and 2) highlight
many residues from these motifs and suggest novel residues for further investigation (Fig. 6.2c, Fig.
6.3b). We can further resolve the significance of individual residues within these motifs by ranking
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Figure 6.3: Positional Constraint Restates the Significance of Known Structural Motifs and
Suggests Novel Residues for Investigation. A. Residues within the transmembrane domain colored by
their tolerance to particular substitutions. Teal residues are intolerant to both hydrophobic and charged
amino acids (globally intolerant), and brown residues are tolerant to hydrophobic amino acids but intolerant
to charged amino acids. These charge sensitive positions tend to point into the membrane, while the
globally intolerant positions face into the core of the protein. B. The crystal structure of the hydroxybenzyl
isoproterenol-activated state of the β2AR (PDB: 4LDL) with residues from the mutationally intolerant
Clusters 1 and 2 highlighted in magenta. C-F Selected vignettes of residues from the mutationally intolerant
UMAP clusters. C. W286 of the CWxP motif and the neighboring G315 are positioned in close proximity.
Substitutions at G315 are likely to cause a steric clash with W286 (PDB: 4LDL). D. An inactive state
water-mediated hydrogen bond network (red) associates N51 and Y326 (PDB: 2RH1). Disruption of this
network may destabilize the receptor E. The ligand-bound orthosteric site surface colored by mutational
tolerance the unique sensitivity of the receptor-ligand contacts and displays the assay’s discriminatory power
between agonists (PDB: 4LDL). F. Mutationally intolerant β2AR residues at the G protein interface from
the β2AR-Gs complex crystal structure (PDB: 3SN6), V222, I135, and Q229.
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the mutational tolerance of every position at EC100 (Supplementary Fig. 6.11). In fact, 8 of the
10 most intolerant positions belong to known structural motifs. However, the most mutationally
intolerant residue is the uncharacterized G315. In the active state, G315’s alpha carbon points
directly at W286 of the CWxP motif, and any substitution at G315 will likely clash with W286
(Fig. 6.3c). Additionally, W286 is the second most intolerant position, reinforcing its essentiality for
receptor function. Recent simulations suggest networks of water-mediated hydrogen bonds play a
critical role in GPCR function [26]. Y326 of the NPxxY motif, the 5th most intolerant position,
switches between two such networks during the active state transition. In the inactive state, Y326
networks with N51 and D79, two of the top 20 most intolerant positions (Fig. 6.3d).
Next, we wondered if residues in the orthosteric site that directly contact isoproterenol would
respond differently to mutation than residues that contact other agonists. Using the crystal structure
of the β2AR bound to hydroxybenzyl isoproterenol, we find that positions responsible for binding
the derivatized hydroxybenzyl tail are significantly less sensitive to mutation than residues that
contact the catecholamine head common to both molecules at EC100 (p = 0.0162; Fig. 6.3e,
Supplementary Fig. 6.11). Given this discrimination, we believe DMS can be a powerful tool for
mapping ligand-receptor contacts.
The numerous β2AR crystal structures in various complexes and conformational states enable
us to evaluate the functional consequences of predicted intermolecular interactions. For example,
cholesterol is an important modulator of β2AR and the timolol-bound inactive state structure
elucidated the coarse location of a cholesterol binding site (PDB: 3D4S; [27]). As previously
predicted, W1584.50x50 is the most mutationally intolerant of the residues (Supplementary Fig.
6.11). Furthermore, the relative contribution of most individual residues for stabilizing the Gs-β2AR
interface is unknown [7, 28, 29, 30, 31, 32, 33, 34]. Interestingly, most residues are tolerant to
substitution, but three of the most intolerant positions are I135, V222, and Q229 respectively (Fig.
6.3f). Q229 appears to coordinate polar interactions between D381 and R385 of the α5 helix of Gs,
whereas V222 and I135 form a hydrophobic pocket on the receptor surface.
The mutationally intolerant UMAP clusters also highlight residues from tolerant regions of the
structure. For instance, the uncharacterized W9923.50x50, of ECL1, is proximal to the disulfide
bond C106-C191, which is important for stabilization of the high-affinity receptor state (Fig. 6.4a)
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[35, 36]. Aromatic residues are known to facilitate disulfide bond formation, but our data suggest
only tryptophan is tolerated [37]. We hypothesize W9923.50x50’s indole group hydrogen bonds with
the backbone carbonyl of neighboring G102, positioning W9923.50x50 towards the disulfide bond.
Other aromatic residues are unable to hydrogen bond and are less likely to be positioned properly.
This observation lead us to inquire whether the structural latching between W9923.50x50 and
the disulfide bond is specific to human β2AR or generic to all class A GPCRs. Comparing over 25
high-resolution structures of class A GPCRs from five functionally different sub-families and six
different species revealed that position the trp and disulfide bond consistently contact each other
(Fig. 6.4a). Three exceptions to this trend are the human S1P1 sphingosine receptor, A2A adenosine
receptor and bovine rhodopsin. Expectedly, the S1P1 sphingosine receptor lacks the conserved
disulfide bond and has a relatively long ECL1, uncharacteristic properties of class A GPCRs. For
both the human A2A adenosine receptor and the bovine rhodopsin, the trp is substituted by another
aromatic residue, phenylalanine. In addition to the trp-disulfide bond non-covalent interaction, we
also observe the backbone geometry of ECL1 is highly similar among the class A GPCRs (data not
shown). Based on the evolutionary coupling analysis and structural comparison of class A GPCRs,
we find the trp in ECL1 together with the disulfide bond connecting ECL2 and the extracellular end
of TM3 form a conserved “extracellular structural latch” that is maintained consistently in different
GPCRs spanning diverse molecular functions and phylogenetic origins.
Next, we were interested in understanding the dynamics of the structural latch. While the overall
RMSD between the inactive and active states for human β2AR (PDB: 2RH1 vs. 3P0G) and M2
muscarinic receptor (PDB: 3UON vs. 4MQS) are 1.32 and 1.78 respectively, the RMSD of the latch
is nearly identical in both receptors (Fig. 6.4b). Additionally, we examined 100 frames each sampled
from deactivating simulations of the human β2AR to investigate whether the latch is maintained
during the conformational transition between the two states. The residues forming the structural
latch in human β2AR (W9923.50x50, C106, and C191) are locked in their chi1 angles, as seen in the
inactive (2RH1) or active (3P0G) state structures, with standard deviations around 7-8 degrees
each (data not shown). The low variability of the side chain geometry of these residues during
the conformational transition between the active and inactive states asserts that the extracellular
structural latch is rigid and indeed conformation independent. Furthermore, the majority of 15 other
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residues that undergo very low chi1 rotamer changes are in proximity to the extracellular structural
latch (data not shown). This suggests that the extracellular structural latch is a part of a larger
rigid plug present at the interface of the transmembrane and extracellular region, which could be
important for the structural integrity and thereby function of the receptor.
Conformation dictates GPCR function, therefore identifying individual mutations that stabilize
particular states provides insight into the biochemistry of receptor activation. We filtered for
mutations that lead to greater than WT activity without agonist stimulation to search for variants
with increased basal activation rates or expression levels. Mapping these mutations onto the 2D snake
plot, reveals they are not uniformly distributed throughout the protein, rather they are enriched in
the termini, TM1, TM5, ICL3, and Helix 8 (Supplementary Fig. 6.12). Concentration at the N-
and C-termini is unsurprising, as these regions have known involvement in surface expression [38].
Similarly, the enrichment of mutants in ICL3 reiterates its role in G protein binding [39, 40, 41].
Of note, a group of mutations in TM5 face TM6, which undergoes a large conformational change
during receptor activation (Supplementary Fig. 6.12). The activating mutant E62R of ICL1 is also
salient as R63 and L64 are both highly intolerant, suggesting an underappreciated role of ICL1 in
receptor activation (Supplementary Fig. 6.11). Lastly, understanding how human variation affects
β2AR signaling and GPCRs in general is critical. We find approximately 60% of reported variants
in the genome Aggregation Database (gnomAD) result in a loss of function of the β2AR at EC100
(Supplementary Fig. 6.12).
6.4 Discussion
Our findings showcase a new generalizable approach for deep mutational scanning of human protein
targets with transcriptional reporters. Genetic reporters enable precise measurements of gene-specific
phenotypes that can be widely applied across the proteome. We show comprehensive mutagenesis can
allude to the structural organization of the protein and the local environment of individual residues.
These results suggest deep mutational scanning can work in concert with other techniques (e.g.
X-ray crystallography and Cryo-EM) to augment our understanding of GPCR structure. Moreover,
we identify key residues for β2AR function including uncharacterized positions that inform about
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Figure 6.4: Conserved Extracellular Tryptophan-Disulphide ‘Structural Latch’ in Class A
GPCRs is Rigid and Conformation-Independent. A. W9923.50x50 is mutationally intolerant and
appears to be contacting the C106-C191 disulfide bond of the ECL1. A structural comparison of Class A
GPCR structures reveals the Trp-disulfide bond contact is conserved in 22 of the 25 receptors. B. The
Trp-disulfide bond contact is maintained in both the inactive and active state structures for the β2AR and
M2 muscarinic receptor.
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receptor stability and activation.
Looking forward, our method is well poised to investigate many outstanding questions in GPCR
biology. First, individual GPCRs are known to signal through multiple pathways: both through
interactions with multiple G protein alpha subunits as well as beta-arrestin signaling [42]. Through
systematic mutational interrogation across these pathways’ genetic reporters, we can understand
the different mechanisms that underpin their signal transduction and the molecular basis for biased
signaling [43]. Second, GPCRs are often targeted by synthetic molecules with either unknown or
predicted binding sites. We find ligands imprint a mutational signature on their receptor contacts and
each ligand’s mutational profile can reveal their molecular contacts either in the case of orthosteric
ligands or allosteric modulators. Lastly, the identification of mutations that can stabilize specific
conformations or increase receptor expression can aid in GPCR structural determination [44, 45].
6.5 Materials and Methods
Experimental Methods
Endogenous ADRB2 Deletion using CRISPR/Cas9
Cas9 and sgRNAs targeting the sole exon of ADRB2 were cloned and transfected into HEK293T
cells according to the protocol outlined in Ran et al. [46]. After transfection, cells were seeded in
a 96-well plate at a density of 0.5 cells/well. Wells were examined for single colonies after 3 days
and expanded to 24-well plates after 7 days. Clones were screened for ADRB2 deletion by screening
them for the inability to endogenously activate a cAMP genetic reporter when stimulated with the
ADRB2 ligand isoproterenol. Clones were seeded side by side wild type HEK293T cells at a density
of 7,333 cells/well in a pol 96-well plate. 24 hours later, cells were transfected with 10 ng/well of a
plasmid encoding luciferase driven by a cyclic AMP response element and 5 ng/well of a plasmid
encoding Renilla luciferase with lipofectamine 2000. 24 hours later, media was removed and cells
were stimulated with 25µL of a range of 0 to 10µM isoproterenol (Sigma-Aldrich) in CD293 (Thermo
Fisher Scientific) for 4 hours. After agonist stimulation, the Dual-Glo Luciferase Assay kit was
administered according to the manufacturer’s instructions. Luminescence was measured using the
M1000 plate reader (Tecan). All luminescence values were normalized to Renilla luciferase activity
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to control for transfection efficiency in a given well. Data were analyzed with Microsoft Excel and R.
Landing Pad Genome Editing
The H11 locus was edited using TALEN plasmids received from Addgene (#51554, #51555).
HEK293T cells were seeded at a density of 75k cells in a 24-well plate. 24 hours after seeding cells
were transfected with 50 ng LT plasmid, 50 ng RT plasmid, and 400 ng of the Linearized Landing
Pad using Lipofectamine 2000. 2 days after transfection, cells were expanded to a 6-well plate and
one day after expansion 500 µg/ml hygromycin B (Thermo FIsher Scientific) was added to the media.
Cells were grown under selection for 10 days. After selection, cells were seeded in a 96-well plate at
a density of 0.5 cells/well. Wells were examined for single colonies after 3 days and expanded to
24-well plates after 7 days. gDNA was purified using the Quick-gDNA Miniprep kit (Zymo Research)
from the colonies and PCR was performed with Hifi Master Mix to ensure the landing pad was
present at the correct locus (LP001F and R). The reaction and cycling conditions are optimized as
follows: 95◦C for 3 minutes, 35 cycles of 98◦C for 20 seconds, 63◦C for 15 seconds, and 72◦C for
40 seconds, followed by an extension of 72◦C for 2 minutes. To ensure a single landing pad was
present per cell, HEK293T cell lines with both singly and doubly-integrated landing pads along with
untransduced (WT) HEK293T cells were plated at 4 x 10ˆ5 cells per 6-well. All landing pad cells
were transfected the next day with 1.094µg of both an attB-containing eGFP and mCherry donor
plasmid and 0.3125µg of the BxB1 expression vector or a pUC19 control. Two singly-integrated
landing pad cell samples were also transfected with 2.1875µg of either an attB-containing eGFP and
mCherry donor plasmid with 0.3125µg of the BxB1 expression vector. Cells were transfected at a
1:1.5 DNA:Lipofectamine ratio with Lipofectamine 3000. 2 days later cells were passaged at 1:10
and were analyzed using flow cytometry 10 days later after 4 total passages. Samples were flown
using the LSRII at the UCLA Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell
Research Flow Cytometry Core. Cytometer settings were adjusted to the settings: FSC – 183 V,
SSC – 227 V, PE-Texas Red – 336 V, Alexa Fluor 488 – 275 V.
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Individual Donor Bxb1 Recombinase Plasmid Integrations
HEK293T derived cells engineered to contain the Bxb1 Recombinase site at the H11 locus were
seeded at a density of 350k cells in a 6-well plate (Corning). 24 hours after seeding cells were
transfected with 2 µg Donor plasmid and 500 ng plasmid encoding the Bxb1 recombinase using
Lipofectamine 3000 (Thermo Fisher Scientific). 3 days after transfection cells were expanded to a
T-75 flask (Corning) and 8 µg/ml blasticidin (Thermo Fisher Scientific) was added one day after
expansion. Cells were kept under selection 7-10 days and passaged twice 1:10 to ensure removal of
transient plasmid DNA.
Ligand-Receptor Activation Luciferase Assay for Genomically Integrated Receptor-
Reporter Constructs
HEK293T and HEK293T derived cells integrated with the combined receptor/reporter plasmids
were plated at a density of 7333 cells/well in 100 µL DMEM in poly-D-lysine coated 96-well plates.
48 hours later, media was removed and cells were stimulated with 25µL of a range of isoproterenol
concentrations in CD293 for 4 hours. After agonist stimulation, the Dual-Glo Luciferase Assay kit
was administered according to the manufacturer’s instructions. Luminescence was measured using
the M1000 plate reader. Data were analyzed with Microsoft Excel and R.
Ligand-Receptor Activation q-RT PCR Assay for Genomically Integrated Receptor-
Reporter Constructs
HEK293T and HEK293T derived cells integrated with the combined receptor/reporter plasmids were
plated at a density of 200k cells/well in 2 mL DMEM in 6-well plates. 48 hours after seeding, media
was removed and cells were induced with various concentrations of either forskolin (Sigma-Aldrich) or
isoproterenol diluted in 1 ml of OptiMEM (Thermo Fisher) per plate for 3 hours. After stimulation,
media was removed and 600 µL of RLT buffer (Qiagen) was added to each well to lyse cells. Lysate
from each sample were homogenized with the QIAshredder kit (Qiagen) and total RNA was prepared
from each sample using the RNeasy Mini Kit with the optional on-column DNAse step (Qiagen). 5
µg of total RNA per sample was reverse transcribed with Superscript III (Thermo-Fisher) using
a gene specific primer for the reporter gene and GAPDH (Supplementary Table X) according the
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manufacturer’s protocol. The reaction conditions are as follows: Annealing: [ 65◦C for 5 min, 0◦C
for 1 min] Extension: [ 52◦C for 60 min, 70◦C for 15 min]. 10% of the RT reaction was amplified in
triplicate for both genes, the reporter gene and GAPDH (Supplementary Table X), using the SYBR
FAST qPCR Master mix (Kapa Biosystems) with a CFX Connect Thermocycler (Biorad). The
reaction and cycling conditions are optimized as follows: 95◦C for 3 minutes, 40 cycles of 95◦C for 3
seconds and 60◦C for 20 seconds. Reporter gene expression was normalized to GAPDH expression
for each sample. Data were analyzed with Microsoft Excel and R.
Variant Library Generation and Cloning
The ADRB2 missense variant library was created by splitting the protein coding sequence into
8 distinct segments (∼52 a.a. each) and synthesizing all single amino acid substitutions for each
segment separately as an oligonucleotide library (Agilent). 500 pg of the oligonucleotide library was
amplified with biotinylated primers unique for each segment (Supplementary Table X) with the
Real-Time Library Amplification Kit (Kapa Biosystems) on a CFX Connect Thermocycler (Biorad).
The reaction and cycling conditions are as follows: 98◦C for 45 seconds, X cycles of 98◦C for 15
seconds, 65◦C for 30 seconds, and 72◦C for 30 seconds, followed by an extension of 72◦C for 1 minute.
The number of cycles for the amplification was determined to ensure the amplification was in the
exponential phase at least two cycles before the amplification reached saturation. The PCR products
were cleaned up with the DNA Clean and Concentrator Kit (Zymo Research) and digested with
restriction enzymes BamHI and BspQI, BbsI and BspQI, or BbsI and NheI (New England Biolabs).
Digestions were cleaned up with the DNA Clean and Concentrator Kit and digested ends of the
amplified library were removed by performing a streptavidin bead cleanup with the Dynabeads
M-280 and the DynaMag (Thermo Fisher). Each library segment was to be cloned into a different
vector that includes components of the ADRB2 reporter and the wild type sequence portion of
ADRB2 upstream of the segment being cloned. These eight different base vectors were digested with
restriction enzymes BamHI and BspQI, BbsI and BspQI, or BbsI and NheI. The base vectors were
cleaned up with the DNA Clean and Concentrator Kit and the library segments were ligated into
the base vectors with T4 DNA ligase (New England Biolabs). The ligations were transformed into
5-alpha Electrocompetent cells (New England Biolabs) directly into liquid culture. Cultures were
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grown at 30◦C overnight to maintain library diversity and dilutions were plated on agarose plates to
ensure transformation efficiency was high enogh to cover the entire library (>100 transformants per
library member). DNA was prepared 16 hours later with the DNA Miniprep Kit (Qiagen). The
vectors were digested with BspQI and AgeI or NheI and AgeI (Qiagen). Vectors containing unique
sequences corresponding to each library segment that complete the ADRB2 protein sequence and
reporter were digested with the same restriction enzymes. These fragments were gel isolated from a
1% agarose gel using the Zymoclean Gel DNA Recovery Kit (Zymo Research). These secondary
fragments were cloned into the library vectors with the same protocol as the previous cloning step.
DNA was prepared 16 hours later with the Plasmid Plus DNA Maxiprep Kit (Qiagen).
Variant-Barcode Mapping
After the initial cloning of the variant fragments from the oligonucleotide library into each segment’s
corresponding base vector, the random barcode attached to each variant was associated to its variant
with paired-end sequencing. Each plasmid was amplified with 2 rounds of PCRs with distinct primer
sets for each segment (Supplementary Table X) with HiFi DNA Master Mix (Kapa Biosystems).
For the first round of amplification, the reaction and cycling conditions were optimized as follows:
98◦C for 30 seconds, 10 cycles of 98◦C for 8 seconds, 64◦C for 15 seconds, and 72◦C for 10 seconds,
followed by an extension of 72◦C for 2 minutes. These amplicons were gel isolated from a 1% agarose
gel using the Zymoclean Gel DNA Recovery Kit. Prior to the second round of amplification, the
number of cycles to amplify was determined by performing qPCR with the SYBR FAST QPCR
Master Mix (Kapa) on the CFX Connect Thermocycler according to the manufacturer’s instructions.
The Cq determined from the QPCR plus an addition two cycles was used to as the number of cycles
to amplify the libraries for the second round of amplification. For the second round of amplification,
the reaction and cycling conditions were optimized as follows: 98◦C for 30 seconds, X cycles of 98◦C
for 8 seconds, 62◦C for 15 seconds, and 72◦C for 10 seconds, followed by an extension of 72◦C for 2
minutes. These amplicons were gel isolated from a 1% agarose gel using the Zymoclean Gel DNA
Recovery Kit. Kit. Library concentrations were quantified using a TapeStation 2200 (Agilent) and a
Qubit (Thermo Fisher). The libraries were sequenced with paired end 150-bp reads on a NextSeq
500 in medium-output mode and paired end 250-bp reads on a MiSeq (Illumina).
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Variant Library Bxb1 Recombinase Plasmid Integrations
HEK293T derived cells engineered to contain the Bxb1 Recombinase site at the H11 locus and
deletion of endogenous ADRB2 were seeded at a density of 2.13 million cells per dish in 6 100 mm x
20 mm tissue-culture treated culture dishes (Corning). 24 hours after seeding cells were transfected
with 11.5 µg Donor plasmid and 2.9 µg plasmid encoding the Bxb1 recombinase using Lipofectamine
3000. 3 days after transfection cells were expanded to T-225 flasks (Corning) and 8 µg/ml blasticidin
was added one day after expansion. Cells were kept under selection 7-10 days and passaged 1:10
four times to ensure removal of transient plasmid DNA.
Multiplexed Variant Functional Assay Agonist Stimulation, RNA Preparation and Se-
quencing
HEK293T derived cells engineered to contain the Bxb1 Recombinase site at the H11 locus, deletion
of endogenous ADRB2, and integration of the ADRB2 mutagenic library were seeded at a density of
3,237,868 cells per dish in 150 mm x 25 mm tissue-culture treated culture dishes. 10 dishes were
seeded for each biological replicate of each drug condition. 48 hours after seeding, media was removed
and cells were induced with various concentrations of either forskolin or isoproterenol diluted in
9 ml of OptiMEM per plate for 3 hours. After stimulation, media was removed and 3.24 ml of
RLT buffer was added to each well to lyse cells. Lysate from dishes belonging to the same replicate
were pooled and vortexed thoroghly. 5 ml of lysate from each sample were homogenized with the
QIAshredder kit and total RNA was prepared from each sample using the RNeasy Midi Kit with
the optional on-column DNAse step (Qiagen) and eluted into 500 ul H2O. 40 reverse transcriptase
reactions were carried out for each sample using the Superscript IV RT kit (Thermo Fisher). For
each reaction 11 ul of total RNA were added to 1 ul dNTPs (Qiagen) and 1 ul 2 uM RT primer
(Supplementary Table X). The primers were annealed to the template by heating to 65◦C for 5
minutes and cooling down to 0◦C for 1 minute. After annealing, 4 ul of RT buffer, 1 ul DTT, 1 ul of
RNAseOUT, and 1 ul SSIV were added to the mixture and cDNA synthesis was performed. The
reaction and cycling conditions are as follows: 52◦C for 1 hour, 80◦C for 10 minutes. cDNA from the
same sample was pooled together and treated with 100 µg/ml RNAse A (Thermo Fisher) and 200 U
of RNase H (Enzymatics) at 37◦C for 30 minutes. cDNA was concentrated using the Amicon Ultra
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0.5 mL 30k Centrifµgal Filter (Millipore) according to the manufacturer’s instructions with a final
spin step time of 15 minutes. To determine the number of cycles necessary for library amplification
in preparation for RNA-seq, 1 ul of cDNA from each sample was amplified with SYBR FAST QPCR
Master Mix according to the manufacturer’s instructions using primers for library amplification and
adaptor addition (Supplementary Table X). Each sample was subsequently amplified for 4 cycles
more than the Cq calculated in the QPCR run adjusting for sample volume. The entire volume
of concentrated cDNA for each sample was amplified with sequencing adaptors using NEB-Next
High-Fidelity 2x PCR Master Mix (New England Biolabs): 25 ul Master Mix, 2.5 ul of both 10 uM
forward and reverse primer (Supplementary Table X), 4 ul of cDNA, and 16 ul H2O. The reaction
and cycling conditions are as follows: 98◦C for 30 seconds, X cycles of 98◦C for 8 seconds, 66◦C for
20 seconds, and 72◦C for 10 seconds, followed by an extension of 72◦C for 2 minutes. Amplified
DNA was purified with the DNA Clean and Concentrator kit and gel isolated from a 1% agarose
gel with the Zymoclean Gel DNA Recovery Kit. Library concentrations were quantified using a
TapeStation 2200 and a Qubit. The libraries were sequenced with an i7 index read and a single end
75-bp read on a NextSeq 500 in high-output mode.
Quantification and Statistical Analysis
Barcode Mapping
We used the BBTools suite(https://jgi.doe.gov/data-and-tools/bbtools/) of programs to
process our sequencing data using the default settings unless otherwise noted. First, we used BBDuk2
to filter out any reads matching PhiX (k=23, mink=11, hdist=1) and to trim off any Illumina
sequencing adapters. We then used BBMerge to merge our paired end reads. We performed another
round of trimming with BBDuk2 to ensure no adapters were left over after merging and to remove
any sequence with an N base call. After merging and trimming the reads, we used a custom Python
script (bcmap.py) to generate a consensus nucleotide sequence for each barcode.
Briefly the script works as follows. First, we split each read into the 15 nt barcode and its
corresponding variant. We then generate a dictionary that maps each barcode to its list of unique
sequences and their counts. To enable majority basecall we drop any barcode that has less than 3
reads. We then pass the barcodes throgh a series of filters to eliminate potential errors introduced by
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barcodes that are mapped to multiple variants. Since we barcoded and mutagenized the ADRB2 gene
in separate pieces, barcodes can be associated to variants from different pieces. We address this case
by using BBMap to align every barcode’s sequences to the ADRB2 reference and consider that barcode
to be contaminated if any sequence aligns >5 nt away from the most common sequence. Another
source of contamination comes from our chip-synthesized library itself, which contains a significant
number of single base deletions. We consider a barcode contaminated if it has any sequences of
different lengths as it is unlikely that a single base deletion will come from an Illumina sequencer
by chance. However, these filters would not catch the case where a barcode is contaminated with
variants from the same piece of ADRB2. As we only synthesized the missense variants, we expect
variants within the same piece of ADRB2 to be a Levenshtein distance of 4 from each other on
average (approximately two changes to WT and two changes to a new codon). Thus, we drop any
barcode that has a sequence with >1 read at a Levenshtein distance of 4 away from that barcode’s
most common sequence. Lastly, we generate a consensus sequence by taking the majority base call
at each position and call an N at any ties.
After we associate each barcode with its consensus sequence, we use a series of different alignments
to determine that sequence’s identity. To find the designed missense variants in our library, we
use BBMap to search for barcodes that an exact alignment to them. To find frameshift mutations,
we use BBMap to align the consensus sequences to the ADRB2 reference and parse the resulting
CIGAR strings for indels with a simple python script (classify-negs.py). Finding synonymous
mutants required more processing as each sub-library did not start at a complete codon. We first
used the rough BBMap alignment to determine what ADRB2 chunk each sequence was associated
with. We then used a custom python script (synon-filter.py) to trim up to the last whole
clonal codon, as the first few codons of each sequence were part of the clonally backbone and are
unlikely to have any errors. Finally, we translated the resulting sequences, aligned the protein
sequence to the ADRB2 coding sequence with a Smith-Waterman aligner from the Parasail library
(https://github.com/jeffdaily/parasail), and retained perfect translations with the correct
length.
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Data Normalization
We incubated our cellular library with forskolin to activate the cAMP reporter in each cell, providing
an agonist-independent measurement of maximal reporter activity. This measurement can be used
to approximate cellular copy number. To ensure that barcodes with low cellular representation are
excluded from our analyses we require that all forskolin barcodes be present in both repeats, we
normalize our read counts to sequencing depth, we average the two repeats together, and filter out
any barcodes less than 0.2 RPM (∼8-10 reads at our sequencing depth). Next, we use this list of
barcodes to control for copy-number variation in our measurements. We first require that all of the
barcodes in the forskolin condition are also present in our drug conditions, and add a pseudocount
that is scaled relative to the condition with the fewest number of reads (
N
minN
). This explicitly
sets missing barcodes to the pseudocount. We then normalize each condition to its read depth
(including added pseudocounts) and divide this value by its associated forskolin value. We also
excluded barcodes with high forskolin counts (>= 10 RPM) as they are systematically less induced
in the drug conditions relative to other barcodes.
With a filtered set of barcodes in place, we averaged together all measurements for each variant
(median 11 barcodes per variant), keeping the repeats separate. To make our values more interpretable,
defined activity as the ratio of these values to the mean frameshift. We then averaged the relative
activities of the two repeats together and used propagation of uncertainty to combine their standard
deviations.
Conservation, EVMutation, and gnomAD
To calculate sequence conservation, we aligned 55 ADRB2 orthologs from the OMA database (entry:
HUMAN24043) using MAFFT with the default settings (mafft –reorder –auto). We then used the
Jensen-Shannon Divergence to score this alignment and majority basecall to generate a consensus
sequence ignoring any gaps if they made up < 35% of the alignment at that position. Using EMBOSS
Needle to align this consensus sequence back to the ADRB2 reference, we found the consensus
sequence had a two nt insertion at positions 360 and 361. We excluded these positions for the
purposes of our analyses. For both EVMutation and gnomAD, we simply downloaded the results for
ADRB2.
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Unsupervised Learning
We performed a number of preprocessing steps before running UMAP on our data. First, we grouped
amino acids into 8 different classes based on their physiochemical properties ((+) - H, K; (-) - D, E;
Aromatic - F, W, Y; Amide - N, Q; Nucleophilic - C, S, T; Hydrophobic - I, L, V, M; Small - G, A;
Proline - P) and averaged their relative activities. Next, we standardized the log2 relative activity
values of each group and used mean imputation to model missing data for any missing AA groups at
a given position. Finally, we combined the data from every drug condition into a 412 x 32 design
matrix in which the columns are an AA group at a specific condition and the rows are the positions
in the protein.
With our data processed, we used the R implementation of UMAP to run hyperparameter search
of all combinations of UMAP embeddings with the parameters n_neighbors = (4, 8, 16, 32)
and n_components = (2, 3, 4, 5, 6, 7, 8, 9, 10), holding min_dist=0 and n_epochs=2000
constant. This provided a variety of different representations of our data that we used HDBSCAN
to search for clusters in these embeddings (R package dbscan; minPts = 10). To ease inter-
pretation of the clustering, we plotted the HDBSCAN results onto a 2D UMAP embedding with
the following parameters: n_neighbors=4, min_dist=0, n_components=2, n_epochs=2000, and
random_state=3308004 using the Python implementation (https://github.com/lmcinnes/umap).
We found the cluster assignments to be largely robust across the different embeddings, and used
them to guide our manual cluster assignment.
Identification of Activating and Hypomorphic Mutations
We defined a variant to be “activating” if its mean activity minus its standard deviation were greater
than the mean synonymous variant. Similarly, we defined a variant to be hypomorphic if its mean
activity plus its standard deviation were less than the mean synonymous variant.
Mutational Tolerance
We defined mutational tolerance as a given residue’s ability to accommodate all amino acid substitu-
tions. To calculate this, we first capped the maximum our activity values at WT-like activity (the
mean of the synonymous barcodes). Similarly, we capped the minimum activity at the mean of the
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frameshifts (1 on our activity scale). By limiting our activity measurements to this range, we ensure
that individual substitutions do not have an outsized effect on the mutational tolerance. Next, we
averaged the activities of every amino acid substitution for each position in the β2AR. Finally, we
scaled the mutational tolerance values to lie on a 0-1 scale.
Statistical Tests
All statistical tests unless otherwise noted are the two-sided Mann-Whitney U and were performed
in R (version 3.5.x) using the wilcox.test function.
Structural Modeling and Solvent Accessible Surface Area
All molecular graphics and analyses were performed with the UCSF Chimera package. To determine
if a given in the β2AR points into the core of the protein or into the lipid membrane, we used
FreeSASA (version 2.0.3) to calculate the Solvent Accessible Surface Area (SASA) of the Gs-bound
β2AR (PDB: 3SN6). The Gs occludes the intracellular surface of the β2AR thereby reducing the
SASA of residues on the intracellular surface. Similarly, the extracellular surface is mostly blocked
by the extracellular loops. Finally, we used the Orientations of Proteins in Membranes (OPM)
database to filter out any residues outside of the lipid membrane from our analyses. To quantify
charge sensitivity, we calculated the average activity for H, K, R, D, and E substitutions at each
agonist concentration for residues in the lipid membrane. We then multiplied the values by -1
and standardized the results within each concentration such that the values were mean-centered
and scaled by their standard deviation. We calculated hydrophobic sensitivity (I, L, V, M) in
an analogous manner. Next, we classified residues that had above average charge sensitivity and
below average hydrophobic sensitivity as being exclusively charge sensitive. Conversely, we classified
residues that had above average charge sensitivity and above average hydrophobic sensitivity as
being intolerant.
Code Availability
All code is available at www.github.com/KosuriLab/ADRB2. Sequencing data can be accessed from
the sequencing read archive (SRA) with the accession number XXXXXXXXX
204
6.6 Supplementary Information
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Figure 6.5: Schematic of Generation, Functional Assessment, and Analysis of All 7,828 Missense
Variants of the β2AR. We synthesized missense variants on an oligonucleotide microarray, amplified the
oligos and appended random DNA barcode sequences, and cloned the variants into WT background vectors.
We then mapped barcode-variant pairs with next-generation sequencing and cloned the remainder of the WT
receptor and genetic reporter into the construct. Next, we integrated the variant library en masse into a
serine recombinase landing pad engineered at the H11 locus of ∆ADRB2 HEK293T cells. The recombination
strategy ensures a single receptor variant/genetic reporter is integrated per cell to avoid crosstalk between
genetic reporters. After selection,we stimulated the library with various concentrations of ADRB2 agonist,
isoproterenol. Finally, we determined mutant activity by measuring the relative abundance of each variant’s
barcoded cAMP-responsive genetic reporter transcripts with RNA-seq.
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Figure 6.6: Engineering HEK293T Cells for Clonal and Functional Integration of an ADRB2
Genetic Reporter. A. Schematic of functional assay to ensure the landing pad is present at single copy
in the genome and can recombine a single donor plasmid per cell. Single copy integration is essential to
ensure receptor’s of variable functionality do not activate barcoded reporters mapped to other variants. Upon
co-transfection of the promoterless GFP and mCherry plasmids with bxb1 recombinase sites, a cell line
with a single landing pad will exclusively integrate one cassette. Therefore, cells will be either GFP+ or
mCherry+ but never both. B. Flow Cytometry plots detailing the percentage of GFP+ and mCherry+ cells
when transfected with an equimolar ratio of promoterless GFP and mCherry expression cassettes with or
without Bxb1 recombinase expression. C. Activation of a cAMP-responsive genetic reporter via a luciferase
assay integrated in the landing pad when stimulated with isoproterenol in a WT or ∆ADRB2 background.
Activation of the reporter in the WT background emphasizes the importance for generation of the ∆ADRB2
for the purpose of multiplexed experiment. D. Activation of a genetic reporter with or without exogenous
ADRB2 expression via a luciferase assay integrated in the landing pad when stimulated with isoproterenol in
∆ADRB2 cells. E. Activation of an equivalent integrated genetic reporter/ADRB2 cassette via qRT-PCR of
the reporter transcript in ∆ADRB2 cells. F. Schematic detailing the recombination of the reporter/receptor
expression plasmid into the landing pad locus.
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Figure 6.7: Individual and Global Multiplexed Assay Validation. A. To validate our genetic reporter,
we compared the measured mutant activity screened individually in the landing pad locus via a luciferase assay
to via the multiplexed mutational scan. We recapitulated results individually observed in the DMS for both
null and hypomorphic mutations. B. The distribution of activity for frameshifts are significantly different
that the distribution of our designed missense mutations across increasing isoproterenol concentrations
(p << 0.001). C. We also find the relative activity for frameshift mutations mapped to each codon in the
ADRB2 sequence is markedly decreased in the C-terminus of the protein (dotted line), and is consistent across
agonist concentration. Blue line represents the LOESS fit. D. The measurements between barcodes at the
RNA-seq level are well correlated (r = 0.867, r = 0.871, r = 0.864, r = 0.868) at all agonist concentrations (0,
0.150, 0. 625, and 5 µM Iso). Similarly, the mean forskolin-normalized values for each variant are correlated
at every concentration (r = 0.657, r = 0.686, r = 0.729, r = 0.750). Bars represent log10 counts per hex-bin.
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Figure 6.8: Activity of Proline Mutations by Protein Domain. Proline substitutions in the trans-
membrane domain results in lower activity across all agonist conditions.
Figure 6.9: Correlation with Sequence Conservation and Covariation. A. Mutational tolerance
is highly correlated with sequence conservation and is maximized at EC100 (ρ = −0.689, ρ = −0.719, ρ =
−0.747, ρ = −0.634 for -Iso, 0.150 µM Iso, 0.625 µM Iso, and 5 µM Iso, respectively). Here we calculated
sequence conservation using the Jensen-Shannon divergence from a multiple alignment of 55 ADRB2 orthologs
from the OMA database. The blue line is the least squares fit. B. Similarly, our measure of relative activity
for individual substitutions is well correlated with the predictions from EVMutation, and is maximized at
EC100 (ρ = 0.370, ρ = 0.460, ρ = 0.521, ρ = 0.504). The blue line is the least squares fit.
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Figure 6.10: Cluster Assignment is Robust Across Different UMAP Embeddings. Given the high
dimensionality of our data, we used UMAP to learn lower-dimension representations of our data before
clustering with HDBSCAN (minimum cluster size = 10). To ensure that the clustering results are not biased
by a particular UMAP embedding, we ran a hyperparameter search over the dimension and nearest neighbor
parameters of UMAP. We then plot the HDBSCAN cluster assignments on a 2D UMAP embedding to ease
visualization. Points that HDBSCAN does not assign to a cluster are colored powder blue. We find that
groups of residues reliably cluster together regardless of the UMAP embedding, and manually assign all
residues to six distinct clusters following the robust HDBSCAN assignment.
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Figure 6.11: Mutational Profile Suggests Side Chain Orientation and Environment. A. The
crystal structure of the hydroxybenzyl isoproterenol-activated state of the β2AR (PDB: 4LDL) with residues
colored by UMAP cluster identity. B. Distributions of Solvent Accessible Surface Area (SASA) for each
cluster at EC100. C. Hydrophobic versus Charge Sensitivity across all drug conditions. Points are colored
by cluster identity. We define residues to be globally intolerant to substitution if their Hydrophobic and
Charge Sensitivity is greater than 0. Similarly, we define residues to be uniquely charge sensitive if their
Hydrophobic Sensitivity is less than 1 and their Charge Sensitivity is greater than 1. D. Distributions of
SASA for intolerant and charge sensitive clusters are significantly different across all drug concentrations (all
p < 0.0005).
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Figure 6.12: Inspection of Mutationally Intolerant Residues. A. Rank order plot of mutational
tolerance at 0.625 µM isoproterenol for all 412 β2AR residues mutagenized. Residues in known structural
motifs (colored points) are significantly more sensitive to mutation than other positions on the protein
(p << 0.001). B. Residues that interact with the head (orange) of hydroxybenzyl isoproterenol have
significantly lower mutational tolerance than those that interact with the hydroxybenzyl functional group
on the tail (purple). These differences are significantly different at EC50 (p = 0.028), EC100 (p = 0.016),
and saturating agonist concentration (p = 0.008). C. Box plot displaying the mutational tolerance of all
predicted contacts of the cholesterol binding pocket determined in the timolol-bound structure of the β2AR
inactive state (PDB: 3D4S). The highly conserved W1584.50 is the most constrained residue. D. ECL1, with
residues belonging to cluster 1 and 2 colored magenta, contains a region of sensitivity where R63 and L64 are
both intolerant to substitution. However, neighboring E62 displays greater than WT activity at multiple
individual mutations (PDB: 3SN6).
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Figure 6.13: Evaluation of Individual Missense Variants. A. The inactive state β2AR structure
highlighted in regions where residues display greater than WT activity without agonist stimulation for at
least one individual mutation (yellow). These mutations localize to the extracellular membrane interface
of TM1, TM2, and ECL1. B. Other concentrations of these mutants are found in the lower half of TM1,
helix 8, and the TM5-TM6 interface. The blue colored structure represents the shift in TM6 upon adoption
of the active state. C. 2-D snake plot with residues colored by the number of individual mutations that
lead to greater than WT activity in the no agonist condition. These residues are enriched in the loops and
termini which are truncated in the crystal structures. D. Activity of all ADRB2 mutants present in the
gnomAD database plotted against to their allele frequency. We classified variants into four categories as
follows: null mutants (purple) are variants whose mean plus a standard deviation (SD) are less than 1 (the
mean frameshift); activating mutants (orange) are variants whose mean minus a SD are greater than the
mean synonymous mutant (dashed line); hypomorphic mutants (periwinkle) are variants whose mean plus a
SD are less than the mean synonymous variant; the rest of the variants are considered WT-like (white).
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